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ABSTRACT 
FOXM1 transcription factor regulates the expression of a multitude of genes, 
which are important for cell proliferation, mitosis, and differentiation. 
Although it is abundantly expressed in majority of human solid tumours, its 
role in early stages of human neoplasia remains unclear. Oral squamous cell 
carcinoma (OSCC) is characterized by sequential genomic alterations, which 
lead to invasive malignancy. In this study, it is shown that FOXM1 is 
significantly upregulated in early oral pre-malignant and OSCC tissues and 
cultured keratinocytes. Furthermore, the current study suggests that FOXM1B 
is the main isoform driving the cell cycle dependent expression of FOXM1, 
and that it is expressed mainly at the G2 phase of human epithelial 
keratinocytes. In an attempt to understand why FOXM1 precedes epithelial 
malignancy, the present study investigated 1) the genomic profile of FOXM1B 
overexpressing human epithelial keratinocytes, and 2) whether FOXM1B 
overexpression interferes with the innate program of keratinocyte 
differentiation, which is frequently reported as being the earliest oncogenic 
event in epithelial neoplasia. First, by using a high-resolution Affymetrix 
single nucleotide polymorphism (SNP) mapping technique, this study provides 
the first evidence that FOXM1B overexpression alone in primay human 
keratinocytes was sufficient to induce genomic instability, mainly in the form 
of copy number alterations. FOXM1B overexpression also cooperated with 
damaging agents relevant to human epidermal (UVB) and oral epithelial 
cancer (Nicotine), to promote genomic instability in human keratinocytes. 
Second, by using a 3D-organotypic culture model of oral mucosa, sustained 
overexpression of FOXM1 was found to induce a hyper-proliferative 
phenotype with suprabasal proliferation, exhibiting perturbed markers of 
epithelial differentiation such as cytokeratin 13 and filaggrin, resembling early 
oral dysplastic epithelium. Based on these observations it is hypothesised that 
aberrant upregulation of FOXM1B serves as a ‘first hit’ whereby cells acquire 
genomic instability, and an abnormal differentiation program. The latter event 
promotes epithelial proliferation at the expense of terminal differentiation, 
allowing sufficient time for the accumulation of additional genetic 
aberrations/mutations required for tumour promotion and expansion. 
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1 General Introduction 
1.1 Oral Mucosa 
Human epithelia are tissues composed of cells lining the cavities and surfaces 
of the body. They are classified into different groups, according to their 
structure and the amount of layers of which they are composed. The oral 
mucosa is made up of squamous (flat and thin) epithelial cells which are 
arranged in multiple layers, and is therefore classified as a stratified squamous 
epithelium (SSE). The stratification of such complex epithelia is the result of 
cell proliferation and sequential differentiation.  The general consensus 
regarding SSE is that proliferation is the main property of cells located at the 
lowermost layers of the epithelium, and is gradually constricted as cells 
migrate upwards to the outermost epithelial layers. The differentiation of 
epithelial cells is initiated as soon as they start migrating to the upper layers of 
the SSE, to finally give rise to terminally differentiated squames that line the 
outer visible surfaces of the tissue.  
 
The human oral mucosa can be subdivided into three functionally and 
structurally different types: (a) lining mucosa, (b) masticatory mucosa and (c) 
specialised mucosa (anatomical distribution of the oral epithelium is shown in 
Figure 1.1). Lining mucosa can be found in the lips, cheeks (buccal), soft 
palate, and the floor of the mouth. The masticatory mucosa is the rigid and 
tough protective cover of the hard palate and the gingiva. The third type of 
oral mucosa, the specialised mucosa, is located on the dorsum of the tongue 
and consists of more specialised structures such as the taste receptors. The 
average surface area of the oral epithelium is ~214 cm2, of which lining 
mucosa seems to cover ~60%, while masticatory and specialised mucosal 
cover ~25% and ~15% respectively (Collins and Dawes, 1987; Squier and 
Kremer, 2001). 
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Figure 1.1: Anatomic locations of oral mucosal epithelium within the oral cavity 
The diagram shows the anatomic locations and the extent of the lining, masticatory, 
and specialised mucosa. Masticatory mucosa is shown in black, lining mucosa is 
shown in grey, and specialised mucosa is shown in dark grey shading (Squier, 1989). 
 
1.1.1 Epithelial differentiation 
Arguably, the human oral epithelium shares many similarities with the human 
epidermis, and as such, oral epithelial differentiation is generally described 
and understood through the extensively studied epidermal model of epithelial 
renewal. However, contrarily to the epidermis, the differentiation processes in 
oral epithelia can show considerable site- and type-related variability.   
 
Human stratified squamous epithelia generally contain four distinct cell layers. 
These include the basal layer (stratum basale; SB), spinal layer (stratum 
spinosum; SS), granular layer (stratum granulosum; SG), and the outermost 
cornified layer (stratum corneum; SC). There is however some site-related 
variability in the case of oral mucosa (see Table 1.1 and Figure 1.2). 
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Table 1.1: The differentiation pattern of human oral epithelia according to their 
anatomical site 
Type of Epithelium Differentiation 
Pattern 
Stratification 
Epidermis Cornified/(Ortho)-
Keratinised 
4-layered ; SB,SS,SG,SC 
Hard Palate Cornified/(Ortho)-
Keratinised 
4-layered ; SB,SS,SG,SC 
Buccal Mucosa Non Keratinised 3-layered; SB, SF,SD 
Gingival Epithelium (Para)-/(Ortho)-keratinised 4-layered; SB,SP,SG,SC 
Dorsal Tongue Mixed Cornified/Non-
cornified 
Papillae organisation 
Lateral and Ventral Tongue Non-keratinised Papillae organisation 
Floor of mouth Non keratinised 3-layered; SB,SF,SD 
SB=stratum basale, SS=stratum spinosum, SG=stratum granulosum, SC=stratum 
corneum, SF=stratum filamentosum, SD=stratum distendum (Gibbs and Ponec, 2000; 
Garant, 2003). 
 
Within stratified squamous epithelia, including the oral mucosa and the 
epidermis, the keratinocytes of the basal layer retain the ability for DNA 
synthesis and mitosis. Cessation of cell proliferation is followed by the 
initiation of terminal epithelial differentiation as soon as basal cells start to 
migrate upwards and through the suprabasal layers, to reach the outermost 
epithelial tissue surfaces. The spinal layer forms the first suprabasal layer of 
the differentiation compartment, while the granular layer contains cells that 
have entered the stage of terminal keratinocyte differentiation. Keratinocytes 
finally reach the stratum corneum in the form of terminally differentiated dead 
squames, which are sloughed from the epithelial surfaces and are continuously 
being replaced by inner keratinocytes that are differentiating outward (Fuchs, 
1993).  
 
In oral mucosa epithelia, the outermost layers may contain either fully 
keratinized (ortho-keratinized), partially keratinized (para-keratinized), or non-
keratinized squames, depending upon the type of oral mucosal epithelium. 
Although all epithelial cells mature to terminally differentiated squames, the 
differentiation path can vary between the types of oral mucosa (Table 1.1) The 
maturing cells of masticatory mucosa undergo a differentiation pattern known 
as para- (partial; palate and gingiva) or ortho- (full; hard palate and attached 
gingiva) keratinisation, whereas cells of the lining mucosa do not keratinise 
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(non-keratinised), while more specialised regions of the oral mucosa show 
mixed patterns (Dale et al., 1990). This process, so called epithelial turnover, 
commences with the mitotic division of basal keratinocytes and occurs 
continuously within the epithelial tissue.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Differences in epithelial organisation 
This figure depicts the clear morphological differences between human epidermis 
(A), buccal mucosa (B), and tissue of the hard palate (C). Note the absence of the 
cornified epithelial layers in buccal mucosa. SB: stratum basale, SS: stratum 
spinosum, SG: stratum granulosum, SC: stratum corneum, SF: stratum filamentosum, 
SD: stratum distendum. (modified from Gibbs & Ponec, 2000). 
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1.1.2 Stratum basale 
The cells that reside in the stratum basale (basal keratinocytes) have a cuboidal 
shape, with a high nuclear to cytoplasm ratio, and are positioned perpendicular 
to the basement membrane (see Figure 1.2). The basement membrane, which 
provides the support for basal keratinocytes, is a specialised extracellular 
network consisting of special collagen fibrils and the basal lamina, which is 
located just beneath all basal epithelial cells (Garant, 2003). Basal cells are 
anchored to the basal lamina by hemi-desmosomes, which are stable anchoring 
structures of the inner basal surface of keratinocytes and serve to attach the 
cell to the underlying basement membrane, by connecting the intermediate 
keratin filaments of keratinocytes with the extracellular matrix (ECM) 
(Burgeson and Christiano, 1997), as well as through focal adhesions which are 
formed by the clustering of integrins located at the basal surface of 
keratinocytes connecting the actin cytoskeleton with the ECM (De Strooper et 
al., 1989; Peltonen et al., 1989; Hynes, 1992; Jensen et al., 1999; van der Flier 
and Sonnenberg, 2001; Fuchs, 2008). Keratin filaments are the major 
component of epithelial keratinocytes and constitute as much as 85% of the 
cellular protein in cornified epidermal keratinocytes (Presland and Dale, 
2000). The cells of the basal, and those of the spinous layer, are attached to 
each other by means of cadherin (calcium dependent adhesion molecules)-
based adherens junctions, and of desmosomal glycoproteins (desmosomes) 
respectively (Fuchs, 1990; Fuchs, 1993; Garrod, 1993; Nievers et al., 1999; 
van der Flier and Sonnenberg, 2001; Blanpain and Fuchs, 2006; Blanpain et 
al., 2007; Fuchs, 2008). The former connect the actin filament cytoskeletons of 
adjacent cells by using different cadherin proteins, while the latter are 
membrane junctions that interconnect cells into three-dimensional lattices 
(Garrod, 1993), by connecting the keratin filament cytoskeletons of adjacent 
cells. A distinguishing attribute of basal keratinocytes is that their intracellular 
cytoskeleton is composed of two specialised keratin filaments, K5 and K14 
(Dale et al., 1990; Fuchs, 1993). In addition to the latter, the basal 
keratinocytes of lining oral epithelia, such as buccal mucosa, also show 
expression of K19 filaments (Dale et al., 1990).  
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This compartment is responsible for the total proliferative output of the 
epithelial tissue. Although the basal layer is regarded as being the only 
proliferative layer within squamous stratified epithelia, some proliferative 
activity can be seen in the first suprabasal layers of the epidermis (Penneys et 
al., 1970; Lavker and Sun, 1982; van Neste et al., 1983; Watt, 1998) , while in 
the oral epithelial as well as in other tissues of the lining mucosa, proliferative 
activity is mainly present in a few layers above the basal, so called the epi- or 
para- basal layers (Liu et al., 1998; Gibbs and Ponec, 2000; Seery and Watt, 
2000) (see Figure 1.2). This demonstrates that the transition from the 
proliferative basal, to the differentiation compartment is not abrupt, but instead 
gradual, at least in terms of the cells’ capability to divide. Early studies with 
tritiated (3H-TdR) thymidine administration (thymidine analogue that is 
incorporated in the DNA of cells during DNA synthesis) have demonstrated 
that basal keratinocytes are capable of DNA synthesis, and that the actual rate 
of epithelial tissue renewal is proportional to the rate of basal keratinocyte 
division (reviewed in Adams, 1976). In general, non-keratinising tissues have 
a higher turnover rate compared to keratinised tissues. For example, the time 
needed for a basal dividing keratinocyte of the hard palate (ortho-keratinized 
tissue) of the mouse to reach the final stages of maturation is 6-7 days, while 
the same process takes only 3.5-5.5 days for the buccal mucosa (non-
keratinized) (Hamilton and Blackwood, 1974). Similarly, the cornification of a 
basal epidermal keratinocyte is calculated to take approximately 10-14 days in 
mice, and 28-30 days in humans (Potten and Morris, 1988; Potten et al., 2002). 
However, this time may be rapidly reduced in the case of wound healing or 
pathologic hyperproliferative conditions. Based on these observations, it is 
estimated that basal keratinocyte mitotic divisions occur more frequently in 
non-keratinised epithelial tissues. 
 
According to the epidermal model of epithelial homeostasis, a steady rate of 
epithelial renewal is achieved by the ‘asymmetric’ division of distinct 
immature basal keratinocytes (stem cells). This results in the generation of one 
stem cell, and one lineage-committed cell (transit amplifying; TA), which is 
destined to migrate upwards and terminally differentiate, after quick but 
limited rounds of cell division (Watt, 1998). The keratinocytes in transit divide 
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one to five times while undergoing the initial phases of differentiation, during 
which time they start migrating upward to the epithelial surface (Watt, 1998) 
(Figure 1.3). 
Figure 1.3: The organisation of the epidermis  
Basal keratinocyte stem cells (pink) divide asymmetrically to give rise to one basal 
undifferentiated, and one differentiating transit amplifying daughter (green). The 
daughters of transit amplifying cells are committed to terminal differentiation and 
withdraw irreversibly from the cell cycle while moving upwards. Adapted from 
(Owens and Watt, 2003) 
 
1.1.3 Stratum spinosum 
The spinal layer (or prickle cell layer) consists of 4-8 layers and is the first 
layer of the differentiation compartment. The intracellular cytoskeleton of 
spinal keratinocytes of the oral ortho-keratinising epithelium is composed of 
K1, K10, and K6/16 filaments while the expression of K5 and K14 is 
gradually decreased as cell migrate further from the basal layer (Fuchs, 1993). 
The non-keratinising oral epithelial keratinocytes of the stratum filamentosum 
(the analogue of stratum spinosum in the non-keratinising oral tissues) have a 
unique keratin expression pattern as their intracellular cytoskeleton is 
composed of K4 and K13 (Dale et al., 1990; Presland and Dale, 2000). Spinal 
keratinocytes are strongly attached to each other by desmosomes, and although 
most keratinocytes within and above the spinal layer are normally post-
mitotic, they still retain their metabolic activity. Much of their metabolic 
activity is devoted to the production of glutamine and lysine-rich envelope 
proteins like involucrin, which provides a scaffold for the cross-linking of 
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other envelope proteins (Fuchs, 1990; Candi et al., 2005). The envelope 
proteins are vital for the formation of the cornified envelope, which is an 
insoluble protein structure that is assembled by transglutaminases (TGs). The 
latter are calcium dependent enzymes which mediate the formation of a 
covalently linked network of proteins, to finally replace the plasma membrane 
of terminally differentiated keratinocytes, and to also act as a scaffold for lipid 
attachment (Steven and Steinert, 1994; Candi et al., 2005).  
 
1.1.4 Stratum granulosum 
This layer is named after the keratohyalin (keratin precursor) granules (KHGs) 
that are contained therein. As spinous keratinocytes reach the granular layer, 
they start synthesizing pro-filaggrin, a cationic precursor protein which is a 
major constituent of KHGs (Dale et al., 1990). Pro-filaggrin is converted to 
filaggrin during the transition of granular cells to cornified keratinocytes, 
which aggregates the keratin filaments into tight bundles, thereby promoting 
the collapse of keratinocytes into a flattened shape, which is a strong 
characteristic of surface corneocytes (Candi et al., 2005). In non-keratinising 
lining epithelia, filaggrin is almost undetectable in the stratum distendum (the 
analogue of stratum granulosum for the non keratinising epithelia), and hence 
KHGs are not normally present (Smith and Dale, 1986). Additionally, the 
keratin filaments of keratinocytes in the stratum distendum are composed of 
K4 and K13, which contrarily to keratinizing epithelia, are not bundled. 
Additional structural proteins of the cornified envelope including loricrin and 
involucrin are further produced by granular cells and are later cross-linked by 
several transglutaminases.  
 
1.1.5 Stratum corneum 
The outermost layer of cornified SSE, including the epidermis and the ortho-
keratinized oral epithelia, consists of dead squames which are eventually shed 
of its surface. The organelles of such cells undergo autolysis through 
activation of distinct proteases (Candi et al., 2005), while intercellular contacts 
are lost, probably through a serine protease-mediated process (Sondell et al., 
1994; Garant, 2003).  Corneocytes are now composed entirely of keratin 
filaments which remain attached to the plasma membrane through the 
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previously assembled cornified envelope. Cells are tightly attached to each 
other by means of corneo-desmosomes (modified desmosomal structures), 
which are proteolytically degraded at the uppermost layers of the cornified 
layer to allow desquamation (shedding of corneocytes) (Candi et al., 2005). 
The outermost layer of lining oral mucosa (stratum distendum) contains non-
cornified keratinocytes which retain their nuclei and intracellular organelles 
while in the stratum corneum of para-keratinized tissues, as are some parts of 
the gingiva, the corneocytes show incomplete/partial disintegration of the 
nucleus and cytoplasmic organelles. It is noteworthy that unlike rigid cornified 
epithelia, lining mucosa shows remarkable flexibility. This could be possibly 
attributed to the lack of filaggrin expression in granular keratinocytes, the shift 
of keratin expression pattern to K4 and K13 as previously mentioned, as well 
as the greater amount of elastin expression in the submucosal connective tissue 
(Garant, 2003). Although many of the cell envelope’s components (loricrin, 
involucrin) are equally found in para- , ortho-, and non-keratinized oral 
epithelia, the resulting cell envelope of the latter is significantly thinner.
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1.2 Epithelial Stem Cells 
The formation and maintenance of epithelial tissues is owned to cells with 
distinct properties. Epithelial stem cells are suggested to be responsible for 
epithelial tissue renewal during normal homeostasis as well as during wound 
healing. A stem cell is defined as any cell being able to reproduce itself 
throughout the life-span of the host, while being able to give rise to 
differentiated cells (Lajtha, 1979; Slack, 2000). Consequently, a stem cell 
population should, by definition, be primarily undifferentiated. Although this 
holds true, adult tissue stem cells are thought to have a certain degree of 
commitment themselves, such that they can only form the differentiated cells of 
the tissue in which they reside (Slack, 2000).  
 
1.2.1 Heterogeneity of the Basal Layer 
As far as epithelial tissues are concerned, the stem cells of the epidermis are 
among the best studied. Epidermal stem cells are thought to reside in the basal 
layer, the hair follicle bulge, and the base of the sebaceous glands (Fuchs, 
2008). The undifferentiated population of stem cells of the oral mucosa appear 
to be located within the basal layer of the epithelium. However, the exact 
location and organisation of epithelial stem cells within the basal layer is not yet 
clearly defined, mainly due to the lack of highly specific stem cell markers. 
According to the classical Epidermal Proliferative Unit model (EPU) introduced 
by Potten et al. (Potten, 1974), stem cells of the epidermis are arranged into 10-
cell units, each of which contains a central self-renewing stem cell surrounded 
by transit amplifying cells, which consequently commit to terminal 
differentiation and migrate upwards to form cornified dead squames 
(Mackenzie, 1970; Potten, 1974; Mackenzie, 1997; Watt, 2002). A transit 
amplifying cell will further divide one to five times, thereby amplifying the 
effect of a single stem cell division. This amplifying effect significantly lowers 
the requirement for stem cell divisions within the epithelium. This has been 
suggested as a mechanism which allows infrequent divisions of stem cells, 
while at the same time leads to the production of sufficient numbers of 
terminally differentiated keratinocytes (Lajtha, 1979; Jones and Watt, 1993; 
Lavker and Sun, 2000; Potten and Booth, 2002). According to more recent 
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studies based on clone tracing in mouse basal epidermis however, it is suggested 
that only one type of progenitor is able to maintain mammalian epidermis 
through a combination of symmetric and asymmetric divisions that occur at 
rates that accustom the requirements of epithelial homeostasis, rather than 
through the more organised system predicted by the classical stem/TA model 
(Clayton et al., 2007; Jones et al., 2007). 
 
It is expected that putative stem cells of the basal layer would exhibit longer cell 
cycle times, which would inevitably lead to a lower frequency of cell divisions. 
In continuously regenerating tissues such as the hemopoietic system and the 
intestinal epithelium, there appears to be a small number of stem cells which 
typically have a slow cell cycle, due to a prolonged G0 phase, and are the cells 
of origin for the rest of the proliferating cells (Lajtha, 1979; Bickenbach, 1981). 
In mouse epidermis, it is estimated that a stem cell will divide approximately 
every 8 days, which is twice the time needed for a transit amplifying cell to 
complete its cell cycle (Potten, 1974; Potten et al., 1982; Clausen et al., 1986; 
Loeffler et al., 1987; Potten and Morris, 1988; Kirkhus and Clausen, 1990; 
Potten and Booth, 2002). This heterogeneity within the basal layer was studied 
extensively by the use of tritiated thymidine (3H-TdR), which if administered 
for prolonged periods of time, can effectively label most, if not all, basal 
epithelial cells. As 3H-TdR is halved every time a cell divides, it was postulated 
that the slow cycling cells of the epidermis shall retain the thymidine label for 
longer times (Bickenbach, 1981; Potten and Morris, 1988; Clausen and Potten, 
1990). These cells, so called label retaining cells, or LRCs, were found to reside 
towards the centre of columns in the epidermis at a very low frequency (1-4%), 
supporting the existence of the EPU (Potten, 1974; Bickenbach, 1981; Potten 
and Morris, 1988; Mackenzie, 1997; Potten and Booth, 2002), as well as in the 
hair follicle bulge, another suggested site for epidermal stem cells (Cotsarelis et 
al., 1990; Morris and Potten, 1994; Morris and Potten, 1999). Administration of 
3H-TdR in mice, also showed the presence of LRCs in the basal epithelial layers 
of oral mucosa, which accounted for ~0.02% - 0.1% in the palate, ~0% - 0.1% 
for the tongue epithelium, and ~0.06% - 0.1% for buccal epithelium 
(Bickenbach, 1981). Although studies on the presence of LRCs in human 
epithelia are lacking due to the inability of performing in vivo labelling 
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protocols, earlier studies on human embryonic and foetal epidermis grown in 
vitro, revealed the presence of 2% and 4% LRCs in the foetal and embryonic 
tissues respectively (Bickenbach and Holbrook, 1987). A more recent study 
aiming to identify LRCs in organotypic reconstructs of human epidermis 
(Muffler et al., 2008), showed that LRCs do appear at the basal layer at a 
frequency of <1%, which an estimation that is similar to what has been 
previously observed in mouse epidermis (Bickenbach, 1981; Schneider et al., 
2003).  
 
Apart from the heterogeneity in cell cycle times, the proliferative compartment 
of the epidermis was suggested to show significant functional heterogeneity as 
well, which is mainly shown through models of induced hyperplasia and 
epidermal destruction. TPA (12-0-tetradecanoyl phorbol-13-acetate or PMA) is 
a known tumour promoter, which exerts its effects by modulating the balance 
between proliferation and differentiation (Boutwell, 1974; Yuspa et al., 1976; 
Scribner and Suss, 1978). While the majority of epithelial cells respond to TPA 
with cell cycle arrest and terminal differentiation, LRCs are stimulated to 
proliferate while retaining their undifferentiated phenotype (Bickenbach, 1981; 
Morris et al., 1986; Cotsarelis et al., 1990). Further evidence for a functional 
heterogeneity in the basal epidermal populations came from the fact that only a 
10% of the basal population is able to form new epidermis after irradiation of 
mouse skin, despite the fact that 60% of basal cells show proliferative activity 
(Withers, 1967; Potten and Hendry, 1973; Potten and Morris, 1988).  
 
1.2.2 Evidence from Epithelial Keratinocyte Culture 
Many studies have clearly provided a functional link between in vivo and in 
vitro observations regarding the heterogeneity of the basal epidermal 
population. When cultured in vitro, human keratinocytes show the presence of 
discrete populations that can be discriminated based on the speed with which 
they go through the cell cycle (Dover and Potten, 1983). Cultured keratinocytes 
with a high RNA content (i.e. larger volume) cycle faster than their smaller (i.e. 
lower RNA content) counterparts, which raised the possibility that the latter 
may represent a non-cycling quiescent basal population with stem cell 
properties (Eisinger et al., 1979; Barrandon and Green, 1985; Staiano-Coico et 
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al., 1986). A third, non-dividing, population comprised of large cells, was also 
described in human keratinocyte cultures and is thought to represent terminally 
differentiated keratinocytes (Barrandon and Green, 1985; Staiano-Coico et al., 
1986). Resembling the in vivo observations, both human and mouse epidermal 
keratinocytes also show significant diversity in their responses to TPA 
treatment, since only a subpopulation is resistant to terminal differentiation 
upon treatment (Yuspa et al., 1980; Yuspa et al., 1982; Parkinson et al., 1983). 
This was estimated to be ~10% of human keratinocyte cultures, and due to its 
close approximation to the estimated percentage of basal cells that are able to 
re-constitute mouse epidermis, and the fact that they were refractory to 
induction of terminal differentiation, it was posited that the TPA-resistant 
population in culture could represent the in vivo basal stem cell population 
(Parkinson et al., 1983; Parkinson et al., 1987; Potten and Morris, 1988; Clausen 
and Potten, 1990).  
 
The optimal culture of human keratinocytes in vitro requires the presence of 
various growth factors, many of which are supplied from lethally irradiated 
fibroblasts that are used as a feeder layer (Rheinwald, 1980). Under these 
conditions, human keratinocytes show clonal growth in culture, and early 
studies demonstrated the significant heterogeneity in terms of the colony 
forming ability of human keratinocytes. When grown at low density, epidermal 
keratinocytes can form large and actively growing colonies (holoclones), 
smaller irregular colonies composed of flat keratinocytes (paraclones), as well 
as colonies with intermediated features (meroclones) (Barrandon and Green, 
1987; Jones and Watt, 1993). Following serial cultivation and grafting onto 
nude mice, it was suggested that holoclone derived cells were likely to represent 
the self-renewing clonogenic stem cells which are able to give rise to transit 
amplifying keratinocytes, while the remaining populations contained all the 
properties of transit amplifying and terminally differentiated keratinocytes 
(Barrandon and Green, 1987; Jones and Watt, 1993). A strong functional link 
between the in vivo and the in vitro observations was provided when LRCs 
derived from mouse epidermis were found to be clonogenic in vitro, and 
showed enhanced proliferative potential when compared to mature pulse-
labelled keratinocytes (Morris and Potten, 1994). Further work showed that 
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LRCs of mouse epidermis are small, slow growing cells that are able to rapidly 
attach to extracellular matrix proteins such as those present in the basal 
membrane of the epidermis (Bickenbach and Chism, 1998; Li et al., 1998).  
 
Although there is mounting evidence to support the heterogeneity of human 
keratinocyte cultures, two of the distinguishing attributes of stem cells, that is 
slow rate of cell cycle and extensive replicative potential, become less 
noticeable once they are expanded in vitro, and is also directly related to the 
donor age (Barrandon and Green, 1987). Although stem cells are expected to 
transiently maintain those features relative to their more mature counterparts, all 
cultured keratinocytes will inevitably undergo the differentiation path, a fact 
that makes the in vitro manipulation of keratinocyte stem cells a very difficult 
task. 
 
1.2.3 Epithelial Stem Cell Markers 
The molecular analysis and gene expression profiles of epithelial stem cells is 
cumbersome, due to the lack of reliable molecular stem cell markers that can 
readily distinguish stem cells from the larger pool of basal keratinocytes within 
the epithelium either in vivo, or in vitro.  
 
Early studies in human epidermal keratinocytes showed that the population of 
cells that expresses the highest levels of β1 integrins (cell surface molecules 
mediating intercellular adhesion and attachment of basal cells to the basement 
membrane) show enhanced clonogenic capacity, and increased ability to attach 
rapidly to extracellular matrix proteins collagen type IV and fibronectin (Jones 
and Watt, 1993). Contrarily, cells with low levels of β1 integrins form abortive 
colonies, suggestive of transit amplifying and terminally differentiated 
keratinocytes (Jones and Watt, 1993).  
 
The heterogeneity in the levels of expression of β1 integrins is also reflected in 
vivo. There are patches of highly expressing basal keratinocytes interspersed 
with patches of basal cells with lower levels of β1 integrins (Jones and Watt, 
1993; Moles and Watt, 1997). The distribution of β1 integrins is different 
between various anatomical sites, with β1 integrin bright patches being present 
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at the tips of connective tissue papillae in foreskin and scalp epidermis, whereas 
in the palm epidermis, β1 integrins are more strongly expressed at the bottom of 
deep rete ridges (Jones et al., 1995). More importantly, the cells located in β1 
integrin rich sites also show reduced frequency of S-phase activity, consistent 
with the concept that stem cells divide infrequently under normal homeostatic 
conditions (Potten and Morris, 1988; Cotsarelis et al., 1990; Jones et al., 1995). 
 
Functional studies with mouse epidermal keratinocytes demonstrated that cells 
with high levels of integrin α6, but low levels of the proliferation associated 
surface molecule, transferrin receptor CD71, were enriched for quiescent cells 
with a high clonogenic and proliferative capacity in vitro (Li et al. 1998). 
Furthermore, this fraction of cells was highly enriched for LRCs which further 
strengthens the correlation between a slow cycling status and a strong 
proliferative potential (Li et al. 1998), both of which are suggested to be stem 
cell attributes. Interestingly, the putative epidermal stem cell marker, α6 
integrin, was also shown to be heavily expressed in discrete regions at the tips 
of connective tissue papillae of normal oral buccal mucosa, while no functional 
evidence are shown to support that this molecular marker is relevant to the 
epithelial stem cells of the oral mucosa (Kose et al., 2007).  
 
The relationship between quiescence and ‘stemness’ was further demonstrated 
by single-cell gene expression profiling of human keratinocytes, which provided 
evidence that the quiescent state of human keratinocyte stem cells is partly 
achieved by LRIG1 (leucine-rich repeats and immunoglobulin-like domains 1) 
which down-modulates the proliferative effects of c-MYC (Jensen and Watt, 
2006). Consistent with its role in stem cell maintenance, LRIG1 was found to be 
primarily expressed in groups of basal cells at the top of rete ridges of human 
epidermis, while its expression is mutually exclusive with those of EGFR1 and 
Ki67, which is in keeping with the general consensus that epidermal stem cells 
are a slowly dividing population of basal keratinocytes (Jensen and Watt, 2006). 
 
In the setting of the oral mucosa, there are considerably less reports as to the 
identification and isolation of epithelial stem cells. Recent reports suggested that 
the low affinity neurotrophin nerve growth factor receptor (p75NTR) 
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characterises populations of immature basal keratinocyte stem cells of the oral, 
as well as of the closely related, oesophageal epithelia (Okumura et al., 2003; 
Nakamura et al., 2007). Similar to what has been observed in the case of β1 
integrins in human epidermis, the localisation of p75NTR+ keratinocytes is 
different between the various anatomical sites of the oral mucosa. Basal cells 
expressing p75NTR were found primarily at the tips of connective tissue 
papillae in the buccal mucosa, while in oral gingival epithelium its expression 
was seen both at the tips and the bottom of rete ridges (Nakamura et al., 2007). 
The functional studies of oesophageal and oral p75NTR+ keratinocytes in vitro 
suggested that these cells have a strong proliferative potential, are highly 
clonogenic and are able to support the artificial reconstruction of human oral 
mucosa in vitro (Okumura et al., 2003; Nakamura et al., 2007). Others have 
reported that successful isolation of human oral keratinocyte stem cells can be 
achieved by discriminating cells according to their size, with the smallest cells 
being the ones with the highest proliferative potential which were also able to 
successfully form a stratified ex-vivo oral mucosa equivalent (EVPOME) 
(Izumi et al., 2007). However, epithelial stem cell isolation based purely on cell 
size seems like an oversimplification if one considers that organotypic tissue 
reconstruction is not a definite proof of a stem cell identity, since stem and 
transit amplifying epidermal keratinocytes can equally support the re-
epithelisation of organotypic tissues in vitro (Li et al., 2004a).  
 
Within the oesophageal epithelium, which shares many similarities with the oral 
epithelium and especially the lining type (Squier and Kremer, 2001), stem cells 
have been suggested to lay in the basal layer, at the bottom of rete ridges 
(interpapillary zone; IBL), rather than at the tips of connective tissue papillae 
(PBL). The IBL contains cells which, by large, divide in an asymmetric fashion, 
giving rise to one basal and one suprabasal, differentiating daughter (Seery and 
Watt, 2000). The cells of the PBL as well as those of the epibasal (or parabasal; 
one to two layers above the basal) layers divide in high frequency and they do 
so symmetrically, and thus are thought to represent the transit amplifying 
compartment of the oesophageal epithelium (Seery and Watt, 2000). In stark 
contrast to human epidermis however, the cells of the IBL are generally 
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characterised by low levels of integrin β1, while being highly clonogenic in 
vitro.  
 
1.2.4 Stem Cells: Hosts for Initiating Mutations 
The two-stage carcinogenesis models in mice have provided evidence favouring 
the view that epithelial stem cells are the targets of initiating mutations. The 
period between exposure to known carcinogens and the development of tumours 
is regarded to be in the order of several months in mice, and even longer in 
humans (decades). Owing to their prolonged existence within the epithelial 
tissue, stem cells have been long proposed to be good candidates for hosting 
these initiating mutations (Potten and Morris, 1988).  
 
The initiation events typically involve changes in genes that control cell 
proliferation. For example, 7,12 di-mehtylbenz[a]anthracene or DMBA induces 
an A to T transversion in codon 61 of c-Ha-ras, a common skin tumour initiator 
(Fujiki et al., 1989; DiGiovanni, 1992). Tumour promotion involves processes 
that allow the clonal expansion and sustained epithelial proliferation of initiated 
cells, leading to chronic hyperplasia and visible papillomas, which subsequently 
progress to form malignant tumours (DiGiovanni, 1992). This progression 
assumes that multiple genetic alterations are acquired along the way, to allow 
uncontrolled proliferation and malignant transformation (two to three events are 
estimated to be required for transformation of mouse cells, and five in human 
cells (Hahn et al., 1999; Hahn and Weinberg, 2002). In two stage carcinogenesis 
models, DMBA-initiated mouse skin can develop tumours whether promotion is 
begun one week or one year after initiation (Potten and Morris, 1988). This 
suggests that the initiated cells need to remain long enough in the epithelial 
tissue, firstly to be able to respond to tumour promotion after this latent period, 
and second to be able to accumulate all the genetic alterations needed for cancer 
initiation. Evidence have indeed shown that double labelling of epidermal cells 
with 3H-TdR and 14-labelled benzo[a]pyrene (BP) carcinogen can detect the 
same slow cycling population of basal keratinocytes, suggesting that LRCs can 
retain carcinogens for long periods of time (Morris et al., 1986; Potten and 
Morris, 1988).Considering that LRCs display many of the attributes of putative 
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stem cells, it is postulated that epithelial stem cells preferentially retain 
initiating carcinogens, and presumably cancer initiating mutations. 
 
One way to define whether the cells responsible for epithelial regeneration, and 
those responsible for the formation of tumour, are both slow cycling, is to 
efficiently eliminate all actively cycling cells. Selective killing of all rapidly 
dividing cells, but not quiescent cells, with DNA synthesis blocking agents, 
such as fluorouracil 5-fluoro-dUMP (5-FU) leads to extensive skin damage 
characterised by extensive reduction in the numbers of basal cells. However, 
complete hair follicle and epithelial regeneration can be seen after 30 days and 6 
weeks respectively, suggesting the presence of a quiescent stem cell population 
responsible for replenishing the skin epithelium (Morris et al., 1997). More 
importantly, treatment of mouse epidermis with 5-FU before, or after, tumour 
initiation, alters neither the rate of papilloma nor carcinoma formation (Morris 
et al., 1997). These observations strongly suggest that the quiescent cells that 
were able to completely regenerate the epidermis of 5-FU treated mice 
(epidermal stem cells), are also responsible for the formation of epidermal 
tumours following tumour promotion (Morris, 2000). 
 
This paradigm is also illustrated in the case of UVB-induced TP53 mutations in 
human epidermis. Although single TP53 mutated cells can be found in the 
transit amplifying and differentiating compartments, clusters of TP53 mutant 
cells are typically found in stem cell rich regions (Jonason et al., 1996; Owens 
and Watt, 2003). This suggested that stem cells have the capacity for clonal 
expansion that is necessary for the propagation of such insults, and can become 
increasingly pre-disposed to further genetic hits, which emphasizes that the 
response to an oncogenic insult will depend on the cell that sustains it. For 
example, targeted activation of Ras in proliferating cells of the hair follicle can 
lead to the development of malignant carcinomas in mice (Brown et al., 1998; 
Owens and Watt, 2003), as opposed to the development of regression prone 
benign papillomas when the same oncogene is driven by differentiation specific 
promoters (Bailleul et al., 1990; Greenhalgh et al., 1993; Brown et al., 1998). 
From these observations it is reasonable to assume that an oncogenic insult will 
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be successful if it is placed in an epithelial cell which has the ability of 
prolonged survival, and extensive proliferative output, and therefore a stem cell. 
 
The understanding of stem cell fate in epithelial tissues is of vital importance in 
cancer biology, as mutational events in the differentiated cells will have little 
impact in tissue homeostasis since they will be rapidly lost as part of the tissue 
renewal process. Therefore, it is important to define the attributes of epithelial 
stem cells, in order to understand the molecular pathways that mediate their 
responses to various oncogenic stresses. 
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1.3 Oral Cancer 
The epidemiology of oral cavity cancer, pharyngeal and laryngeal cancers are 
similar, so that they are often discussed in unity as head and neck squamous cell 
carcinomas (HNSCCs). HNSCC is the 6th most commonly diagnosed cancer 
with a global yearly incidence of 780,000 new cases (Parkin et al., 2005). 
Squamous cell carcinomas of the oral cavity, including larynx, hypopharynx (or 
laryngopharynx), oropharynx, and nasopharynx represent some of the most 
common malignancies encountered, with a high mortality rate (Ho et al., 2007). 
Patients in early stages of oral cancer show minimal symptoms, which 
significantly delays diagnosis and inevitably leads to poor survival rates 
(Califano et al., 1996). Although the use of surgery followed by adjuvant 
chemotherapy and radiotherapy has improved the 5-year survival rates of naso- , 
-oro, and hypopharynx carcinomas, there has been no improvement in the 
survival rates of HNSCCs involving the oral cavity (Carvalho et al., 2005). 
Some of the major risk factors include tobacco use and alcohol consumption in 
developed countries as well as betel quid chewing and bidi smoking in South 
Central and South East Asia (Parkin et al., 2005; Sturgis and Wei, 2007), while 
infection with human papillomavirus (HPV) has also been implicated in 
HNSCC development. (Munger and Howley, 2002; Perez-Ordonez et al., 2006). 
 
1.3.1 Oral Pre-malignancy 
A pre-cancerous oral lesion is generally defined as a morphologically altered 
tissue, which has a probability of malignant conversion that is higher than that 
of the surrounding normal tissue (Muller, 2007). The earliest detectable 
morphologic changes in the oral mucosa are the appearance of pre-malignant 
lesions, the most commonly described of which are leukoplakia and 
erythroplakia.  
1.3.1.1 Leukoplakia 
Oral leukoplakia is, according to the World Health Organisation (WHO), a 
clinical white patch that cannot be rubbed or scraped off, and cannot have any 
other diagnostic identity (Pindborg et al., 1997). The major risk factor for the 
appearance of leukoplakia is the use of tobacco since its clinical appearance is 
invariably associated with a tobacco smoking history (Mashberg et al., 1973), 
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and more importantly most leukoplakias regress, either temporarily or 
permanently, following smoking cessation (Muller, 2007). Leukoplakias can be 
generally divided into homogeneous and non-homogeneous, with the latter 
being rarer ~10% of leukoplakias (Pindborg et al., 1997), but with a higher risk 
of malignant conversion (Muller, 2007). A characteristic of oral leukoplakias is 
that they are hyperplastic exhibiting epithelial cell expansion with normal 
stratification and no cellular atypia (Warnakulasuriya et al., 2008) and present 
abnormal keratinisation patterns described as hyper-para-keratinisation or 
hyper-ortho-keratinisation. The former represents the incomplete keratinisation 
of corneocytes, while the latter is characterised by the abnormal expansion of 
the cornified orthokeratotic layers of the epithelium. Due to the incomplete 
keratinisation seen in hyper-para-keratotic leukoplakias, hyperplasia and 
acanthosis (expansion of spinal keratinocytes; see also section 1.1.3 and Figure 
1.5) can also be present, and it is generally regarded that this type of leukoplakia 
displays a higher mitotic index (Renstrup, 1963).  A small minority of oral 
leukoplakias can also exhibit degrees of epithelial dysplasia, (more commonly 
seen in the non-homogeneous type) a condition which is defined as a 
precancerous lesion of stratified squamous epithelium displaying cellular atypia 
and loss of normal maturation and stratification (see also Table 1.2 for the 
descriptive features of severe dysplasia, and Figures 1.4, 1.5B, C, D for 
morphologic appearance of dysplastic tissues) (Pindborg et al., 1997; 
Warnakulasuriya et al., 2008). The range of malignant transformation rates for 
oral leukoplakia vary greatly (0.4% -17.5%) (multi-source analysis from 
(Muller, 2007) and are subject to the length of follow-up, tobacco usage, and 
their anatomic location (Muller, 2007).  
1.3.1.2 Erythroplakia 
Erythroplakia, the red analogue of leukoplakia, is defined as being a red patch in 
the mouth that is not diagnosable clinically as any other disease (Pindborg et al., 
1997). Erythroplasia is less commonly seen, but commonly displays features of 
epithelial dysplasia or even microscopic features of carcinoma in situ (CIS), and 
is thus regarded as having a high potential of invasive progression (Mashberg et 
al., 1973). It is estimated that more than 50% of erythroplakias will progress to 
form squamous cell carcinomas over the period of 10 years (Mashberg, 1977). 
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Table 1.2: Features of dysplastic epithelium  
(Warnakulasuriya et al., 2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The fact that erythroplakias are relatively rare, adds further limitations to early 
diagnosis, and although it is difficult to accurately predict which HNSCCs are 
preceded by oral dysplasias, a considerable amount of SCCs are surrounded by 
dysplastic areas (Bouquot et al., 1988; Hogewind et al., 1989; Hunter et al., 
2005). However, the subjective nature of dysplasia assessment and doubtfulness 
over the relative importance of the discerning histological features 
(Warnakulasuriya et al., 2008), are limiting factors in providing an accurate 
prognosis (Hunter et al., 2005). 
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Figure 1.4: Pre-malignant lesions of the oral mucosa 
(A) An area of leukoplakia on the floor of the mouth and verntral tongue. (B) An area 
of erythroplakia on the right tonsillar pillar. (C) Normal oral mucosa epithelium and 
(D) shows a moderately dysplastic epithelium within an area of leukoplakia on the floor 
of the mouth. Adapted from (Hunter et al., 2005). 
 
1.3.2  Squamous Cell Carcinoma 
Squamous cell carcinomas (SCCs) are invasive malignant epithelial tumours 
that show squamous cell differentiation. Although SCCs can originate from pre-
existing dysplastic lesions, this is not always the case as many dysplasias do not 
progress to invasive malignancy (Sugerman and Savage, 1999), and it is 
estimated that 36-48% of oral cavity SCCs are surrounded by, or are adjacent to, 
dysplastic epithelium (Bouquot et al., 1988; Hogewind et al., 1989). The 
progression from a pre-malignant tissue to a CIS is a step of malignant 
transformation without the clinical appearance of stromal invasion (Figure 
1.5E), albeit the distinctive histopathological features of malignant conversion 
require further consideration (Warnakulasuriya et al., 2008). The conversion of 
CIS to invasive cancer is generally defined by the break-down/degradation of 
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the protective basement membrane of the epithelium (Figure 1.5) (Kramer et 
al., 2005), which  allows tumour cells to invade downwards in the connective 
tissue as tumour islands or individual cells (see Figure 1.5 Fi, ii). The 
neoplastic cells can invade further into deeper structures such as the adipose 
tissue, muscle, or bone, while less aggressive forms of SCC can also be seen, 
which are only locally destructive showing minimal invasion into the sub-
epithelial tissues, also known as superficially invasive SCCs (Torske, 2007). 
The degree to which a SCC resembles the normal epithelium is referred to as 
grade (Grades 1-3). A low-grade (Grade 1), well differentiated tumour will 
mostly mimic the normal epithelium in that it has well defined basal, spinal and 
keratinised epithelial cells while most of the typical characteristics of tumour 
cells (high mitotic index, enlarged nuclei, cellular atypia, and necrosis) are at a 
very low frequency (Torske, 2007). On the other hand, poorly differentiated 
SCCs (Grade 3) display little resemblance to normal epithelium showing a very 
low, if any, degree of epithelial differentiation, while moderately differentiated 
tumours display intermediate features (Pindborg et al., 1997). Although 
prognosis is more favourable for cases of well and  moderately differentiated 
oral SCCs, the subjective nature of histological grading of tumours itself can be 
problematic (Torske, 2007), and underscores the need for more accurate 
prognostic tools. 
 
1.3.3 The Genetic ‘Progression’ of HNSCC 
The fact that HNSCC progresses through a series of defined histopathological 
changes has fuelled attempts to correlate these changes to a model of genetic 
progression for HNSCC which, if true, would be expected to reveal genetic 
targets that are key to the progression of pre-malignant lesions and ultimately, 
malignant conversion to HNSCC. The accumulation of such events is thought to 
be driven by an underlying genomic instability (either chromosomal or 
microsatellite instability), which refers to the high rate of genomic alterations 
that take place over time (Negrini et al.), and is a widespread feature of all 
human malignancies (Lengauer et al., 1998).  
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Figure 1.5: The histopathological progression of OSCC 
(A) The hyperplastic epithelium shows (i) keratosis and abnormal expansion of the 
stratum spinosum and an increased maturation compartment, but without any changes 
in tissue architecture while (ii) shows expansion of the basal cell compartment (basal 
cell hyperplasia) again with no change in architecture. (B) Architectural changes can be 
noted in the lower third of the mildly dysplastic epithelium (i, ii) with the presence of 
some cellular atypia. (C) Tissue architectural changes now extend up to the middle 
third of the epithelium (i, ii) and cellular atypia is moderate. (D) Architectural changes 
are extending to the top third of the epithelium (i, ii) while cellular atypia is marked. 
(E) Architectural changes are widespread in the full thickness of the epithelium with 
marked cellular atypia. Cells are still contained within the epithelial basal membrane 
structure. (F) Irregular interface between the basal epithelium and the underlying 
connective tissue with some detaching tumour cells indicating early invasion (i). (ii) 
Epithelial tumour islands are separated from surface epithelium indicating early 
invasive behaviour of the oral carcinoma. Modified from (Warnakulasuriya et al., 
2008) 
 
Initial studies have shown that loss of heterozygosity (LOH)  and allelic 
imbalances on chromosomes 9p and 3p were the most common alterations seen 
in benign oral hyperplasias and dysplasias (Califano et al., 1996; Roz et al., 
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1996; Califano et al., 2000; Rosin et al., 2000) and have been characterized as 
the earliest detectable events in HNSCC progression. A more detailed analysis 
of the genetic material of microdissected pre-malignant and oral SCCs, showed 
that the loss of exon 1α (encodes p16INK4a) of the CDKN2A locus was lost at 
a frequency of 12% in oral pre-malignant lesions, while loss of either exon 1α 
or 2 was seen in the vast majority of oral SCCs (72%) (Shahnavaz et al., 2001). 
The CDKN2A locus on 9p21 encodes p16INK4A and p14ARF, which are 
important mediators of G1 cell cycle regulation, while chromosome region 3p21 
contains FHIT and RSSF1A candidate tumour suppressor genes (Hogg et al., 
2002; Dong et al., 2003; Perez-Ordonez et al., 2006). In support of its important 
role in the generation and maintenance of oral SCCs, it was demonstrated that 
p16INK4A inactivation is directly associated with the immortal phenotype of 
neoplastic oral keratinocytes in vitro (Munro et al., 1999). The importance of 
the above findings is further highlighted by the fact that in patients presenting 
with oral pre-malignant lesions (leukoplakias), 51% of them showed LOH in 
either 9p21 or 3p14 loci (Mao et al., 1996). More importantly, 37% of the 
lesions with LOH progressed to form SCCs, while only 6% of oral lesions 
without LOH occurrences progressed to form oral SCCs (Mao et al., 1996). 
  
Epidermal growth factor receptor (EGFR) amplification has also been identified 
as an early event in HNSCC, largely as a result of trisomy in chromosome 7 
which is present in oral dysplastic epithelium (Grandis and Tweardy, 1993; 
Ford and Grandis, 2003), a fraction of which progresses to HNSCC. Other 
common genetic alterations that occur in HNSCC involve tumour suppressor 
inactivation through p53 mutations (Somers et al., 1992)(LOH on chromosome 
17p13). Mutations in p53 are also observed early in pre-invasive dysplastic 
epithelium (19% in non-invasive and 43% in invasive carcinomas; (Boyle et al., 
1993), and the prevalence of these mutations is proportional to the stage of the 
disease (Shahnavaz et al., 2000). The amplification of cyclin D1 which is seen 
in 35-55% of HNSCCs (Meredith et al., 1995; Rousseau et al., 2001), clearly 
illustrates the progressive dependence of tumour cells on proliferative signals as 
CCND1 overexpression is detected in normal adjacent epithelium and continues 
throughout hyperplasia and early dysplasia (Izzo et al., 1998). Its 
overexpression is later followed by CCND1 whole gene amplification, which 
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becomes detectable in mildly dysplastic tissues and also in carcinoma in situ 
and invasive carcinomas (Izzo et al., 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Model for the genetic progression of HNSCC carcinogenesis 
(modified from Califano et al., 1996 and Perez-Ordonez et al., 2006). 
 
The recapitulation of these in vivo findings was attempted in vitro, aiming to 
understand the effects of these molecular and genetic alterations in the creation 
of oral SCCs. Human oral epithelial keratinocytes could be immortalised by the 
combinatorial actions of only two of the aforementioned genetic alterations, that 
is CCND1 overexpression and inactivation of p53 (Opitz et al., 2001). However, 
the conversion of human oral keratinocytes to a fully malignant phenotype 
required the overexpression of EGFR, CCND1 and c-MYC (also amplified in 
HNSCC (Haughey et al., 1992), as well as tumour suppressor inactivation 
achieved by the introduction of a dominant negative form of p53 (Goessel et al., 
2005). Although an exact model of genetic progression in respect to the specific 
genes involved cannot be accurately predicted for all OSCCs, either from in 
vivo or in vitro studies, it is strongly suggested that genomic instability is 
proportional to the severity of pre-malignant features and to the probability of 
conversion from pre-malignancy to oral SCC. Microsatellite analysis in oral 
premalignant lesions revealed that allelic imbalances are commonly seen (59%) 
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in pre-malignant lesions, albeit more often in those displaying features of 
epithelial dysplasia (77% dysplastic vs. 33% hyperplastic), while allelic losses 
were present in all pre-malignant lesions that progressed to form SCCs later on 
(Rosin et al., 2000). The fact that most, if not all, progressing lesions showed 
LOH on 9p and/or 3p (Rosin et al., 2000) further supports the notion that SCCs 
arise from a clonal outgrowth of genetically unstable populations that 
accumulate further genomic aberrations necessary for cancer initiation. 
 
1.3.4 Field Cancerisation and Clonal Origin of HNSCC 
It is now well accepted that the manifestation of a human tumour requires 
sequential genomic alterations (Vogelstein and Kinzler, 1998). Like most 
epithelial malignancies, HNSCC is thought to arise from a common 
premalignant progenitor, followed by the outgrowth of clonal populations, 
which are usually subjected to cumulative genetic alterations that lead to 
invasive malignancy (Perez-Ordonez et al., 2006).  
 
Almost half a decade ago, Slaughter et al. (Slaughter et al., 1953) put forward 
the idea of field cancerisation when he observed that in all resected tumours, the 
benign epithelium that was surrounding them, was also abnormal. In the 
instances of small tumours, there were always adjacent abnormal foci, which 
were even suggested to ‘merge’ later on and culminate into the clinical 
appearance of recurrent HNSCCs (Slaughter et al., 1953). The multiple origins 
of oral SCCs can also partially explain 1) the incidence of multiple individual 
tumours in distinct anatomical locations of the same individual and 2) the high 
rate of local recurrence seen in the case of SCCs  of the oral cavity (Slaughter et 
al., 1953), which is a significant clinical complication that occurs at a rate of 10-
30% even with histopathologically tumour-free surgical margins after resection 
(Charles et al., 1994). The term of field cancerisation has been further adopted 
to describe epithelial neoplasms of the lung (Franklin et al., 1997), oesophagus 
(Prevo et al., 1999), vulva (Rosenthal et al., 2002), cervix (Chu et al., 1999), 
colon (Jothy et al., 1996), breast (Forsti et al., 2001), bladder (Takahashi et al., 
1998), and skin (Stern et al., 2002).  
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A recent study has shown that in 36% of HNSCC cases, there are several 
tumour-associated genetic alterations found in macroscopically normal mucosa 
adjacent to the tumour (Tabor et al., 2001), supporting the earlier idea of field 
cancerisation. Since in 70% of cases these genetic alterations were present 
beyond the surgical margins (Tabor et al., 2001), at least some pre-neoplastic 
cells are spared after resection, and may be responsible for the recurrence of 
HNSCC tumours after a latent period. The fact that the ‘cancerised’ surrounding 
field lacks some of the alterations seen in the developing tumour (Tabor et al., 
2001), further supported the idea that while oral SCCs are clonal in origin, their 
histopathological progression occurs parallel to the acquisition of  further 
genetic alterations. 
 
The theory of field cancerisation classically suggests that secondary tumours 
occur independently of one another due to the cancerisation of a field by 
sustained exposure to known carcinogens (Chung et al., 1993; van Oijen et al., 
2000; Tabor et al., 2001). Based on the theory that tumours are clonal in origin, 
the multiple foci seen in HNSCC were also thought to arise from the separation 
of the tumour initiating clone into sub-clones, which have the ability to migrate 
within the local environment and get established into adjacent or remote sites 
with the oral cavity (Tabor et al., 2001; Tabor et al., 2002). Although the 
emerging sub-clones would be able to acquire further genetic alterations, 
independently of the originating clone, all should theoretically share the same 
early genetic hits that transformed them in the first place. The surrounding 
altered fields as well as secondary primary tumours (SPTs) have been examined 
in detail with various cytogenetic approaches, but evidence is still inconclusive 
as to whether multifocal or secondary HNSCCs share the same origin with 
primary tumours. By studying the patterns of allelic loss for 9p arm as an early 
marker in tumour progression, Bedi et al. 1996 found that 37% of HNSCC 
tumour pairs shared the same genetic alterations, while the remaining tumour 
pairs showed a different pattern of 9p loss, suggestive of different clonal origins 
(Bedi et al., 1996). Other studies have concluded that a only a small minority of 
secondary, or synchronous, oral carcinomas show evidence of a common clonal 
origin (Scholes et al., 1998; Califano et al., 1999). By comparing the allelotypes 
of numerous pre-malignant lesions and invasive carcinomas, a more recent 
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study suggested that while multiple pre-malignant lesions may arise 
independently, the probability of the mucosal spread of neoplastic cells is 
increased with malignant progression (Jang et al., 2001), possibly explaining the 
emergence of at least some clonally related secondary tumours found in other 
studies.  
 
However, tumour cells are under a constant selection pressure, and their 
survival and progression depends on the rate by which they can beneficially 
alter their genetic material (Cahill et al., 1999). If one considers that multifocal 
or second primary HNSCCs could have the same origin, then their 
heterogeneity in terms of the pattern of allelic losses, as was observed from 
cytogenetic analyses, can also be an indication of the intra-tumoural genetic 
heterogeneity that is a hallmark of many, if not most, types of human 
malignancies (Mirchandani et al., 1995; Fujii et al., 1996; Heim et al., 1997; 
Gorunova et al., 1998; Macintosh et al., 1998; Pandis et al., 1998). It is known 
that most malignant tumours show considerable genetic heterogeneity, and as 
such, collective analysis of tumour samples can mask the presence of a certain 
genotype if the population that bears it is not the dominant one. The failure to 
detect common patterns of allelic loss and chromosome breaks is not therefore 
definitive evidence of the absence of such clones in the total pool of neoplastic 
cells.  As both chromosomal instability, which results from multiple mitotic 
defects,  and microsatellite instability, are consistently seen in human tumour 
evolution (Weaver and Cleveland, 2006; Storchova and Kuffer, 2008), it is 
possible that the clones of SPTs and anatomically remote malignant foci of the 
oral cavity, are indeed related and their genomic alterations can be explained by 
the genetic drift of a single pre-malignant progenitor. 
 
While the jury is still out, it is becoming clear from all these studies that the 
complexity of human oral carcinogenesis is owned to multiple events that take 
place in earlier as well as in later stages of the disease. Even at the level of gene 
expression, large scale microarray analysis shows that most transcriptional 
alterations in HNSCC occur during the transition of normal oral mucosa to pre-
malignant epithelium, rather than from a pre-malignant lesion to invasive 
carcinoma (Ha et al., 2003). Thus, there is a broad range of early molecular and 
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genetic events, the identification of which could provide significant prognostic 
and diagnostic benefit to HNSCC.  
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1.4 FOXM1 Transcription Factor 
 
1.4.1 Forkhead Box Proteins 
Forkhead box (FOX) proteins are a family of transcription factors that share a 
common DNA binding domain (DBD), termed the forkhead box or winged 
helix domain (WHD), are a highly conserved family of transcriptional 
regulators, with at least 43 genes being identified in humans, presenting a 
large functional diversity (reviewed in Myat & Lam, 2007). They regulate cell 
growth, proliferation, apoptosis, differentiation, longevity, and transformation 
and exhibit a diverse range of functions during embryonic development and 
adult tissue homeostasis (Katoh and Katoh, 2004). According to the Human 
Gene Nomenclature Committee (HGNC) (Wain et al., 2002), human gene 
symbols (including DNA, mRNA and protein) should be in upper case, 
therefore “FOXM1” is used throughout this thesis to indicate its human origin 
and “Foxm1” for mouse and rat. 
 
1.4.2 Foxm1 Knock-Out Mouse Models 
Foxm1 is also known in the literature as Trident (mouse), HFH11 (human), 
WIN or INS-1 (rat), MPP2 (human cDNA), or FKHL-16 (Laoukili et al., 
2007). Foxm1 knock out mouse models have provided evidence for the 
important role of this protein, in organogenesis, tissue proliferation, and 
differentiation. Homozygous Foxm1 knock-out (Foxm1-/-) leads to peri-natal 
lethality and/or to post-term death just after birth, due to heart defects in mice 
(Korver et al., 1998). Further analysis revealed ploidy abnormalities in both 
liver and the hearts of Foxm1-/- mice, with markedly increased DNA content 
present in both tissues (polyploidy) (Korver et al., 1998), while targeted 
deletion of Foxm1 DBD and transactivation domains (TAD)  in transgenic 
mice results in the same phenotype (Krupczak-Hollis et al., 2004). 
Additionally, hepatoblasts of Foxm1-/- mice show defective proliferation and 
incomplete differentiation of the biliary epithelial cell lineages of the liver 
(Krupczak-Hollis et al., 2004). Foxm1-/- mice also exhibit gross lung 
pulmonary defects, including hypertrophic arterioral smooth muscle cells, and 
defective peripheral pulmonary arteries (Kim et al., 2005), while Foxm1-/- 
lungs are significantly affected by reduced levels of Platelet endothelial 
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adhesion molecule-1 (Pecam-1), VEGF receptor type 1 (Flt1), and FoxF1 
(Kim et al., 2005). More recently, it was also shown that targeted pancreatic 
inactivation of Foxm1 in mice resulted in the steady reduction of β-cell 
proliferation and mass with age (Zhang et al., 2006). Collectively, Foxm1 
knock-out mouse model established multiple roles of Foxm1 ranging from 
mitosis, embryonic tissue development to ageing. 
 
1.4.3 Human FOXM1 Gene 
The human FOXM1 gene is located at the 12p13.3 chromosome band and is 
comprised of 10 exons, two of which (exons A1 and A2) are alternatively 
spliced (Korver et al., 1997b). The first exon and part of the last exon contain 
3’ and 5’ untranslated sequences, respectively. The three FOXM1 isoforms, 
FOXM1A, FOXM1B, and FOXM1C, are created by alternative splicing of A1 
and A2 exons, with FOXM1B being the only one isoform containing none of 
these exons (Ye et al., 1997) (Figure 1.7).  
 
Although all three protein isoforms of FOXM1 can bind to DNA in vitro 
through the consensus site TAAACA (Korver et al., 1997b), only FOXM1B 
and FOXM1C have trans-activating ability (Korver et al., 1997a; Ye et al., 
1997; Luscher-Firzlaff et al., 1999; Leung et al., 2001; Major et al., 2004; 
Wierstra and Alves, 2006c). FOXM1A is shown to be transcriptionally 
inactive due to the presence of the inhibitory A2 exon in the C-terminal of its 
transactivation domain (Ye et al., 1997), and is suggested to act as a regulator 
of FOXM1 gene activity by competing with FOXM1B and FOXM1C for 
DNA binding and gene transactivation (Laoukili et al., 2007).  
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Figure 1.7: Human FOXM1 gene  
FOXM1 gene is located at chromosome 12p3.3 and encodes 10 exons. The first exon 
and part of the last exon contain 3’ and 5’ untranslated sequences, respectively. Exons 
A1 and A2 area alternatively spliced to give rise to three distinct isoforms. FOXM1A 
contains both exons. Exon A2 is located at the C-terminal of its transactivation 
domain (TAD) and abolishes its transactivation potential (Ye et al., 1997). FOXM1C 
possesses only A1 exon, while FOXM1B has none of the alternatively spliced exons. 
All three isoforms contain the conserved DNA binding domain and the N-terminal 
inhibitory domain that restricts the activation potential of FOXM1 (modified from 
Laoukili et al., 2007) 
 
1.4.4 The Biological Function of FOXM1 
FOXM1 is widely accepted as being a proliferation specific transcription 
factor, as it is mainly expressed in dividing cells, while its expression is almost 
absent in quiescent and terminally differentiated cells (Laoukili et al., 2007). 
Its expression is detected in tissues with a high proliferative index such as the 
thymus, testis, lung and the intestine (Korver et al., 1997b), as well as in 
various immortalized and cancer-derived cell lines (Korver et al., 1997a; Ye et 
al., 1997; Wonsey and Follettie, 2005; Kalin et al., 2006; Kim et al., 2006; Liu 
et al., 2006). In line with the fact that FOXM1 expression is strictly associated 
to cellular proliferation, it was shown that serum stimulation can activate its 
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expression (Korver et al., 1997b), possibly through activation by c-MYC 
which occupies its promoter in vivo (Fernandez et al., 2003).  
 
FOXM1B was shown to have strong proliferative effects when over-expressed 
in the livers on transgenic mice, following partial hepatectomy (a strong 
mitotic inducer), since its overexpression could markedly increase the rate of 
hepatocyte DNA replication and subsequent mitosis (Ye et al., 1999; Wang et 
al., 2002b). More strikingly, overexpression of FOXM1B was sufficient to 
restore the regenerative potential and young phenotype in the livers of aged 
mice by inducing the expression of many G1/S as well as G2/M specific, 
growth promoting, genes including Cyclin D1, Cyclin F, Cyclin B1 and B2, 
Cyclin A2, and Cdc25B (Wang et al., 2001). This proliferative effect was also 
attributed to the fact that FOXM1B overexpression could significantly 
suppress the protein levels of p21cip1/waf-1 and p27Kip1 (Wang et al., 2002a; 
Wang et al., 2002b), which are able to halt the cell cycle at G1 phase by 
blocking the formation cyclin/Cdk complexes, which are required for S and 
M-phase progression by phosphorylating protein substrates, essential for 
mitosis (Pines, 1995; Harbour and Dean, 2000; Ishida et al., 2001). On the 
contrary, hepatic deletion of endogenous Foxm1 in mice is associated with 
reduced proliferation rate and the upregulation of cdk inhibitor p21waf1/cip1 
(Wang et al., 2002a), thus highlighting its instrumental role in cell cycle 
regulation. 
 
In addition to its proposed role in regulating the early phases of cell cycle 
progression, FOXM1 was also found to be implicated in the regulation of 
G2/M phase of the cell cycle. Accurate, but controlled activation of FOXM1 
protein is required to ensure successful execution of the mitotic programme 
and the maintenance of chromosome stability (Laoukili et al., 2005). In line 
with this, Foxm1-/- mouse embryonic fibroblasts (MEFs) and endogenous 
FOXM1 knock-down in U2OS cells (human osteosarcoma cell line), display 
gross chromosomal abnormalities characterized by spindle assembly defects, 
chromosome missegregation, and polyploidization (Laoukili et al., 2005), 
which is consistent with the phenotypes observed in knock-out mouse studies 
(see section 1.4.2). In a separate study, it was found that depletion of FOXM1 
Chapter 1: General Introduction                                                   FOXM1 Transcription Factor 
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 50
by RNAi in human breast cancer cell lines was also sufficient to inhibit cell 
proliferation and cause cell death due to mitotic catastrophe (Wonsey and 
Follettie, 2005). The biological function of FOXM1 can also be illustrated in 
the case of Foxm1-/- mouse derived embryonic fibroblasts (MEFs) and 
FOXM1-depleted human U2OS cells, which show DNA breaks parallel to 
persistent cell cycle arrest and activation of p53 and p21cip1/waf1 proteins (Tan 
et al., 2007). Further to that, FOXM1 deficiency is also accompanied by 
reduced expression of DNA repair genes (Tan et al., 2007), while FOXM1 
overexpression leads to stimulation of their expression both in vitro and in 
vivo (Ye et al., 1999; Tan et al., 2007). It is therefore becoming increasingly 
clear that the functions of FOXM1 extend to a broad range of biological 
processes. 
 
1.4.5 FOXM1 in the Regulation of the Cell Cycle 
1.4.5.1 The multi-step activation of FOXM1 throughout the cell cycle 
Studies from transgenic mouse models provided evidence that FOXM1 has a 
strong regulatory role in cell cycle progression. In addition, its cell cycle 
specific pattern of expression (Korver et al., 1997a) suggests that FOXM1 is 
itself regulated by cell cycle events. 
 
In line with this notion, FOXM1 protein was reported to contain a cyclin/cdk 
binding sequence (LXL motif) which serves for its phosphorylation and 
activation by Cdk2/CyclinE complex during G1/S, and by Cdk2/CyclinB 
complex during G2/M (Major et al., 2004). In addition to the latter, further 
work has demonstrated that FOXM1 is phosphorylated, and subsequently 
activated, also by CyclinD1/Cdk and CyclinA/Cdk complexes during G1 and 
S phases respectively (Wierstra and Alves, 2006b; Laoukili et al., 2008b), 
therefore proposing a multi-step model of FOXM1 activation throughout the 
cell cycle. The finding that FOXM1 can suppress the protein levels of 
important Cdk inhibitors, p21CIP1/WAF1 and p27KIP1 (Wang et al., 2002a; Wang 
et al., 2002b; Wang et al., 2005), further proposed a mechanism by which 
FOXM1 augments its own activation throughout cell cycle progression. The 
phosphorylation of FOXM1 protein is necessary for the transactivation 
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potential of FOXM1 transcription factor. First, because it allows the 
recruitment of p300/CBP co-activator proteins which increase the 
transactivation potential of FOXM1 transcription factor (Major et al., 2004), 
and second because it ablates the repressive function of FOXM1 N-terminus, 
therefore allowing full activation and FOXM1 dependent transcription  
(Wierstra and Alves, 2006a; Wierstra and Alves, 2006b; Laoukili et al., 
2008b).  
 
The clusters of genes that are activated as a result of FOXM1 transactivation 
depend on the phase of the cell cycle that this event takes place. The 
transcriptional network of genes induced by FOXM1 during G1/S transition 
includes Skp2 and Cks1, both of which are subunits of the SCF ubiquitin 
ligase complex that targets p27KIP1 and p21CIP1/WAF-1 for degradation (Wang et 
al., 2005). The growth promoting effect of FOXM1 was further highlighted by 
the finding that it can directly bind to, and activate the transcription of c-MYC, 
an early response transcription factor that stimulates cell cycle progression 
(Amati et al., 1998). However, most of FOXM1 target genes are induced upon 
entry into mitosis, where FOXM1 is though to have an instrumental role. 
FOXM1 transcriptional targets comprise a variety of important G2/M 
regulatory proteins, including Plk1, Aurora B kinase, cyclin B1, cyclin B2, 
Cdc25B, Nek2, CENP-A, CENP-B, and CENP-F (Leung et al., 2001; Laoukili 
et al., 2005; Wang et al., 2005) (see also Figure 1.8). All these proteins are 
directly associated to important mitotic processes including the activation of 
CyclinB/cdk complexes during mitotic entry, chromosome segregation, the 
assembly of the mitotic spindle checkpoint, and centrosome maturation and 
separation during cell division (Nigg, 2001; Meraldi et al., 2004). In fact, the 
phenotype of FOXM1 depleted cells clearly reflects the defective regulation of 
these genes, since in the absence of FOXM1 protein there is chromosome 
misalignment, defective chromosome segregation, defective localization of the 
spindle assembly checkpoint (SAC) proteins on the kinetochore which leads to 
disruption of the SAC, all of which lead either to cell death, or to the 
generation of genetically unstable progenies (Laoukili et al., 2005; Wonsey 
and Follettie, 2005).  
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Whether FOXM1 activation and subsequent transactivation of downstream 
targets occurs as early as in G1 phase, or later, and whether this is regulated by 
nuclear-cytoplasmic shuttling of the protein, remains unclear. For example, in 
the presence of Raf/MeK/MAPK signalling, FOXM1 was shown to translocate 
from the cytoplasm to the nucleus at S/G2 boundary, where it activates the 
expression of its downstream target genes, including Cyclin B1 (Leung et al., 
2001; Ma et al., 2005). Others have also proposed that phosphorylation and 
activation of FOXM1 occurs mainly from late S phase onwards, with its 
activity being highest at the G2 and mitosis (Leung et al., 2001; Laoukili et al., 
2005; Ma et al., 2005; Laoukili et al., 2008b). In support of this, most of the 
established downstream targets of FOXM1 are induced mainly at the G2/M 
phase of the cell cycle (Leung et al., 2001; Laoukili et al., 2005; Laoukili et 
al., 2008b). Despite these apparent discrepancies it is clear that, in addition to 
its cell cycle dependent expression at the mRNA level (Korver et al., 1997a), 
FOXM1 is subjected to numerous post-translational modifications that 
determine the level of its activation, and therefore that of its target genes, 
throughout a normal cell cycle. 
1.4.5.2 Repression of FOXM1 activity 
The repression of growth promoting transcription factors is important for the 
maintenance of a normal cell cycle, and as such, FOXM1 is held in check by 
various mechanisms that limit its transactivation ability. The first 
demonstration that FOXM1 is indeed a target of tumour suppressor proteins 
came from the finding that p19ARF tumour suppressor, a member of the INK4 
family of Cdk inhibitor proteins, can associate with FOXM1 protein in vivo in 
transgenic  mice while it was later found that p19ARF derived peptides can 
inhibit the transcriptional activity of FOXM1 in U2OS human osteosarcoma 
cells (Kalinichenko et al., 2004; Gusarova et al., 2007). It was further 
demonstrated that the activation of FOXM1 is restricted at G1 phase through 
its association with retinoblastoma tumour suppressor (Rb) which specifically 
binds to, and represses the TAD of FOXM1 protein (Major et al., 2004; 
Wierstra and Alves, 2006d). Rb normally constrains cellular proliferation by 
blocking the transactivation ability of growth promoting transcription factors, 
such as E2F1 (Harbour and Dean, 2000), and presumably the same applies for 
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FOXM1 since abrogation of Rb by high risk HPV type E7 oncoprotein results 
in activation of FOXM1 protein (Major et al., 2004). This can also account for 
the low levels of FOXM1 transcriptional activity in quiescent cells.   
 
A very potent inhibitory mechanism of FOXM1 activity is that of auto-
repression, which is imposed by the N-terminal of FOXM1 protein (Wierstra 
and Alves, 2006a; Park et al., 2007; Laoukili et al., 2008b). It is suggested that 
the N-terminal domain of FOXM1 is able to interact with its C-terminal 
activation domain, therefore limiting the overall transactivation potential of 
FOXM1 protein. Further analysis in U2OS cells provided evidence showing 
that FOXM1 protein is capable of binding to the its target genes’ promoters as 
early as in G1 phase, but is unable to activate gene expression due to 
repression by the N-terminal domain (Laoukili et al., 2008b). Following entry 
into G2 phase, CyclinA/cdk complexes are required for efficient 
phosphorylation of FOXM1 which both relieves N-terminal repression, as well 
as it increases the transactivation potential of the TAD (Laoukili et al., 2008b). 
In support of these findings, deletion of the N-terminus can give rise to a 
truncated FOXM1 mutant protein that is insensitive to growth stimulation, and 
is constitutively active throughout the cell cycle without the requirement for 
Cyclin/cdk mediated phosphorylation (Park et al., 2007; Laoukili et al., 
2008b). Cells that express ΔN-FOXM1 show greatly enhanced transactivation 
potential in luciferase reporter systems, as well as significantly enhanced 
activation of downstream target genes, irrespectively of cell cycle status (Park 
et al., 2007; Laoukili et al., 2008b).  
 
The hyperphosphorylated forms of FOXM1 protein present throughout 
mitosis, are then rapidly extinguished from the cell during mitotic exit, serving 
as a mechanism to prevent the existence of active FOXM1 in G1 phase 
(Laoukili et al., 2008a; Park et al., 2008). This is achieved by the ubiquitin 
ligase complex APC (anaphase promoting complex)/Cdh1 (activating 
regulatory protein) (Laoukili et al., 2008a; Park et al., 2008), which recognizes 
target mitotic proteins for degradation (Sudo et al., 2001; Li and Zhang, 2009). 
In fact, some of its substrates include mitotic cyclins, Aurora A and Aurora B 
kinases, and Plk1, the degradation of which is necessary for the maintenance 
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of genomic integrity following exit from mitosis (Sudo et al., 2001; Engelbert 
et al., 2008; Li and Zhang, 2009). In a similar manner, FOXM1 protein is 
targeted for degradation at anaphase, and until  the early stages of G1 phase 
(Laoukili et al., 2008a; Park et al., 2008) by APC/cdh1, which recognizes 
FOXM1 target sequences at the protein’s N-terminal (Laoukili et al., 2008a; 
Park et al., 2008).Although there is currently no evidence to suggest that an N-
terminal deleted variant of FOXM1 exists physiologically, these studies 
provide invaluable insight into the mechanisms that control FOXM1 activity 
throughout cell cycle progression.  
 
Despite the fact that FOXM1 can induce the expression of a multitude of 
genes with roles that range from the stimulation of DNA synthesis to proper 
chromosome segregation, the mechanisms that repress its activity ensure the 
timely transcriptional activation of its targets, and the maintenance of a stable 
cell cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: General Introduction                                                   FOXM1 Transcription Factor 
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 55
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: FOXM1 in cell cycle regulation.  
(A) Phosphorylation of FOXM1 by Raf/MEK/MAPK and CyclinE/Cdk2 complexes 
leads to the nuclear accumulation of FOXM1. (B) Phosphorylation and subsequent 
inactivation of Rb by Cyclin D1 allows full activation of FOXM1, which initiates 
transactivation of downstream targets by binding to DNA. During G1/S phase 
progression, FOXM1 promotes the degradation of p21CIP1/WAF-1 and p27KIP1 while it 
activates Cdc25A. (C) At G2 phase FOXM1 is further activated by phosphorylation 
of CyclinA/Cdk and CyclinB/cdk complexes, and induces the expression of Cdc25B, 
cyclin B1 and cyclin A2, while it directly upregulates important mitotic spindle 
assembly proteins like CENP-F, Aurora B and Plk-1 that ensure normal chromosome 
segregation and genomic stability. (D) During late mitosis (anaphase), FOXM1 is 
sequestered to the cytoplasm where it gets inactivated by binding to Rb and followed 
by APC/Cdh1 mediated protein degradation. 
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1.4.6 The Role of FOXM1 in Carcinogenesis 
FOXM1 gene was found to encode a protein identified by MPM-2 monoclonal 
antibody, which binds specifically to epitopes on mitotic proteins that are 
phosphorylated during the cell cycle (Westendorf et al., 1994). Initial 
observations led to the identification of MPM2 as an interaction partner of 
high risk human papillomavirus type 16 (HPV-16) E7 protein, a common 
cause of human malignancies, which could enhance the transformation 
potential of rat embryo fibroblasts (Luscher-Firzlaff et al., 1999). The first 
study to directly implicate FOXM1 in human cancer was performed by Teh et 
al. (2002) demonstrating that FOXM1B is the main isoform abundantly 
expressed in human basal cell carcinomas and further identified this gene as a 
downstream target of oncogenic transcription factor GLI1 (Teh et al., 2002).  
 
Given the multiple roles of FOXM1 during cell division, it is not surprising 
that this transcription factor has since been listed amid the most common 
differentially expressed genes in majority of solid human tumours including 
prostate, skin, liver, breast, lung, ovary, colon, pancreas, stomach, bladder and 
kidney (van den Boom et al., 2003; Pilarsky et al., 2004). The chromosomal 
band where human FOXM1 gene is located (12p13) is also found to be 
amplified in breast adenocarcinomas (Spirin et al., 1996), nasopharyngeal 
carcinomas (Rodriguez et al., 2005) and HNSCC derived cell lines (Singh et 
al., 2001). This suggests that FOXM1 gain of function provides a selective 
advantage for the clonal expansion of tumourigenic progenies, therefore 
promoting tumour development.  
1.4.6.1 Evidence from in vivo Models of Carcinogenesis 
The oncogenic ability of FOXM1 was further confirmed in carcinogenesis 
models in vivo, clearly demonstrating that not only this transcription factor has 
a strong tumourigenic potential, but in some cases is essential for the 
progression of tumours in transgenic mice.  
 
Sustained expression of human FOXM1 increases the proliferation rates of 
chemically induced (via the DNA damaging diethyl-nitrosamine; DEN; liver 
carcinogen) premalignant hepatocellular lesions, and its overexpression can 
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increase the size of the resultant liver tumours following promotion with 
phenobarbital (PB), without however altering the frequency by which they 
occur (Kalinina et al., 2003) . This apparent paradox was partially attributed to 
the fact that while FOXM1 could induce the expression of proliferation 
associated genes thereby promoting neoplastic cell proliferation, it could also 
concomitantly induce the expression of DNA repair associated genes which 
could potentially have anti-tumour activity (Ye et al., 1999; Kalinina et al., 
2003). Due to this, and given that FOXM1B failed to show any proliferative 
effects on normal hepatocytes, treatment with FOXM1 was therefore 
suggested as a safe alternative to potential liver regeneration therapy (Kalinina 
et al., 2003). It was later found that endogenous levels of Foxm1 are essential 
for the growth and maintenance of hepatic tumours in transgenic mice 
following DEN/(PB), since (a) Foxm1-/- were almost completely protected 
from hepatocellular carcinogenesis (Kalinichenko et al., 2004), and (b) 
conditional knockout of Foxm1 in pre-existing liver carcinomas could 
significantly reduce tumour size and proliferation (Gusarova et al., 2007). 
More importantly, the study by Gusarova et al. (2007) underscored the 
importance of FOXM1 in liver tumourigenesis by demonstrating that 
overexpression of FOXM1 in a p19ARF null background induces rapidly 
growing hepatocellular carcinomas, compared to those of wild-type mice 
(Gusarova et al., 2007). The restoration of  p19ARF  by treatment with p19ARF 
derived peptides inhibited tumour cell proliferation and angiogenesis, and 
induced apoptosis of hepatocellular carcinomas in mice by  reducing Foxm1 
transcriptional activity as evidenced by downregulation of downstream Foxm1 
targets such as Survivin, Aurora B, and Polo-like kinase 1 (Plk1) (Gusarova et 
al., 2007).   
 
Targeted deletion of Foxm1 in the colonic epithelium of transgenic mice is 
also protective from chemically induced carcinogesis, whereas human 
FOXM1 transgenic overexpression results in increased numbers and size of 
colorectal carcinomas following tumour induction (Yoshida et al., 2007). 
These tumours also bared a typical FOXM1-dependent expression signature as 
evidenced d by the up-regulation of Cyclin A2, CyclinB1, and Survivin 
(Leung et al., 2001; Wang et al., 2005; Yoshida et al., 2007). Consistent with 
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previous observations (Kalinina et al., 2003), FOXM1 transgenic 
overexpression does not induce any phenotypic alterations in normal colonic 
mucosa (Yoshida et al., 2007), therefore suggesting again a role for this 
transcription factor in the selective expansion of pre-neoplastic and/or 
tumourigenic progenies. Transgenic expression of FOXM1 in mouse models 
of prostate cancer, can also significantly accelerate the development, 
proliferation, and subsequent growth of prostate tumours, while it was also 
observed that p19ARF tumour suppressor is continuously expressed in FOXM1-
derived prostate carcinomas (Kalin et al., 2006), confirming the earlier 
prediction that sustained overexpression of FOXM1 is required to overcome 
the tumour suppressive effects of p19ARF (Kalinichenko et al., 2004; Kalin et 
al., 2006).  
 
In a similar manner, conditional deletion of Foxm1 in lung mouse cells, prior 
to lung tumour induction with urethane, resulted in significant reduction in 
both the number and size of lung adenomas of transgenic mice (Kim et al., 
2006). Further analysis suggested that the developing tumours of Foxm1-/- 
mice were able to grow due to inefficient suppression of Foxm1 gene 
expression as judged by the fact that 84% of the lung adenomas that developed 
in Foxm1-/- mice, showed reactivation of the oncogene (Kim et al., 2006). The 
latest study to have looked into the role of FOXM1 in a mouse model of lung 
epithelial carcinogenesis, demonstrated that specific targeted deletion of 
endogenous Foxm1 from respiratory epithelial cells resulted in diminution of 
chemically induced lung tumour numbers and tumour cell proliferation (Wang 
et al., 2009). Interestingly, deletion of Foxm1 prior to, or after tumour 
initiation (single with urethane, or two-stage with MCA initiation /BHT 
promotion) resulted in similar suppression in lung tumour growth. This 
suggests that the presence of Foxm1 during the initiation step is not critical. It 
is therefore suggested that Foxm1 is mostly required during the steps of 
tumour progression and expansion (Wang et al., 2009). As was expected, 
transgenic overexpression of FOXM1 in the lungs of mice also leads to 
significant increases in the numbers, size, and proliferation rates of lung 
adenomas induced by MCA (polycyclin aromatic hydrocarbon)/ BHT 
(butylated hydroxytoluene) treatment (Wang et al., 2008b). 
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1.4.6.2 Molecular Mechanisms of FOXM1-Induced Tumourigenesis 
The transcriptional regulation of genes, such as FOXM1, which control 
multiple aspects of cell division, is of great interest in cancer biology, since it 
can provide significant insight into the mechanisms that mediate early as well 
as late events in the progression of human neoplasia. The contribution of 
FOXM1 during this process is well documented, and best illustrated through 
studies that investigate its function in the context of human tumour derived 
cell lines. 
 
Large scale analysis of gene expression data has revealed that FOXM1 is 
significantly overexpressed in human infiltrating ductal breast carcinomas 
(Dahl et al., 2005; Wonsey and Follettie, 2005; Dahl et al., 2006). This 
observation was also confirmed in two separate studies showing increased 
expression of FOXM1 in breast carcinomas, and especially those with highly 
invasive properties (Bektas et al., 2008), while FOXM1 expression was also 
found to  be associated with poor breast cancer prognosis (Martin et al., 2008). 
However, others have reported that there is no significant correlation between 
FOXM1 expression and breast tumour grade (Francis et al., 2009). In 
agreement with the in vivo observations, FOXM1 was also found 
overexpressed in transformed human breast cancer cell lines (Wonsey and 
Follettie, 2005; Bektas et al., 2008). It is noteworthy that FOXM1 
overexpression is evident in breast cancer cell lines, even when compared to 
their un-transformed but spontaneously immortalised, and thus proliferatively 
active, counterparts (Wonsey and Follettie, 2005; Bektas et al., 2008). This 
strongly suggests that the effect of FOXM1 expression is directly associated 
with malignant transformation rather than just with the proliferative potential 
of immortalised cells in vitro. Expectedly, downregulation of FOXM1 by 
siRNA in human breast cancer cell line BT-20 leads to reduced proliferation, 
while chronic depletion of FOXM1 protein by shRNA leads to decreased 
viability followed by a phenotype that is highly reminiscent of that observed 
by Laoukili et al. (2005) , which is characterised by disruption of the mitotic 
spindle, centrosome amplification, and polyploidization, which leads to cell 
death (Laoukili et al., 2005; Wonsey and Follettie, 2005).  
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More insight into the potential mechanism by which FOXM1 may be 
implicated in human breast carcinogenesis, was provided by Madureira et al. 
(2006) who showed that in human breast cancer cell lines, there is a tight 
relationship between the expression pattern of FOXM1 and that of estrogen 
receptor α (ERα) (Madureira et al., 2006), the most common cause in the 
pathogenesis of human breast cancer (Sommer and Fuqua, 2001). Further to 
that, it was shown that FOXM1 can bind to the promoter of ERα gene, and 
directly induce its expression in human breast carcinoma derived cells 
(Madureira et al., 2006), suggesting a mechanism by FOXM1 may be 
regulating the abundance of ERα in human breast cancer. This relationship 
was shown to be reciprocal since the expression of FOXM1 itself can also be 
induced by estrogen receptor ligand treatment of estrogen responsive breast 
cancer cell lines, a mechanism that is mediated by ERα which directly binds 
to, and activates the promoter of FOXM1 (Millour et al.). Another link 
between FOXM1 and breast cancer pathogenesis was provided by evidence 
from breast carcinoma cell lines, showing that FOXM1 is a downstream target 
of epidermal growth factor receptor 2 (HER2) (Francis et al., 2009), which is 
amplified in 15% - 20% of invasive breast carcinomas and results in increased 
metastatic potential and a poor clinical outcome (Slamon et al., 1987; Slamon 
et al., 1989).  
 
More importantly, it was shown that tamoxifen (OHT; estrogen receptor 
antagonist) was unable to repress the levels of FOXM1 in OHT resistant breast 
cancer clones, which maintained their proliferative capacity for longer times 
after treatment, as opposed to their OHT sensitive counterparts (Millour et al.). 
This implicated FOXM1 in the mechanism of acquired resistance to anti-
estrogen treatment of breast cancer. In the same context, it was shown more 
recently that ectopic expression of the truncated ΔN-FOXM1 can also render 
MCF-7 breast cancer cells resistant to cisplatin treatment, presumably by 
potentiating DNA repair associated pathways as judged by the maintenance of 
cell viability and the reduction in the recruitment of γH2Ax at sites of DNA 
strand breaks following treatment (Kwok et al., 2010). Consistent with this 
potential role of FOXM1, its selective inhibition by thiostrepton (FOXM1 
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inhibitor (Bhat et al., 2009)  was sufficient to abrogate acquired cisplatin 
resistance of MCF-7 breast cancer cells (Kwok et al., 2010).  
 
Although the paradigm of breast carcinogenesis is among the most extensively 
studied in vitro, and provides several mechanisms by which FOXM1 exerts in 
tumourigenic potential, its over-expression has also been reported in a large 
variety of other human tumours and tumour-derived cell lines. Its 
overexpression has been reported in the majority of human lung 
adenocarcinomas (50% at mRNA and 78% at protein level) and lung 
squamous cell carcinomas (67% at mRNA and 68% at protein level). A more 
recent study, by examining 69 samples of lung SCCs, reported that 
intratumoural FOXM1 expression was not detected in more than 37% of SCCs 
(Yang et al., 2009). Despite the low frequency of FOXM1 immunoreactivity, 
it was shown that its presence is invariably associated with poor differentiation 
status, lymph node metastasis, and consequently poor patient survival (Yang et 
al., 2009). Furthermore, expression of FOXM1 in lung tumours is positively 
correlated with proliferation associated PCNA (proliferating cell nuclear 
antigen) and the expressions of cyclin A2 and cyclin B1 (Kim et al., 2006), 
both of which are established FOXM1 targets. Additionally, depletion of 
FOXM1 protein leads to significant reduction of the proliferative potential and 
anchorage independent growth rate of human lung cancer cell lines in vitro 
(Kim et al., 2006). Human prostate tumours also exhibit significantly elevated 
levels of FOXM1 protein that is even more evident in advanced tumour stages, 
and is related to proliferation and metastasis (Kalin et al., 2006; Chandran et 
al., 2007). In line with these observations, microarray gene expression analysis 
has also shown that FOXM1 is consistently overexpressed in metastatic 
prostate tumour samples (Chandran et al., 2007). 
 
The cell cycle regulatory role of FOXM1B transcription factor is also a very 
important determinant of the tumourigenicity of glioma cells. Forced 
overexpression of FOXM1 in glioma cell lines was shown to enhance 
anchorage-independent growth and their ability to induce tumours when 
grafted in nude mice (Liu et al., 2006). In agreement with the expression 
pattern of FOXM1 observed in other human tumours, gliomas exhibit 
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increased FOXM1 protein and mRNA levels that show a positive relationship 
with more advanced states of the disease and decreased patient survival (Liu et 
al., 2006). In the same context, FOXM1 was shown to transcriptionally 
activate matrix metalloproteinalse-2 (MMP2) expression, thus enhancing the 
invasion of glioma cells (Dai et al., 2007), a process which is critical, and 
largely contributes to the poor prognosis generally associated with glioma 
tumours (Giese et al., 2003). Others have also reported that ability of FOXM1 
to promote tumour cell invasion and migration is through the activation of 
JNK-1, which was found to be necessary for the upregulation of MMP-9 in 
U2OS human osteosarcoma cells (Wang et al., 2008a). In line with these 
observations, downregulation of FOXM1 by RNAi results in a rapid reduction 
of the metastatic potential of human glioma cells, and suppresses glioma 
growth in the brain of nude mice, resulting in increased overall survival time 
(Kim et al., 2006; Liu et al., 2006; Dai et al., 2007). Decreased levels of cyclin 
B1, cyclin A2, cyclin D1 as well as increased nuclear accumulation of p27kip1 
have been shown to mediate these growth suppressive effects following 
inhibition of FOXM1, in agreement with observation from in vivo mouse 
models (see section 1.4.6.1).  
 
Another study points to a role for FOXM1 in the maintenance of the malignant 
properties of human pancreatic cancer cell lines. More specifically, FOXM1 
depletion results in the activation of growth inhibitory proteins p21cip1/waf1 and 
p27KIP1 that mediate partial cell cycle arrest and reduced DNA replication, but 
also in the downregulation of matrix metalloproteinases MMP-2 and MMP-9 
and vascular endothelial growth factor (VEGF) (Wang et al., 2008a). 
Collectively, these effects lead to significant reduction of the invasive and 
migratory activity of pancreatic cancer cells on Matrigel-coated membranes, 
and by using an in vitro assay of angiogenesis Wang et al. (2007) showed that 
treatment with cell culture medium secreted by FOXM1-depleted cells is 
sufficient to inhibit endothelial cell tube formation (in vitro measure of 
angiogenesis) of pancreatic cancer cell lines  (Wang et al., 2007).  
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Taken together, these studies clearly demonstrate that apart from being a 
proliferation specific transcription factor, FOXM1 is necessary for the 
progression of human malignancies.  
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Aims and Hypothesis 
Despite the fact that FOXM1 is overexpressed in the majority of human 
malignancies (Pilarsky et al., 2004), its expression has not yet been 
investigated in the case of human oral SCCs. This study will aim to investigate 
the regulation of FOXM1 expression in human oral squamous cell carcinomas 
in vitro and in vivo. Given the stepwise model of oral carcinogenesis, and the 
fact that FOXM1 has a tumour promoting function, it is hypothesised that 
FOXM1 also has a role in the progression of human oral squamous cell 
carcinoma. Therefore, this study will specifically aim to investigate the 
mechanism of FOXM1 in early pre-malignant lesions of human oral mucosa. 
 
To date, studies of FOXM1 as a cancer causing gene have been performed in 
the context of transformed and/or immortalized human cell lines, undoubtedly 
providing invaluable insight into the molecular mechanisms mediated by 
FOXM1. However, due to the aberrant molecular background already present 
in most cell line systems, the role of FOXM1 in the earliest stage of neoplasia 
could not be delineated and it is not fully understood. Therefore this study 
aims to understand the regulation of FOXM1 and the effect of its 
overexpression, in normal primary human epithelial keratinocytes as they 
represent the main target population of human malignancies. Due to the 
established role of FOXM1 in the maintenance of genomic integrity (Laoukili 
et al., 2005), this study will also follow the hypothesis that FOXM1 
overexpression compromises the genomic integrity of primary human 
keratinocytes, possibly contributing to human cancer initiation. This study will 
specifically aim to understand whether FOXM1 overexpression in primary 
oral keratinocyte stem cells contributes to the generation of pre-malignant 
progenies, trying to provide an explanation to why FOXM1 is overexpressed 
in the majority of human epithelial malignancies.  
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2 Materials and Methods 
 
2.1 Cell Culture 
 
2.1.1 Primary Normal Human Keratinocyte Extraction and 
Establishment 
Primary normal human oral keratinocyte (NHOK# 1, 2, 3, 4, 5, 376, 881, 355, 
and 113) and normal human epidermal keratinocyte strains (NHEK# 1, 2, and 
3) were established from clinically normal oral buccal or gingival tissue and 
normal skin respectively. Donor tissues were collected in transport medium, 
consisting of DMEM (Lonza, Slough UK) with 3% (v/v) 
penicillin/streptomycin (Gibco Invitrogen, Paisley, UK). Tissues were minced 
using sterile scalpel and forceps, prior to digestion in Trypsin/EDTA solution 
(0.5 g/L of trypsin and 0.2 g/L of EDTA•4Na in Hanks' Balanced Salt Solution 
without CaCl2) (Gibco Invitrogen) for 4 hours at 37oC under continuous 
shaking. The digested tissues were then passed through 75 μm cell strainers 
(BD Falcon Oxfordshire, UK) and keratinocytes were recovered underneath in 
DMEM medium (Lonza, Slough UK) with 10% FBS (FirstLink, Birmingham 
UK). Cells were spun at 140 x g for 5 minutes and finally resuspended in 
complete growth FAD medium with 3% (v/v) penicillin/streptomycin and 1% 
(v/v) antibiotic/antimycotic (PAA Laboratories, Somerset UK). FAD medium 
consisted of DMEM (4.5 g/L glutamine): F12 (Ham’s F12 nutrient mixture; 
Gibco Invitrogen) in 3:1 ratio with 10% (v/v) FBS (FirstLink, Birmingham 
UK) and various mitogens (0.4 µg/ml hydrocortisone, 0.1 nM cholera toxin, 5 
µg/ml transferrin, 20 pM lyothryonine, 0.18 mM adenine, 5µg/ml insulin and 
10 ng/ml EGF; mitogens were either bought from Sigma Aldrich, Dorset UK, 
or were kindly provided by Prof. Mike Philpott from the Centre for Cutaneous 
Research at ICMS). All cells were plated in 6 cm dishes containing pre-plated 
3T3 feeder layers (for feeder layer preparation see section 2.2.1). FAD 
medium was replaced 72 hours later with FAD medium containing only 1% 
penicillin/streptomycin and FAD medium was changed every other day 
thereafter. The first keratinocyte colonies became visible 4-6 days after 
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plating. Keratinocytes were let to grow to around 80% confluence prior to 
cryopreservation in freezing medium consisting of 10% (v/v) DMSO (Sigma 
Aldrich) 90% (v/v) FBS (FirstLink, Birmingham, UK). Keratinocyte 
population doublings were marked 0 at this point and all experiments were 
carried out with keratinocytes from the frozen stocks. 
 
2.1.2 Primary Normal Human Keratinocyte Culture 
Upon recovery from liquid nitrogen, keratinocytes were grown either in FAD 
medium in the presence of 3T3 feeders or in serum free media (K-SFM; Gibco 
Invitrogen) supplemented with 25 µg/ml of bovine pituitary extract (BPE) 
(Gibco Invitrogen), 0.2 ng/ml of epidermal growth factor (EGF) (Gibco 
Invitrogen) and either low or high concentrations of calcium (0.09 mM or 0.4 
mM CaCl2 respectively) (Rheinwald et al., 2002). Keratinocytes were 
passaged once they reached 60-70% confluence when grown in FAD + 3T3 
feeder layer co-culture or at 40-50% confluence when grown in serum free 
conditions. All cells were grown at 37oC in a humidified atmosphere of 10% 
(serum containing media) or 5% (serum-free media) CO2/95% air. In order to 
obtain a pure keratinocyte population when growing keratinocytes in a 3T3 
feeder co-culture system, the 3T3 feeder layer needs to be thoroughly 
removed. Cells were initially washed 1x in PBS and were then incubated at 
37oC for 10 minutes in the presence of versene (0.2 g/L EDTA-4Na in 
phosphate-buffered saline; Gibco Invitrogen). Next, versene solution 
containing any detached feeders was replaced with PBS. Any remaining 
feeders were removed by thorough and repeated pipetting, until only 
keratinocyte colonies were visible under the microscope. Then, keratinocytes 
were tyrpsinised in the presence of Trypsin/EDTA solution (0.5 g/L of trypsin 
and 0.2 g/L of EDTA•4Na in Hanks' Balanced Salt Solution without CaCl2, 
MgCl2 • 6H2O, and MgSO4 • 7H2O) (Gibco Invitrogen) for at least 15 minutes, 
until a single cell suspension of keratinocytes was obtained. Cells were then 
recovered in serum containing media, spun at 140 x g for 5 minutes, and 
finally resuspended in FAD complete medium before plating. For 
keratinocytes growing in serum-free media, feeder layer free conditions, 
versene treatment and feeder removal steps were omitted. Keratinocytes were 
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typically plated at a density of 5x103/cm2 and were let to grow for an average 
of 5-6 days upon which time they have reached 60-80% confluence. 
 
2.1.3 Cell Line Culture 
N/TERT-1 (N/TERT) keratinocytes are derived from clinically normal 
foreskin tissue and are further immortalised by the addition of ectopic 
telomerase, followed by spontaneous downregulation/loss of p16INK4a 
(Dickson et al., 2000). N/TERT keratinocytes were cultured in K-SFM (Gibco 
Invitrogen) medium. SVpgC2a oral premalignant cell line is derived from 
normal oral keratinocytes that have been immortalised by ectopic expression 
of SV40-T antigen (Kulkarni et al., 1995). SVpgC2a keratinocytes were grown 
in serum free EpiLife medium (Cascade Biologics, Paisley UK) (0.04 mM 
CaCl2) containing human keratinocyte growth supplements (HKGS; Cascade 
Biologics). Normal human telomerase-immortalised oral keratinocytes 
OKF6/T (Dickson et al., 2000) were grown in K-SFM medium. Oral 
premalignant cell lines POE9n-hTERT (Rheinwald et al., 2002), POE9n 
(Rheinwald et al., 2002), DOK (Chang et al., 1992; Munro et al., 1999), D19 
(McGregor et al., 2002), D20 (McGregor et al., 2002) and primary head and 
neck cancer derived cell lines CA1 and UK1 (Harper et al., 2007), CaLH2 
(Harper et al., 2007), CaLH3 (Harper et al., 2007), CaDec11, CaDec12, H357 
(Prime et al., 1990), 5PT (Mackenzie, 2004), PE/CA-PJ15, and Vb6 (Harper et 
al., 2007), were kindly provided by Prof. Ian MacKenzie (ICMS, Centre of 
Cutaneous Research, Queen Mary University of London). BICR31 (Loughran 
et al., 1997), SCC4, SCC9, SCC15, and SCC25 (Rheinwald and Beckett, 
1981) cell lines were kindly provided by Prof. Ken Parkinson (Clinical and 
Diagnostic Oral Sciences, Queen Mary University of London). Detailed 
information on the keratinocyte cell lines used herein, are displayed in Table 
2.1. Normal human oral and NIH3T3 fibroblasts (kindly provided by Prof. 
Ken Parkinson), Phoenix amphotropic (PhxA) (human embryonic 293T 
derived; supplied by Nolan Lab (Medical Centre, Stanford University Medical 
School, CA), and HeLa cells were all grown in DMEM (Lonza) with 10% 
FBS (FirstLink) and 1% penicillin/streptomycin (Gibco Invitrogen). All cells 
were grown at 37 oC in a humidified atmosphere of 10% (serum containing 
media) or 5% (serum-free media) CO2/95% air. All cell lines were cultured 
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and passaged according to the aforementioned conditions (see section 2.1.2) 
that apply for primary human keratinocytes, omitting the feeder 
preparation/removal steps, unless needed (SCC15). 
Table 2.1: Cell lines origin and culture conditions 
*N/A: Not Available *GF: Growth Factors 
Cell 
Line 
Origin 
Genetic 
Modification 
Known 
Abnormalities 
Culture 
Medium 
Cell Line 
References 
5PT HNSCC None N/A K-SFM 
(Mackenzie, 
2004) 
BICR31 
Advanced non 
metastasized  
HNSCC 
None 
CDKN2A locus 
deletion, p53 
mutation 
FAD 
(Loughran 
et al., 1997) 
CA1 HNSCC None N/A K-SFM (Harper et al., 2007) 
CaDec11 HNSCC None N/A FAD - 
CaDec12 HNSCC None N/A FAD - 
CaLH2 HNSCC None N/A FAD (Harper et al., 2007) 
CaLH3 HNSCC None N/A FAD 
(Harper et 
al., 2007) 
D19 
Erythroplakia  
derived 
keratinocytes 
from lateral 
tongue 
None p16INK4a downregulation FAD 
(McGregor 
et al., 2002) 
D20 
Severely 
dysplastic oral 
epithelium from 
lateral tongue 
None p16INK4a downregulation K-SFM 
(McGregor 
et al., 2002) 
DOK 
Dysplastic Oral 
Epithelium of 
the tongue 
None 
p16INK4a and 
p53 mutation, 
aneuploid 
K-SFM 
(Chang et 
al., 1992; 
Munro et 
al., 1999) 
H357 HNSCC None N/A K-SFM (Prime et al., 1990) 
N/TERT Newborn foreskin hTERT 
p16INK4a 
downregulation K-SFM 
(Dickson et 
al., 2000) 
PE/CA-
PJ15 
Human Tongue 
SCC None N/A FAD 
(Kulasekara 
et al., 2009) 
OKF6/T Normal buccal mucosa hTERT 
p16INK4a 
downregulation K-SFM 
(Rheinwald 
et al., 2002) 
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2.2 Cell Treatments 
 
2.2.1 Feeder Layer Preparations 
Feeder layers were prepared by treating NIH3T3 fibroblasts with Mitomycin C 
to induce replication arrest. Although arrested, cells still retain the abilities of 
cell to matrix and cell-cell adhesion, and extracellular protein production, 
which are necessary for the initial growth phases of primary human 
keratinocytes when grown in high calcium, serum-containing media. NIH3T3 
feeder layers were prepared by treating confluent NIH3T3 cultures in DMEM 
(Lonza) with 10% FBS (FirstLink) and 1% penicillin/streptomycin (Gibco 
Invitrogen) in the presence of 10 μg/ml mitomycin C (Sigma Aldrich) for 4 
hours at 37oC in a humidified atmosphere of 10%CO2/90% air. Mitomycin C-
treated NIH3T3 were plated at a density of 1.8x104/cm2, 24 hours prior to 
Cell Line Origin 
Genetic 
modification 
Abnormalitie
s 
(known) 
Culture 
Medium 
Cell Line 
References 
POE9n 
Pre-malignant 
dysplastic oral 
epithelial 
lesion 
None 
CDKN2A/IN
K4a deletion, 
p53 
expression 
loss 
K-SFM 
(Rheinwald et 
al., 2002) 
POE9n-
hTERT 
Premalignant 
dysplastic oral 
epithelial 
lesion 
hTERT 
CDKN2A/IN
K4a deletion, 
p53 
expression 
loss 
K-SFM 
(Rheinwald et 
al., 2002) 
SCC4 
Tongue 
squamous cell 
carcinoma 
None N/A FAD 
(Rheinwald 
and Beckett, 
1981) 
SCC9 
Tongue 
squamous cell 
carcinoma 
None N/A FAD 
(Rheinwald 
and Beckett, 
1981) 
SCC15 
Tongue 
squamous cell 
carcinoma 
None p16 promoter methylation 
FAD on 3T3 
feeder layer 
(Rheinwald 
and Beckett, 
1981) 
SCC25 
Tongue 
squamous cell 
carcinoma 
None N/A FAD 
(Rheinwald 
and Beckett, 
1981) 
SVpgC2a 
Normal 
buccal 
mucosa 
SV40-T 
Aneuploid, 
partially 
resistant to 
GF 
EpiLife 
(Kulkarni et 
al., 1995) 
UK1 Head and Neck SCC None N/A FAD 
(Harper et al., 
2007) 
VB6 H357 derived subclone Integrin avβ6 N/A FAD 
(Harper et al., 
2007) 
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keratinocyte plating. PhxA cells were also used as feeder layers for retroviral 
transduction experiments (see section 2.3.3.2). PhxA cells were prepared by 
treating confluent PhxA cultures in DMEM with 10% FBS and 1% 
penicillin/streptomycin in the presence of 2 μg/ml mitomycin C for 2 hours at 
37oC in a humidified atmosphere of 10%CO2/90% air. Treated PhxA cells 
were then plated at a density of 1.1x105/cm2. 
 
2.2.2 Cell Cycle Synchronization 
To synchronize N/TERT and HeLa cells at G1/S phase by double thymidine 
block, 2x105 cells were plated in 6 cm dishes. When cells reached 40-50% 
confluence, 2 mM thymidine (Sigma Aldrich) was added and cells were 
incubated for 16 hours. Cells were then washed twice with PBS and grown in 
complete medium for another 9 hours. Thereafter, cells were treated again 
with 2 mM thymidine (Sigma Aldrich) for another 12-16 hours. Release from 
the second thymidine block was performed by washing twice with PBS and 
replacing with complete growth medium, and cells were harvested at indicated 
time points. 
 
2.2.3 Proteasome Inhibitor (MG132) Treatments 
Semi-confluent cultures were treated with MG132 (Sigma Aldrich) (10-6M for 
24 hours), or vehicle control (0.001% DMSO; Sigma Aldrich), for 24 hours 
prior to harvesting. 
 
2.2.4 Oral Carcinogens Treatment 
Nicotine (Nicotine Hemisulfate salt; Sigma N-1019, Dorset UK) treatment of 
oral keratinocytes (NHOK or SVpgC2a) was performed by treating semi-
confluent keratinocyte cultures in serum-free conditions with various 
concentrations of nicotine as mentioned. Nicotine dilutions were prepared in 
double-distilled sterile H2O (ddH2O) (Barnstead Nanopure, ThermoScientific, 
Cambridgeshire UK). Control treatments consisted of the same volume of 
double distilled sterile ddH2O alone. 
 
Chapter 2: Materials and Methods   
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 72
2.3 Retrovirus Mediated Gene Transfer 
 
2.3.1 Retroviral Vectors 
Retrovirus mediated gene transfer represents one of the most efficient methods 
(a minimum of 87% was achieved in this study) for inducing long-term, stable 
gene expression in human keratinocytes, since simple plasmid transfection 
methods are particularly ineffective in this cell type. Retroviral vectors are 
used to induce the expression of a specific protein in keratinocytes. In this 
study, replication incompetent retroviral vectors have been used to allow a 
one-time infection of target cells and to minimize safety hazards that may arise 
from continuous spreading of replication competent retroviruses. This is 
achieved by removal of viral packaging genes from the retroviral backbone, 
therefore incapacitating the self-replication machinery of retroviral vectors. 
The viral packaging proteins that are needed for retrovirus production are 
provided in trans by retrovirus packaging cell systems (e.g. Phoenix Cells) 
(Figure 2.1). In this study, pSIN (Self Inactivating) vectors were employed 
(Figure 2.1) (Deng et al., 1997; Teh et al., 2002). These vectors were 
constructed by deleting the enhancer and the promoter in the U3 region of the 
3’ LTR (Long Terminal Repeat) thereby abolishing any transcriptional 
activity driven by the LTR so that no full-length vector RNA is produced in 
transduced cells. After the first round of replication, the changes are copied 
into both the 5’ and 3’ ends of LTRs, and therefore gene expression is only 
driven by the internal CMV promoter. 
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Figure 2.1: Retroviral Vectors, Packaging and Viral Particle Production. 
(A) pSIN retroviral vector constructs are shown. pSIN-MCS (i) contains a multiple 
cloning site, but it lacks a promoter or a gene. pSIN-EGFP (ii) and pSIN-EGFP-
FOXM1B (iii) contain genes driven by an internal CMV promoter. (B) Upon 
transfection of retroviral vectors (i) in PhxA packaging cells, retroviral packaging is 
initiated by the presence of retroviral packaging proteins (ii) that are stably expressed 
by PhxA cells. 
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Figure 2.2: Retroviral Transduction 
(A) Following viral packaging, retroviral particles are released from PhxA cells into 
the growth medium. Upon collection, retroviral particles are then used to infect target 
cells, which recognize the amphotropic cell surface molecules of the retroviruses. (B) 
Once the retrovirus enters the cell, it begins its life cycle. Retroviral integrase cleaves 
the host genomic DNA and integrates the retroviral DNA cassette into the host’s 
genome. The expression of the gene of interest is thereafter being driven by the 
presence of the internal CMV promoter. 
 
2.3.2 Retrovirus Production 
For the production of retroviral particles containing the genes of interest, the 
retroviral producer cell line PhoenixA (PhxA) was used. PhxA cell line was 
created by stable trasfection of 293T cells with constructs expressing gag-pol, 
and envelope proteins for ecotropic and amphotropic viruses (supplied by 
Nolan Lab, Medical Centre, Stanford University Medical School, CA). PhxA 
(amphotropic) were used for the production of amphotropic retroviruses 
bearing the MCS (empty), CMV-EGFP or CMV-EGFP-FOXM1B transgene. 
For retrovirus production, PhxA packaging cells were plated in 10 cm dishes 
and were transfected with 10 μg of viral plasmid DNA using FuGENE 6 
reagent (Roche, Hertfordshire UK) in a 1:2 DNA: FuGENE ratio. Transfected 
PhxA cells were incubated for 48 hours and then sub-cultured in selection 
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medium consisting of DMEM (Lonza) with 10% FBS (FirstLink) and 
puromycin (3µg/ml) (Sigma Aldrich). Cells were maintained in selection 
medium for 1 week, after which they were incubated overnight at 32oC in 
complete normal growth medium without puromycin. Retroviral supernatants 
were collected the next day and were thereafter collected once daily for 2-3 
days post-confluent. Upon collection, retroviral supernatants were spun at high 
speed centrifugation at 871 x g for 10 minutes to remove any non-adherent 
PhxA cells present in the medium. Retroviral supernatants were then snap-
frozen in liquid nitrogen before being stored at -80oC until use. 
 
2.3.3 Retroviral Supernatant Quantification and Titration 
The retroviral titre can vary significantly between retrovirus preparations, 
mainly depending upon the nature of the retroviral vector (i.e. gene of interest 
may be affecting the survival of PhxA cells), as well as on the culture and 
selection methods. Therefore, titration of the retroviral supernatant is 
important to achieve equal transduction efficiencies in target cells. Titration of 
the retroviral supernatant can be achieved by direct quantification of a 
retrovirus specific component present in the retroviral supernatant (detailed 
protocols below). Also, transduction efficiency can be directly assessed by 
absolute quantification of the incorporated transgene within the host genomic 
DNA (gDNA) (i.e. EGFP copy number) in the target cells immediately after 
transduction (shown in results section 2.3.4). Herein, both techniques were 
used to ensure that target cells receive equal number of the transgene. 
2.3.3.1 Retrovirus Purification and Viral Titre Quantification 
Retroviral supernatants (RVSN) containing pSIN-EGFP or pSIN-EGFP-
FOXM1B were collected as described in section 2.3.2. The protocol used to 
quantify retroviral vector titres is a modified version of the protocol described 
in Sanburn and Cornetta, 1999 (Sanburn and Cornetta, 1999). A volume of 
300 μl of RVSN was added in a mixture of 900 μl TriZol (Roche Diagnostics 
Ltd, England, UK) with 10 μg tRNA carrier (Sigma Aldrich) and 240 μl 
chloroform. The mixture was then vortexed for 30 seconds, incubated at room 
temperature for 10 minutes and then spun at 8,000 x g at room temperature in 
a table-top centrifuge. The aqueous layer was isolated and retroviral genome 
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RNA was precipitated with 600 μl isopropanol, followed by centrifugation at 
8,000 xg for 10 minutes. The dried pellet was resuspended in reverse 
transcription mixture (Promega; detailed in section 2.7) containing only EGFP 
specific primers (1μM) and was incubated at 42oC for 1 hour, followed by 5 
minutes at 85oC. Then, 2 μl of the resultant cDNA was used in SYBR 1 
Master Mix (Roche) reaction (detailed in section 2.8) with 5 μM EGFP 
primers and reaction mix was run using a standard qRT-PCR protocol (see 
section 2.8).  
 
2.3.4 Retroviral Transduction of Human Keratinocytes 
2.3.4.1 Retroviral Transduction in Serum-Free Conditions 
Cells to be infected were plated at a density of 7.5x104/cm2. The next day, 
cells were incubated for 15 minutes in the presence of polybrene 
(hexadimethrine bromide) (5 μg/ml; Sigma Aldrich) prior to adding retroviral 
supernatant containing equal concentrations of polybrene. Cells were then 
spun at 14 x g for 1 hour at 32oC, washed twice in PBS and finally incubated 
for 48-72 hours in normal growth medium prior to any experiments. 
2.3.4.2 Retroviral Transduction in Feeder-Layer System 
To infect NHOKs in a feeder layer system, keratinocytes were co-cultured 
with Mitomycin C-treated 3T3 and transfected/selected PhxA cells. Initially, 
mitomycin C-treated 3T3 feeder cells were plated at a density of 5x103/cm2. 
The next day, NHOKs were seeded at a density of 1.9x103/cm2. For flow 
sorted keratinocytes, a cell density of 54–1000 cells /cm2 was used instead. 
Two hours after keratinocyte plating, mitomycin C-treated PhxA cells were 
plated on top at a density of 1.1x105/cm2 and polybrene was added at a final 
concentration of 5 μg/ml (Day 0 of retroviral transduction). Normal growth 
medium (FAD), without polybrene, was replaced the next day (Day 2 of 
retroviral transduction). Next, (Day 3) PhxA-3T3 feeder layer was gently 
removed with PBS and freshly prepared mitomycin C-treated 3T3 feeders 
were added at a density of 1.8x104/cm2. 
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2.3.5 Optimization of Retroviral Gene Delivery 
Retrovirus-mediated gene transfer has proven to be an invaluable tool for fast 
and stable gene delivery on a wide range of mammalian cell types. However, 
there are certain factors to be considered when employing such a method. 
These include the determination of the retroviral titre and transduction 
efficiency, both of which are critical factors for successful gene integration 
and stable transgene expression.  
 
Transgene incorporation is a random event whereby exogenous genes are 
integrated in arbitrary positions of the host genome. Depending upon the 
retroviral titre and transduction efficiency, multiple copies of the viral 
transgene may be introduced in each host cell genome. The ratio of viral 
particles to target cells is called multiplicity of infection (MOI), and can 
influence the extent of transgene expression and the genomic stability of the 
host. It has been reported that MOI of 15 in human keratinocytes is able to 
induce long-term gene delivery with strong transgene expression, without the 
need for further selection (Robbins et al., 2001; Lazarov et al., 2002).  
 
In this study I used pSIN (Self-INactivating) retroviral constructs bearing 
EGFP or EGFP-FOXM1B expression cassettes for stable gene delivery in 
human keratinocytes. Expression of both transgenes is driven by the CMV 
promoter. In order to achieve maximum transduction efficiency, N/TERT cells 
were subjected to low speed centrifugation in the presence of different 
concentrations of the retroviral supernatant, and were allowed to express the 
transgenes for 72 hours (Figure 2.3 A). Fluorescence microscopy showed that 
protein expression correlated with retrovirus concentration, indicated by both 
fluorescence intensity and the percentage of transduced cells (Figure 2.3 B). 
However, fluorescence intensity is not an accurate marker for the quantitation 
of transgene incorporation because the gene of interest may be subjected to 
post-transcriptional and post-translational modifications. In order to directly 
quantify the absolute copy number of transgenes incorporated in our target 
cells, qPCR was employed. Genomic DNA was extracted 72 hours post-
transduction and the copy number of EGFP transgene was quantified by 
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qPCR, using primers that would detect either EGFP alone (control cells) or 
EGFP fused with FOXM1B (Figure 2.3 A).  
 
Initial experiments showed that EGFP retroviral transduction was at least 10-
fold more efficient when compared to EGFP-FOXM1B. Thus, EGFP retroviral 
supernatant preparation was further diluted before achieving comparable 
transduction levels for both transgenes. This could have been both a result of 
higher concentrations of retroviral particles in the EGFP supernatant, or due to 
favourable incorporation of a smaller sized transgene. Genomic EGFP copy 
number shows a dose-dependent relationship with increasing concentration of 
retrovirus in both EGFP and EGFP-FOXM1B transduced cells (Figure 2.3 B, 
C). Linear regression analysis showed a highly significant (R2>0.96) positive 
correlation between retroviral concentration and genome EGFP copy number 
per 10ng of gDNA (Figure 2.3 D). In order to achieve equal transgene copy 
number incorporation of both EGFP and EGFP-FOXM1B into host cells, the 
appropriate volume of retroviral supernatant was calculated based on the 
respective regression analyses. Assuming that each cell contains ~6.5pg of 
DNA (Dole et al., 2003), and according to results shown in Figure 2.3 C, 
where a maximum of 2.5x104 EGFP transgenes are detected in 10ng of gDNA 
(~1000 cells), is can be deduced that by using this retroviral transduction 
method each cells could receive up to ~16 copies of each transgene. All 
subsequent experiments were carried out using appropriate retroviral 
concentration to achieve an incorporation rate of ~10 copies/cell. 
Chapter 2: Materials and Methods   
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 79
 
 
Figure 2.3: Optimization of retroviral gene delivery.  
(A) N/TERT human keratinocytes were transduced with various concentrations of 
retroviral supernatant and gDNA was extracted after 72 hours. qPCR was performed 
on 10ng of DNA using EGFP specific primers. (B) Fluorescent microscopy indicated 
that transgene expression was directly related to retrovirus concentration. Inset 
images show the intracellular localization of EGFP and EGFP-FOXM1B protein 
distributions in transduced N/TERT keratinocytes. (C) Quantification of EGFP or 
EGFP-FOXM1B transgenes copy number in N/TERT human keratinocytes.  
 
2.4 Cell Counting and Clonogenic Assays 
Cell number and density were determined using CAsy® Cell Counter 
(Innovatis, Sittingbourne UK). Each sample was prepared three times in 
CAsyTon® (Innovatis) buffer and triplicate measurements of 200 μl sample 
volume were taken each time. Viable cells were measured by excluding cells 
smaller that 10 μm in size. Keratinocyte population doublings were calculated 
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as follows: PD = 3.32 * [log10 (N1) – log10 (N0)] where N1 = total yield and 
N0 = initial number of seeded keratinocytes. Clonogenicity percentages were 
determined by the percentage of initial keratinocytes plated that were able to 
form visible colonies after 12 days in culture. For colony forming assays, 
keratinocyte cultures were washed once with PBS and were fixed in 4% (v/v) 
formaldehyde (Sigma Aldrich) in PBS for 20 minutes at room temperature. 
Then, cells were washed 1x with PBS and stained with 1% Rhodamine B 
(Sigma) in PBS for 30 minutes at room temperature. Bright field images of 
Rhodamine B-stained dishes were digitally captured (AutoChemi imaging 
system (UVP, Upland, CA). Colony area coverage measurements were 
performed using Adobe Photoshop CS4 and CorelDraw X by using the quick 
selection tool with a constant hardness value among samples to acquire 
quantitative pixel counts. To measure the relative surface areas covered by 
each keratinocyte clone, a well of a 6-well plate was selected, and its pixel 
count was assigned as being representative of 35mm2. Therefore, the actual 
surface area (mm2) of each individual keratinocyte clone was deduced from its 
pixel count value relative to that of a 35mm2 well (Zhu and Watt, 1999).  
 
2.5 Organotypic Culture on De-Epidermalized Dermis 
(DED) 
A three-dimension in vitro functional reconstruction of oral mucosa epithelum 
can be achieved by organotypic cultures of primary oral keratinocytes and 
fibroblasts on DED. This allows a better representation of the in vivo situation, 
compared to monolayer culture models. Organotypic cultures of oral mucosa 
show histological and immunohistochemical characteristics very close to that 
of normal oral mucosa (Ophof et al., 2002; Moharamzadeh et al., 2007). The 
procedure entails the culture of primary fibroblasts, preferentially derived 
from the tissue of interest (i.e. oral mucosal fibroblasts), within the reticular 
side of the DED. After fibroblasts are established and have migrated within the 
DED (usually within 24 hours), oral keratinocytes are placed on the papillary 
(epidermal) side of the DED which where then allowed to grow for an initial 
period of 24-48 hours. After this stage, the organotypic rafts are raised to the 
air-liquid interface to allow keratinocyte differentiation and the induction of 
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tissue keratinisation. This allows functional investigation of epithelial 
differentiation patterns, in the presence or absence of exogenous factors (i.e. 
forced expression or suppression of target genes of interest). Herein, primary 
human oral keratinocytes were genetically manipulated (pSIN-MCS, pSIN-
EGFP, pSIN-EGFP-FOXM1B) as described above, and were cultured on 
DEDs, in the presence of primary normal human oral fibroblasts. (Figure 2.4)  
 
2.5.1 Organotypic Culture Protocol 
Glycerol preserved human donor skin (Euro Skin Bank, Beverwijk, the 
Netherlands) was initiated by thoroughly washing in PBS and incubated at 
37oC at 10%CO2/90% air in PBS with 1% antibiotic-antimycotic Solution 
(PAA Laboratories, Somerset UK) for 14 days. The epidermis was then 
mechanically removed by using sterile forceps and scalpel, and the de-
epidermalised dermis (DED) was cut in 1.5x1.5cm squares. At day 0, 5x105 
primary human oral fibroblasts were seeded in the reticular, and were allowed 
to grow for 24 hours. On day 1, 5x105 primary human oral keratinocytes 
(pSINMCS, pSINEGFP, pSINEGFP_FOXM1B) were seeded on the papillary 
surface, and were allowed to grow for 48hrs. On day 3, the DEDs were 
washed once in PBS and were gently cut in half, across the centre of the ring 
shaped region where keratinocytes were initially seeded during day 1. The 
organotypic rafts were then raised at the air-liquid interface by placing them 
on top of 1 cm high stainless steel grids within wells of a 6-well plate. The 
organotypic rafts were allowed to grow for 2-4 weeks and were refed every 48 
hours with FAD medium. Each of the identical pieces of the organotypic raft 
was then fixed in either 4% (vol/vol) formaldehyde (Sigma Aldrich) in PBS 
overnight at 4oC for paraffin embedding processing, or was embedded in 
mounting medium (Thermo Fisher Scientific, Loughborogh, UK) for frozen 
sectioning. Paraffin embedding was carried out in the facilities of Centre for 
Cutaneous Research, ICMS by Dr. Wesley Harrison. Both paraffin and frozen 
processed tissue sections were cut at 4 μm thickness at the pathology core 
facility (Bart’s and the London School of Medicine and Dentistry, ICMS). 
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Figure 2.4: Organotypic Three Dimensional Reconstruction of Oral Mucosa 
(A) De-epidermalised dermis (DED) is positioned with the papillary (dermal) surface 
facing up, and human primary oral fibroblasts are seeded within stainless steel rings 
placed onto the DED as shown in the diagram. (B) After 24 hours, the DED is 
reversed, to expose the reticular side (epidermal), where primary human keratinocytes 
are seeded. (C) Following 48 hours incubation, stainless steel rings are removed, and 
the DED is raised to air-liquid interface to allow epithelial keratinisation for the next 
2-4 weeks. (D) A visible opaque cell layer (i) of keratinized epithelium is visible 
macroscopically. Image source (Di) (Moharamzadeh et al., 2007). Histological H&E 
staining shows that all epithelial layers are present the in organotypic tissue sections 
indicating a functional reconstruction of oral mucosa epithelium (ii). SB=stratum 
basale, SS=stratum spinosum, SG=stratum granulosum, SC=stratum corneum. 
2.6 RNA extraction from cultured cells 
 
Chapter 2: Materials and Methods   
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 83
2.6.1 Total RNA Extraction 
Total RNA was extracted from cells using RNeasy Mini Kit (Qiagen, West 
Sussex UK). Semi-confluent cultures were harvested in 350 μl of RLT lysis 
buffer containing 10 μl/ml β-mercaptoethanol (β-ME) (Sigma Aldrich). Next, 
cell lysates were collected in eppendorf tubes before being snap frozen in dry 
ice. Cell lysates were either kept at -80oC for long-term storage or processed 
immediately. cell lysates were homogenized by passing them through 
QIAshredder columns (Qiagen) and centrifuged at 14,000 x g for 2 minutes. 
Next, 70% ethanol was added to precipitation RNA. RNA was captured in 
RNA spin columns (Qiagen) by centrifugation for 15 seconds at 8,000 x g, and 
then columns were rinsed with RW1 buffer, and washed twice in RPE buffer. 
RNA was finally eluted in 20-30 μl of RNAse free water (Qiagen) and RNA 
concentration was measured with NanoDropTM ND-1000 (ThermoScientific, 
Cambridgeshire UK). 
 
2.6.2 Direct mRNA Extraction 
PolyA+ tail mRNA was extracted using Dynabeads®Oligo(dT)25 (Invitrogen, 
Paisley UK) according to manufacturer’s instructions. Briefly, semi-confluent 
cultures were lysed in 0.5-1 ml of RNA Lysis/Binding Buffer (100 mM Tris-
HCL, pH 7.5, 500mM LiCl, 10mM EDTA, 1% LiDS, 5mM dithiothreitol 
(DTT)) (Invitrogen) and stored at -80oC or were processed immediately. Upon 
processing 30 μl of Dynabeads®Oligo(dT)25 were added to RNA lysates and 
were rotated for 15 minutes at room temperature. RNA lysates were attached 
to Ambion® 6 Tube Magnetic Stand and Dynabeads®Oligo(dT)25 magnetic 
beads were concentrated at the back of each eppendorf tube. Supernatant was 
removed, tubes were released from the magnetic stand and the beads were 
washed with 1 ml of Washing Buffer A (10mM Tris-HCl, pH 7.5, 0.15M LiCl, 
1mM EDTA, 0.1% LiDS) (Invitrogen), then the procedure was repeated and 
beads were re-washed in 0.8 ml Washing Buffer B (10 mM Tris-HCl, pH 7.5, 
0.15M LiCl, 1mM EDTA) (Invitrogen). Supernatant was again removed and 
beads were finally resuspended in 10 μl of 10 mM Tris-HCl, pH 7.5. 
Resuspended beads were incubated for 2 minutes at 80oC to release mRNA, 
and tubes were immediately returned to the magnetic stand to minimize re-
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annealing of mRNA to beads. mRNA in the supernatant was immediately used 
in reverse transcription reaction described below. (section 2.2.7) 
 
2.7 Reverse Transcription 
Purified RNA (1-2 µg of total RNA, as described in section 2.6.1 or 10 µl 
mRNA in Tris-HCL, as described in section 2.6.2) was reverse transcribed 
into cDNA with the Reverse Transcription Kit (Promega, Hampshire UK) with 
slight modifications to manufacturer’s protocol. A typical reverse transcription 
reaction to convert 1 μg of total RNA contained the following (all reagents 
were supplied with Reverse Transcription Kit from Promega, Hampshire UK): 
 
MgCl2     5 μl  
10x Reverse Transcription Buffer 2.5 μl 
10mM dNTPs    2.5 μl 
Oligo(dT) Primers   0.5 μl 
Random Primers   0.5 μl 
RNAsin®    0.5 μl 
AMVRT (10units/ul)   0.75 μl 
RNA*     10 μl (1µg; 100 ng/μl RNA)  
   
Total     25 ± 0.25 μl 
* For more than 1μg of RNA, the reaction volume was increased 
accordingly 
The mixture was incubated for 10 minutes at room temperature before 
incubating at 42oC for 30 minutes, followed by reverse transcriptase 
inactivation at 85oC for 5 minutes. Finally, RT mix was diluted (1:3) with 50 
μl of molecular biology grade H2O (Sigma Aldrich) before being used in 
downstream PCR applications. 
 
2.8 Real-Time Absolute Quantitative PCR (qRT-PCR) 
Real-time absolute quantitative Real Time-PCR (qRT-PCR) was performed 
using Light Cycler®  480 SYBR green I Master (Roche Diagnostics Ltd, 
England, UK) (hot-start Taq polymerase master mix) with a standard final 
concentration of 0.5 μM for each primer in the LightCycler® 480 qPCR system 
(Roche). SYBR green I Master contained 5x10-6 % Bromophenol blue (Sigma 
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Aldrich) to visually assist with sample loading in Roche qPCR 96-well white 
opaque plates (Roche). 
 
2.8.1 Generation of Standard Curves 
To acquire a standard curve for each gene, each primer pair was initially 
mixed with SYBR green I Master and a template cDNA (cocktail from a wide 
range of normal and HNSCC derived keratinocytes) in the following reaction 
mixture. 
 
SYBRI  20 μl 
H2O   20 µl 
Template cDNA 5 μl 
5μM F/R Primer 7 µl 
Total   50 ± 2 µl 
 
The above qRT-PCR reactions were run in LightCycler 480 qPCR system on a 
typical amplification protocol that included denaturation at 95°C for 10 min, 
followed by 45 cycles of 95°C for 10 s, 60°C annealing for 6 s, and 72°C 
elongation (incubation time depends on the length of the product; 1 s/25 base 
pairs). Fluorescence readings were acquired at 75oC following the elongation 
step. At the end of the 45 cycles, samples were subjected to a melting analysis 
to confirm amplification specificity of the PCR products. Single product 
amplification was also visualized on AutoChemi imaging system (UVP, 
Upland, CA) after separation of DNA products in 2% Agarose (Sigma 
Aldrich) gels stained with 0.5µg/ml Ethidium Bromide (Sigma Aldrich). 
Amplified templates were then purified using Qiagen PCR Purification kit 
(Qiagen) according to manufacturer’s instructions. Amplified products were 
mixed with 5x volume (i.e. 50 µl PCR product + 250 µl) of PB buffer 
(Qiagen) and then placed in a Qiagen spin column and  were spun at 14,000 x 
g on a table top centrifuge for 1 minute, and elute was discarded. Columns 
were washed once in 500 µl PE buffer (Qiagen) before centrifugation at 
14,000 x g for 1 minute. Finally, Qiagen spin columns were spun at 14,000 x g 
to completely dry the filter. Purified PCR products were eluted in 20-30 µl of 
dH2O, and concentrations were measured using NanoDrop (ThermoScientific, 
Wilmington USA). DNA concentrations were used to calculate the absolute 
copy number of amplified products, based on the Avogadro principle, as 
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follows: Total Copy number (x) = 6.02x1014 / basepair (nt) x (660) x DNA 
concentration. Serial 10-fold dilutions (102 – 107 cDNA copies) of the 
amplified products were prepared in tRNA carrier (5 μg/ml) (Sigma Aldrich). 
A qRT-PCR run was prepared, using a dilution series range of 102-107 for each 
gene. A single qRT-PCR reaction was prepared as follows:  
 
SYBRI  4 µl 
Template cDNA 2 μl 
5μM F/R Primer 1 µl 
H2O   4.5µl 
Total   10 ± 1.5 µl 
 
Samples were run on a typical PCR amplification protocol as mentioned 
above. Standard curves for each given gene were thus calculated by the 
LightCycler® 480 qPCR software program, and were thereafter used for 
absolute copy number quantitative PCR. 
 
2.8.2 Gene Amplification by qRT-PCR 
A panel of 8 human reference genes (HPRT1, UBC, GAPDH, RPLP0, ESD, 
18SRNA, POLR2A and YAP1) were initially tested on a panel of human oral 
tissues used in this study (including normal gingival mucosa, normal buccal 
mucosa, normal tongue, dysplasias and HNSCC tissues), and keratinocyte cell 
types (including both primary and cell lines). Using the GeNorm algorithm  
analysis method (Vandesompele et al., 2002) and the LightCycler 480 Relative 
Quantification Software (with built-in multiple reference genes normalisation 
algorithm, Roche Diagnostics Ltd, England, UK), of the 8 reference genes, 
two were identified as being most reliable and stable reference genes: 
polymerase (RNA) II (DNA directed) polypeptide A (POLR2A) and Yes-
associated protein 1 (YAP1) across the aforementioned panel of human 
keratinocyte cells and tissues. POLR2A and YAP1 were used as reference 
genes for all subsequent qRT-PCR experiments to calculate target gene 
expression levels. Given that the LightCycler 480 software was fast, 
convenient and produces highly similar results to the GeNorm analysis 
method, all subsequent data analysis was performed using the LC480 software 
to expedite work flow. Samples were analyzed in triplicates and values of 
statistical significance were calculated using either Microsoft Excel student’s 
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t-test or Graphpad Instat software (Graphpad) by using two-sided P values or 
using ANOVA analysis for multiple sample comparisons. All primer 
sequences are listed in primer table (Table 2.2). 
Table 2.2: Primer Table: 
Genes Sequence (5’-3’) Product 
(bp) 
CCNB1-F 
CCNB1-R 
CATGGTGCACTTTCCTCCTT 
AGGTAATGTTGTAGAGTTGGTGTCC 
102 
CENPA-F 
CENPA-R 
GCACCCAGTGTTTCTGTCAGT 
CCAGACAGCATCGCAGAAT 
104 
CENPF-F 
CENPF-R 
GCTGCAAGAAGAACTCAGTGG 
GTGTGAGCTCCTTCAATTGATCT 
104 
CEP55_P-F 
CEP55_P-R 
GCGCTCGAGGCTGAGGCAAGACGATCG 
GCGAGATCTCCTGCCCTGGGACAACG 
154 
CEP55-F 
CEP55-R 
TGAAGAGAAAGACGTATTGAAACAA 
GCAGTTTGGAGCCACAGTCT 
112 
CK4-F 
CK4-R 
TCCTGAAGGTCCTCTATGATGC 
GTACTGGGCACGGACCTC 
134 
EGFP-F 
EGFP-R 
TGGCCGACAAGCAGAAGAAC 
CTTCTCGTTGGGGTCTTTGCTC 
138 
FOXM1A-F 
FOXM1A-R 
TGGGGAACAGGTGGTGTTTGG 
GCTAGCAGCACTGATAAACAAAG 
120 
FOXM1B -F 
FOXM1B –R 
CCAGGTGTTTAAGCAGCAGA 
TCCTCAGCTAGCAGCACCTTG 
287 
FOXM1C-F 
FOXM1C-R 
CAATTGCCCGAGCATTGGAATCA 
TCCTCAGCTAGCAGCACCTTG 
279 
HELLS_P-F 
HELLS_P-R 
ACTCCGCCTGGTCCATCACTTCT 
CGCGCGGCTCACATCTTAAGTG 
167 
HELLS-F 
HELLS-R 
GGATGGCTGAATTCAAAAGATT 
CAAAGTCCCTTTCCGTTTGT 
113 
NEK2-F 
NEK2-R 
CATTGGCACAGGCTCCTAC 
GAGCCATAGTCAAGTTCTTTCCA 
90 
NESTIN-F 
NESTIN-R 
GAGGTGGCCACGTACAGG 
AAGCTGAGGGAAGTCTTGGA 
86 
NUMB-F 
NUMB-R 
GTAAAGGGCACAGCCAAGAT 
AAAACTTTGCCGTAATTTGTTCA 
69 
p75NTR-F 
p75NTR-R 
TCATCCCTGTCTATTGCTCCA 
TGTTCTGCTTGCAGCTGTTC 
110 
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POLR2A-F 
POLR2A-R 
GCAAATTCACCAAGAGAGACG 
CACGTCGACAGGAACATCAG 
72 
YAP1-F 
YAP1-R 
CCCAGATGAACGTCACAGC 
GATTCTCTGGTTCATGGCTGA 
82 
 
2.9 Immunoblotting 
 
2.9.1 Protein Extraction 
Total cell proteins were  extracted from cultured cells in 1x RIPA buffer [50 mM 
Tris 1 M, pH 7.3, 150 mM NaCl, 0.02% (w/v) SDS, 1% (v/v) Nonidet P-40, 10 
mM sodium orthovanadate, 1x CM-EDTA complete mini EDTA-free cocktail 
tablets (Roche Diagnostics, Burgess Hill UK)]. Cell lysates were kept on ice for 20 
minutes and then centrifuged at 20,000 x g at 4°C for 20 min, and the supernatant 
was snap frozen in dry ice before being stored at -80°C. Protein concentrations were 
measured using the Dc Protein Assay Kit (BioRad, Hertfordshire, UK). 
 
2.9.2 Western Blotting 
Extracted proteins were diluted in 5x SDS sample buffer (0.3 M Tris-HCL, 0.25 M 
DTT, 0.1 % Bromophenol Blue (v/v) , 50% Glycerol (v/v) , 10% SDS (w/v)) and 
briefly denatured for 5 min at 100°C before loading on either pre-cast 4-12% or 
10% NuPAGE® (Invitrogen, Paisley UK) gels, or on  standard 6% or 8% SDS-
polyacrylamide gels. Gels were typically run in the presence of NuPAGE® MES-
SDS running buffer (Invitrogen) for pre-cast gels, or standard 1x SDS based 
running buffer (3.0 g Trizma Base, 14.4 g Glycine, 1 g SDS, 1 L of dH2O) at a 
constant rate of 90V until molecular weight marker (Precision Plus Protein All Blue 
Standards; Bio-Rad Laboratories, Hertfordshire UK) separation was evident, after 
which point voltage was increased to 120V. Proteins were then transferred to 
nitrocellulose membranes (Hybond C-extra; Amersham; GE Healthcare UK) in a 
Bio-Rad transfer tank containing 1x Transfer Buffer (25 mM Tris, 192 mM 
Glycine, 20% methanol) at a constant current of 300 mA for 90 minutes or at 
constant 25V for overnight transfer at 4oC. Membranes were then blocked in 5% 
non-fat dry milk in TBS (Tris buffered saline) containing 0.1% Tween-20 (Sigma 
Aldrich) (TBST) for 30 min at room temperature. Next, membranes were probed 
with primary antibodies in either 3% TBST milk or 5% BSA (bovine serum 
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albumin; Sigma, Dorset UK) –TBST. Secondary antibodies were diluted in 3% 
TBST non fat dry milk. Primary antibodies used are listed in antibody table (Table 
2.2). Secondary antibodies used were polyclonal rabbit anti-mouse 
immunoglobulin/HRP (DakoCytomation, Cambridgeshire UK), polyclonal goat 
anti-rabbit immunoglobulin/HRP (DakoCytomation). Immunodetection was 
performed with enhanced chemiluminescence reagent ECL plus (Amersham, GE 
Healthcare UK). For protein dephosphorylation, cell lysates were incubated at 37°C 
for 1 hour in a mix containing 7.5 μg protein, 1x CM-EDTA complete mini EDTA-
free protease inhibitors (Roche), 1x NEB buffer 3 and 1 unit/µg of protein of calf-
intestinal alkaline phosphatase (CIP; New England Biolabs, UK). Samples were 
then denatured for 5 minutes at 100°C and were run on 6% SDS PAGE and 
immunoblotted with the corresponding antibody (See antibodies Table 2.2 ) 
 
2.10 Immunocyto/histo-chemistry Paraffin (IHC-P)/Frozen 
(IHC-F) 
Organotypic raft sections, cut at a thickness of 4 µm, were initially heated at 
60oC for eight minutes. Sections were then deparaffinised in Xylene (3x for 5 
minutes) and then dehydrated in (95% ethanol, 90% ethanol, 70% ethanol for 
5 minutes each) and finally rehydrated by incubating for 5 minutes in water. 
Antigen unmasking was performed by incubating sections in sub-boiling 
temperature for 20 minutes in high pH (9.0) antigen retrieval solution 
(DakoCytomation). The sections were allowed to cool down to room 
temperature for 30 minutes before washing 2x in TBST and  were then 
permeabilised with TBS 0.2% Triton-X (Sigma) for 10 minutes at room 
temperature. Protein blocking was performed by 1 hour incubation in 10% 
Goat Serum (Sigma) in TBST at room temperature. Primary antibody probing 
was performed by overnight incubation at 4oC in 1%BSA TBST. Sections 
were then washed 3x in TBST and probed with fluorescence conjugated 
secondary antibodies (diluted in 1% BSA in TBST) for 1 hour at room 
temperature. Finally sections were washed 3x in TBST and mounted with 
Shadon Immu-MountTM (Thermo Scientific) solution cotaining DAPI (DAPI 
dilactate; Sigma) at a final concentration of 300 ng/ml. For frozen section 
staining, the fixation protocols included 4% (v/v) formaldehyde in PBS for 20 
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minutes at room temperature or ice cold methanol: acetone (1:1) for 10 
minutes at room temperature. The staining procedure was thereafter the same 
as mentioned above for paraffin embedded tissues. Similarly, cultured 
keratinocytes were fixed in either 4% (v/v)  formaldehyde (Sigma) in PBS for 
20 minutes at room temperature or in ice cold acetone methanol 1:1 for 10 
minutes. When the latter fixation protocol was used, the permeabilisation step 
was omitted. The staining protocol was thereafter the same as described above. 
Table 2.3: Table of Antibodies 
Antigen Antibody (Cat. No) Species Supplier 
Dilution/Conc
entration 
CD271 
(p75NTR) – PE 557196 Mouse BD Biosciences 
20 μl / 106 cells / 
100 μl (FC) 
CD29 (β1 
integrin) – FITC Ab 23834 Rabbit Abcam 
10 μl / 106 cells / 
100 μl (FC) 
EGFP Ab 2390 Rabbit Abcam 
1:2000 (WB) 
1:100 (IHC-P, 
IHC-F) 
Filaggrin 15CID Mouse Monosan 1:50 (IHC-P) 
FOXM1 
MPP2 (C:20) sc-
502 
 
Rabbit Santa Cruz 
1:1000 (WB) 
1:100 (IHC-P, 
IHC-F) 
GAPDH 9485 Rabbit Abcam 1:20000 (WB) 
Integin β1 sc-13590 Mouse Santa Cruz 1:100 (IHC-F) 
Involucrin Ab68 Mouse Abcam 1:40,000 (WB) 
Involucrin H120 Rabbit Santa Cruz 1:250 (IHC-P) 
Cytokeratin 13 Ab 48575 Mouse Abcam 1:50 (IHC-F, IHC-P) 
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Cytokeratin 16 - Mouse CRUK 1:100 (IHC-P) 
Ki-67 M7240 (clone MIB-1) Mouse 
Dako 
Cytomation 
1:500 (IHC-P-
IHC-F) 
p16INK4a 
(CDKN2a) 551154 Mouse BD Biosciences 1:2000 (WB) 
p21 (CDKN1a) sc-817 Mouse Santa Cruz 1:500 (WB) 
p63 (4A4) sc-8431 Mouse Santa Cruz 1:2000 (WB) 
p75NTR MAB365 Mouse Millipore 1:100 (IHC-F) 
PARP 9542 Rabbit Cell Signalling 1:1000 (WB) 
Phospho-p38 
(Thr180/Tyr182) 9215 Rabbit Cell Signalling 1:1000 (WB) 
Phospho-p53 
(Ser 15) 9284 Rabbit Cell Signalling 1:1000 (WB) 
Phospho-Rb (Ser 
780) 9307 Rabbit Cell Signalling 1:4000 (WB) 
TGAse-1 Pab0061 Rabbit Covalab-UK 1:250 (IHC-P) 
β-catenin 
(CTTNB1) C7082 Mouse Sigma 1:5000 (WB) 
β-tubulin sc-9104 Rabbit Santa Cruz 1:5000 (WB) 
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2.11 Time-Lapse Fluorescence Video microscopy and 
digital pixel densitometry 
Time-lapse microscopy was performed at 20 minute intervals for 72 hours 
where fluorescence and brightfield images (n=6) were recorded from each test 
well at each time point using the Metamorph software linked to a fluorescence 
microscope (Nikon Eclipse TE200S) equipped with a temperature-controlled 
humidified chamber with 5% CO2/95% atmospheric air. Live-cell EGFP 
fluorescence expression levels were quantified using Adobe Photoshop CS3 
(Adobe Systems Incorporated, USA) utilizing the Colour Range tool for EGFP 
quantification or Lasso tool for manual selection of epidermal area and 
subsequent pixel area readout from the Histogram data chart. Whilst we have 
also used ImageJ program for pixel densitometry and obtained similar results, 
Photoshop was the preferred choice for its accuracy, reproducibility and ease 
of use. 
 
2.12 Flow Cytometry 
 
2.12.1 Cell Cycle Analysis 
Flow Cytometry analytical runs were performed on a BDLSRII fitted with an 
Argon Laser 488 nm, violet diode 405 nm, red diode 633 nm and a UV laser 
35036 nm (San Jose, California, USA) at the Flow Cytometry Core Facility, at 
the Institute of Cell and Molecular Sciences, Bart’s and the London School of 
Medicine and Dentistry, by Dr. Gary Warnes. For flow cytometry – Hoechst-
33342 (Sigma) analysis cells were trypsinised and centrifuged at 218 x g for 5 
minutes. After washing with 1x PBS, cell pellets were resuspended in 2ml of 
Hoechst-33342 10 µg/ml in PBS. After 1h incubation at 37oC/10%CO2/90% 
air, cells were passed through a 75 µm cell strainer (BD Biosciences) and 
cellular DNA content was measured by flow cytometry where 30-50,000 
events per sample were acquired. For flow cytometry - propidium iodide (PI; 
Sigma) analysis culture medium was centrifuged together with trypsinised 
cells to include detached cells in analysis. After washing once in PBS, cell 
pellets were resuspended in 1 ml of ice-cold 70% ethanol under light vortexing 
to avoid the formation of cell clumps. Cells were then incubated either for 2 
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hours or overnight at 4 oC. Cells were washed once in PBS, before 
resuspending in 500 µl of PI/RNaseA mix (500 µg/ml PI, 5 mg/ml RNaseA; 
Sigma), 100m M NaCitrate, PBS), incubated for 20 min in the dark at room 
temperature and cellular DNA content was measured by flow cytometry by 
collecting 25,000 events per sample. 
 
2.12.2 Fluorescence Activated Cell Sorting (FACS) 
Fluorescence activated cell sorting experiments were performed on BD 
FACSAria Cell-Sorter (BD Biosciences, Oxford UK) at the Flow Cytometry 
Core Facility, at the Institute of Cell and Molecular Sciences, Bart’s and the 
London School of Medicine and Dentistry, by Dr. Gary Warnes and Dr. 
Sandra Martins. For FACS, keratinocytes were tyrpsinised, spun at low speed 
centrifugation at 140 x g for 5 minutes, and resuspended in cold PBS. Cells 
were then counted as described (see section 2.2.4). Cells were then spun again 
as above and finally resuspended in cold FACS buffer consisting of PBS with 
5% FBS, and 1% penicillin/streptomycin at a concentration of 106 cells/100 μl. 
 
2.12.3 Oral Keratinocyte Stem Cell Sorting 
Keratinocytes were stained by direct immunofluorescence for 15 minutes on 
ice with either FIT-C conjugated anti-integrin β1 (CD29-FITC; Abcam, 
Cambridge UK), PE conjugated anti-p75NTR (CD271-PE; BD Biosciences, 
Oxford UK) or both at a concentration of 10 μl/106 cells in 100 μl of FACS 
buffer for anti-integrin β1 or with 20 μl/106 cells in 100 μl for anti-p75NTR. 
Cells were spun at low speed centrifugation at 140 x g for 3 minutes, washed 
once in cold PBS, spun again at 140 x g for 3 minutes, and finally resuspended 
in cold FACS buffer for live cell sorting, which essentially consisted of FAD 
medium that contained only 5% FBS. For dead cell exclusion 200 ng/ml DAPI 
(DAPI dilactate; Sigma) were finally added in FACS buffer. DAPI positive 
cells were gated out, and integrin β1 or p75NTR positive/negative fractions 
were sorted by selecting the highest/lowest 20% of stained cells respectively. 
Double-positive cells consisted of the combined percentage of positive 
fractions for both antibodies. Random sorted control populations were selected 
randomly from the total pool of DAPI negative cells. Keratinocytes were 
directly plated, through the automated cell dispenser, to achieve maximum 
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accuracy, on 6-well plates at concentrations ranging from of 5x102 to 1x104 
keratinocytes per 35 mm well, which already contained a pre-plated (24 hours 
ago) mitomycin C treated 3T3 feeder layer (see section 2.2.1 for feeder layer 
preparations). 
 
2.13 DNA Extraction and Quantification 
Genomic DNA (gDNA) was extracted from confluent keratinocyte cultures 
using Nucleon Genomic DNA Extraction kit BACC3 (RPN8512, Amersham 
Biosciences, Bucks, United Kingdom) according to the manufacturer's 
instructions. Confluent keratinocyte cultures were lysed in Buffer B (350 
µl/100mm dish; Amersham Biosciences, Bucks, UK) and lysates were very 
gently scraped into eppendorf tubes. Proteins were precipitated by the addition 
of 5 M sodium perchlorate (100 µl, Amersham Biosciences) and gentle 
mixing, followed by addition of 700 µl chloroform (Sigma). Phase separation 
was followed by addition of nucleon resin (Amersham Biosciences) and tubes 
were spun at 1,000 x g for 2 minutes at 4oC. Top aqueous layer was removed 
and DNA was precipitated by addition of room temperature 100% ethanol. 
DNA was pelleted at 20,000 x g for 10 minutes at 4oC. DNA pellet was 
washed in 70% ethanol, before being spun at 20,000 x g at 4oC for 5 minutes. 
Finally, DNA pellet was air dried before being dissolved in reduced EDTA-
Tris buffer (0.5 mM EDTA,10 mM Tris pH 7.5). gDNA concentrations and 
purity were determined using the NanoDropTM ND-1000 (ThermoScientific, 
Cambridgeshire UK). 
 
2.14 10K SNP Microarray Mapping Assay 
 
2.14.1 GeneChip® Mapping Assay 
The GeneChip® Mapping Assay (Affymetrix Inc., Santa Clara, CA) genotypes 
at least 10,000 human single nucleotide polymorphisms (SNPs), on a single 
array. Although this tool is classically used for the identification of genotypic 
regions that are linked, or associated to, a particular phenotype, it is also useful 
for the identification of regions of chromosomal abnormalities that may occur 
during the progression of human malignancies.  
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Allele discrimination and genotyping is achieved by allele specific 
hybridization (ASH). The array contains pairs of 25-mer DNA probes, each of 
which (sense and antisense) corresponds to both of the two possible alleles of 
a genomic region that contains one SNP. By hybridizing the target DNA on 
the arrays, it is possible to determine whether a given SNP is homozygous (i.e. 
AA or BB) or heterozygous (i.e. AB), by analyzing the resulting signal 
generated by hybridization. The 25-mer probes contain a sequence that is a 
perfect match to allele A (PMA) and B (PMB). Specificity of DNA 
hybridization is controlled by the addition of single base-pair mismatches at 
the centre of each 25-mer (MMA and MMB). An example of a hybridized 
SNP is shown on Figure 2.5 
 
Figure 2.5 : Allele specific hybridization 
(A) This probe contains sense and anti-sense 25-mer DNA sequences that correspond 
to both of the two possible alleles of a SNP (PMA and PMB). They also contain 
mismatch sequences for A and B (MMA and MMB). (B) If target DNA is AA or BB, 
then hybridization signal will be derived solely from either PMA or PMB. If target 
DNA is AB, then hybridization signal will come from both PMA and PMB. Image 
obtained from protocol provided by Affymetrix. 
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For DNA to hybridize on the array, it must first be biochemically prepared. 
Genomic DNA is first broken down in many pieces by restriction enzyme 
digestion, and is then ligated to adaptors that specifically recognize the base 
overhangs. A generic primer is thereafter used to recognize the sequence of the 
adaptor, and to amplify all ligated sequences resulting in the generation of 
250-1000 bp genomic DNA fragments. The amplified DNA is finally 
fragmented, labeled and hybridized to GeneChip® arrays.  
 
2.14.2 Genomic DNA Preparation and Data Analysis 
Primary NHEK and N/TERT gDNA samples were processed as described 
previously (Kelsell et al., 2005; Teh et al., 2005; Blaydon et al., 2006) with 
slight modification to the standard GeneChip Mapping 10K (V2.0) Xba Assay 
protocol (Affymetrix Inc., Santa Clara, CA). An amount of 350-500 ng of 
DNA was digested with XbaI and ligation to the XbaI adaptor prior to PCR 
amplification using AmpliTaq Gold with Buffer II (Applied Biosystems, 
Foster City, CA). The PCR amplification profile on an MJ DNA Engine 
thermal cycler was: 95/180, 59/15, 72/60 (°C/sec) for 40 cycles followed by a 
termination step at 72°C for 7 minutes. PCR products were purified using 
Ultrafree-MC 30,000 NMWL filter columns (Cat#UFC-3LTK00; Amicon) 
and DNA concentrations determined using NanoDrop spectrophotometer. 
Hybridisation and scanning of the arrays were processed as described 
previously (Kelsell et al., 2005; Teh et al., 2005; Blaydon et al., 2006) and has 
been performed by Ms. Tracy Chaplin-Perkins at the Cancer Research UK 
Medical Oncology Laboratory, Institute of Dentistry, Barts & The London 
School of Medicine and Dentistry, Queen Mary University of London, United 
Kingdom. LOH and LOH likelihood were analyzed using Affymetrix 
GeneChip Genotyping Analysis software (GTYPE, version 4.1) where the 
threshold for statistical significance was P ≤ 10-6 as recommended by 
Affymetrix (Kennedy et al., 2003; Liu et al., 2003). The data were cross 
verified and genome ploidy ± standard deviation for Log 2 ratio values were 
obtained using an independent algorithm, Copy Number Analyzer for 
GeneChip (CNAG, version 2), which has been shown to improve signal-to-
noise ratios in heterogeneous genomes (Nannya et al., 2005). The SNP call 
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rates for the control (mock transduced), EGFP and FOXM1B transduced 
primary NHEK cells were 98.45%, 98.24% and 97.27%, respectively. Putative 
genes within or adjacent to the LOH SNPs were identified using Affymetrix 
Integrated Genome Browser (IGB, version 4.56) using the NCBI Human 
Genome Assembly (version 36; March 2006). Data were also analyzed using 
Ideogram Browser v.0.20.4 from http://www.informatik.uni-
ulm.de/ni/staff/HKestler/ideo/ (Muller et al., 2007) for easier visualization and 
illustration of the analyzed results. 
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3 Regulation of FOXM1 in Oral Squamous Cell 
Carcinoma 
3.1 Introduction 
Despite the fact that the FOXM1 is overexpressed in the majority of human solid 
tumours, the regulation of its expression in oral epithelial malignancies has not been 
investigated. Oral squamous cell carcinomas (OSCCs) are highly aggressive and a 
major cause of mortality and morbidity worldwide. The link between tumour growth 
and overexpression of FOXM1 in certain tumours of epithelial origin, predicts an 
important role of this transcription factor in the initiation and progression of 
OSCCs. Therefore, this study initially aimed to understand how FOXM1 is 
regulated at both the transcription and protein levels in a variety of normal, pre-
malignant, and OSCC tissues, and tissue derived cells.   
 
Recent studies conducted in our group have shown that concomitant exposure to 
nicotine, a major constituent of tobacco (risk factor associated with the genesis of 
OSCCs), and overexpression of FOXM1B isoform, can mediate the transition of 
pre-malignant keratinocytes to a malignantly transformed cell line, as judged by its 
ability to form colonies in soft agar (Gemenetzidis et al., 2009). During the course 
of FOXM1B-induced malignant transformation, certain genomic loci, containing 
genes important in chromatin remodelling, gene expression regulation, and mitotic 
division, were frequently amplified (Gemenetzidis et al., 2009). Therefore, this 
study will also examine the potential effects of nicotine, in the expression of 
FOXM1, and further assess the possibility that FOXM1 can directly regulate the 
expression of genes that are important in the malignant conversion of oral 
keratinocytes.  
 
3.2 Results 
 
3.2.1 FOXM1 Protein Levels Correlate with Disease Progression 
FOXM1 protein levels were investigated in a cohort of 25 patients’ tissue samples 
containing normal oral mucosa, oral pre-malignant (dysplastic) lesions, OSCCs, and 
metastatic tumour tissue samples by means of immunohistochemistry (Sample 
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processing and IHC shown in Figure 3.1 were performed by Dr. Ahmed Waseem, 
Centre for Clinical and Diagnostic Oral Sciences, Bart’s and the London School of 
Medicine and Dentistry). In normal oral mucosa, FOXM1 appears to be present 
mainly in the parabasal layers of normal epithelium, with few cells staining positive 
at the basal layers (Figure 3.1A). FOXM1 transcription factor is localized to the 
nucleus prior to, and during mitotic cell division. Consistent with the low index of 
proliferative activity of epithelial tissues under homeostatic conditions, the 
localisation of FOXM1 protein was mainly cytoplasmic in normal oral mucosa 
(Figure 3.1A). However, it can be noted that many cells in the suprabasal, post-
mitotic layers of the epithelium have been positively stained, possibly due to non-
specific staining. FOXM1 protein levels in mild/moderately dysplastic tissues were 
not only markedly increased compared to normal tissue, but also became strictly 
nuclear, indicating increased FOXM1 protein activity (Figure 3.1B). Further 
upregulation of FOXM1 protein can be noted in moderately/severely and severely 
dysplastic/carcinoma in situ (CIS) tissues of oral mucosa, where FOXM1 remains 
predominantly nuclear (Figure 3.1 C, D). Protein levels remained high in tissues 
derived from both primary OSCC and lymph node metastases (Figure 3.1 E, F). 
Quantitative immunohistochemistry analysis of stained tissues confirmed the 
findings, whereby FOXM1 protein displays a progressive upregulation during the 
transition from normal to dysplastic, OSCC, and tissues derived from local 
metastases. 
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Figure 3.1: Upregulation of FOXM1 in pre-malignant and OSCC tissues 
Immunohistochemistry of FOXM1 protein on a panel of formalin fixed, paraffin embedded 
(A) normal human oral mucosa, (B) mild/moderate dysplasia, (C) moderate/severe 
dysplasia, (D) severe dysplasia/carcinoma in situ, (E) primary OSCC, (F) and lymph node 
OSCC metastasis.  
 
 
3.2.2 FOXM1 Expression in Pre-Malignant and OSCC-derived Cell 
Lines 
A panel of different cell lines/primary cells derived either from clinically normal 
oral mucosa or diseased tissues was employed to investigate FOXM1 protein levels 
in vitro. Protein levels were first examined in all different cell types by means of 
immunofluorescence. Results clearly demonstrate that, in agreement to in vivo 
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observations, FOXM1 protein levels are increased in culture keratinocytes derived 
from early premalignant, as well as in keratinocytes derived from late-stage 
advanced OSCC tumours, compared to normal oral keratinocytes (Figure 3.2). 
Notably, the nuclear presence of FOXM1 is enhanced in normal oral keratinocytes, 
compared to what was observed in vivo, possibly due to the increased proliferation 
rates of primary keratinocytes during in vitro culture expansion. 
 
Next, protein lysates were prepared from keratinocytes derived from normal oral 
mucosa, dysplastic, and OSCC tissues, and FOXM1 protein levels were assessed by 
means of immunoblotting. Results show a clear upregulation of FOXM1 protein 
levels in all pre-malignant and OSCC derived cell lines compared to early passage 
normal oral primary keratinocytes (Figure 3.3).  
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Figure 3.2: FOXM1 immunocytochemistry in pre-Malignant and OSCC 
cultured keratinocytes 
Cultured primary human oral (NHOK1, NHOK355), oral pre-malignant (D20, POE9n) and 
OSCC derived (5PT, UK1) keratinocytes were examined for FOXM1 protein levels by 
immunofluorescence, using normal primary oral keratinocytes (NHOK1, NHOK355) as 
control cells. Nuclear DNA was counterstained with DAPI. 
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Figure 3.3: Elevated FOXM1 protein levels in OSCC keratinocytes 
(A) Immunoblotting for endogenous FOXM1 protein in normal (NHOK1 and 
NHOK355), dysplasia (POE9n and D20) and OSCC (CaLH2, CaDec12, UK1 and 
5PT) derived keratinocytes as indicated. β-Tubulin was used as a protein loading 
control in each sample.  
 
 
3.2.3 Downstream Targets of FOXM1 are Overexpressed in OSCC 
Although FOXM1 protein is required for binding to its downstream targets, its 
post-translational modification (mainly phosphorylation) is essential for 
subsequent activation of target gene expression (Wierstra and Alves, 2006b; 
Wierstra and Alves, 2007; Laoukili et al., 2008b). Therefore, FOXM1 protein 
activity was assessed in OSCC derived keratinocytes to understand whether 
overexpressed FOXM1 protein is also transcriptionally active. Protein 
separation on lower percentage SDS-PAGE, revealed the presence of a slow 
migrating band immunoreactive to anti-FOXM1 antibody. This form of 
FOXM1 protein was sensitive to treatment with calf intestinal phosphatase 
(CIP), suggesting that this slow migrating band corresponds to a post-
translationally modified form of FOXM1. This could be either the 
phosphorylated, transcriptionally active form of FOXM1 (FOXM1pp), or the 
product of further protein modifications which can also lead to an increase in 
molecular size (e.g. glycosylation). It can be noted that in 5PT cells, which 
show the highest protein levels of FOXM1 among all cell lines (Figures 3.2, 
3.3), FOXM1pp was less sensitive to CIP treatment, probably due to the 
presence of excessive post-translational protein modification, which could 
suggest that FOXM1 protein in 5PT cells is mainly modified by means other 
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than phosphorylation alone. This intense protein band shift of 5PT cells can 
also be observed in Figure 3.4 A. 
 
To further confirm that FOXM1 remains transcriptionally active in OSCC cell 
lines, the mRNA expression levels of FOXM1 downstream targets CENP-F, 
CENP-A, NEK2, CCNB1 (Leung et al., 2001; Laoukili et al., 2005; Wang et 
al., 2005; Wonsey and Follettie, 2005) were examined. The mRNA expression 
levels of all aforementioned targets were significantly upregulated in OSCC 
derived cell line UK1 (Figure 3.4 B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: FOXM1 protein is active in OSCC derived keratinocytes 
(A) UK1 and 5PT keratinocytes were lysed and CIP treated or untreated control protein 
extracts were immunoblotted against anti-FOXM1 antibody. (B) qPCR data showed that 
known FOXM1B target genes such as CENPF, CENPA, NEK2 and cyclin B1 are 
upregulated in UK1 compared to NHOK1 cells. Bars represent the mean fold difference 
from NHOK1 (arbitrary value of 1) normal control ±SEM for triplicate samples. *(P≤0.05), 
**(P≤0.01) and ***(P≤0.001) indicate significant increase in FOXM1 protein levels when 
compared to NHOK1 cells.  
 
3.2.4 FOXM1 Isoform Specific Expression in OSCC Cell Lines 
Although the data presented here strongly support that FOXM1 protein levels are 
significantly and progressively upregulated in early premalignant and OSCC 
derived tissues, the transcriptional regulation of FOXM1, especially its three 
alternatively spliced isoforms, was unclear. Therefore, the mRNA expression levels 
of each of the three FOXM1 isoforms was investigated in a large panel comprising 
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NHOK control, pre-malignant, and OSCC derived keratinocytes, by the use of well-
characterized and previously validated, FOXM1 isoform specific primers. FOXM1 
isoforms are created upon alternative splicing of exons A1 and A2 (see Figure 1.7). 
FOXM1A has both A1 and A2 exons whilst FOXM1C possesses only A1 exon, and 
FOXM1B has neither of the alternatively spliced exons. Based on these molecular 
structures, isoform-specific primers have been designed (Figure 3.5 A) (primer 
design and specificity validation was performed by Dr. Muy-Teck Teh, Centre for 
Clinical and Diagnostic Oral Sciences, Barts and The London School of Medicine 
and Dentistry). The amplification specificity for each isoform is shown in Figure 
3.5 B. Melting analysis showed the presence of single PCR products, indicated by a 
single peak for each isoform amplified (Figure 3.5 C). PCR products of each 
reaction were visualized on 2% Agarose gels confirming the presence of single 
products which rules out cross-amplification of other isoforms (Figure 3.5 D). 
  
Chapter 3: Regulation of FOXM1 in OSCC  
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 107
 
 
 
Figure 3.5: FOXM1 isoform-specific qPCR 
(A) Primer design based on the gene structure of the three FOXM1 isoforms. Primers were 
designed to recognize alternative exons A1 and A2 (FOXM1A), or A1 only (FOXM1C), or 
none of the above (FOXM1B). qRT-PCR product amplification (B) and melting peak 
analysis (C) at the end of qPCR analysis showing single PCR product for each isoform 
validating amplification specificity. (D) Agarose gel electrophoresis confirmed the presence 
of single PCR product of the expected molecular size for each isoform. 
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Absolute qPCR was performed to compare the expression levels of all FOXM1 
isoforms, between primary NHOK from clinically healthy tissues, to a variety of 
oral pre-malignant (moderate and severe dysplasias) and OSCC cell lines. It was 
found that all three FOXM1 isoforms (FOXM1A, FOXM1B, and FOXM1C) were 
upregulated in both premalignant and OSCC derived cell lines. FOXM1A levels 
were upregulated in OSCC cell lines by 2.3 to 2.5-fold over control normal cells, 
but were not significantly (P>0.05) increased in pre-malignant keratinocytes 
(Figure 3.6). Both FOMX1B (2.3 to 4-fold) and FOXM1C (2.7 to 3.2-fold) isoform 
expressions were significantly increased in both pre-malignant and OSCC cell lines 
(Figure 3.7 A, B).  
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Figure 3.6: FOXM1A expression in oral cancer cell lines 
FOXM1A isoform expression pattern in normal, premalignant and OSCC keratinocytes. 
Normal, pre-malignant, and OSCC keratinocytes were used to study the expression levels of 
FOXM1. mRNA was extracted and qPCR was used to detect expression levels of FOXM1A 
isoform. Relative fold mRNA copy numbers FOXM1A in premalignant and OSCC cells 
was calculated using the average mRNA copy number of a large array of normal oral 
keratinocytes. FOXM1A showed a non-significant (P>0.05) upregulation of expression in 
pre-malignant oral keratinocytes, whilst mRNA levels were 2.5 fold increased in OSCC 
derived cell lines (**P≤0.01). Bars represent the relative fold difference of mRNA copy 
number compared to the average mRNA copy number value of eight different normal 
control samples (arbitrary value of 1) ±SEM for triplicate samples. The cell line panel that 
was used for expression analysis is shown at the bottom. Cell lines were used in the 
specified order from top to bottom for each group. 
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Figure 3.7 FOXM1B and FOXM1C expression in oral cancer cell lines 
FOXM1B and FOXM1C isoforms expression pattern in normal, premalignant and OSCC 
keratinocytes. Normal, pre-malignant, and OSCC keratinocytes were used to study the 
expression levels of FOXM1. mRNA was extracted and qPCR was used to detect 
expression levels of FOXM1B (A) and FOXM1C (B) isoforms. FOXM1B expression (A) 
shows a gradual upregulation in pre-malignant cancer cell lines by 2.3 fold (*P≤0.05) and is 
significantly (**P≤0.01) increased by 4-fold in OSCC derived cell lines. (B) FOXM1C is 
significantly upregulated in oral pre-malignant (2.7-fold) (***P≤0.001) and OSCC derived 
cells (3.2-fold) (**P≤0.01). Bars represent the relative fold difference of mRNA copy 
number compared to the average mRNA copy number value of eight different normal 
control samples (arbitrary value of 1) ±SEM for triplicate samples. 
 
 
3.2.5 Nicotine as a Causative Agent Contributing to FOXM1 
Upregulation 
The generation of OSCC is strongly associated with the exposure of the 
epithelium to known risk factors, such as tobacco and betel quid (Sturgis and 
Wei, 2007). A previous study in our group had identified that nicotine directly 
activated FOXM1 expression (Gemenetzidis et al., 2009). 
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To investigate how endogenous FOXM1 protein levels are regulated in 
response to nicotine exposure, oral keratinocytes were cultured in the presence 
of increasing nicotine concentrations, or vehicle control (DMSO), for 24 hours 
prior to preparing total protein extracts. FOXM1 protein levels showed a 
dramatic increase even in the presence of nicotine concentrations as low as 10-
6M (Figure 3.8 Ai). This response was similar for both premalignant SVpgC2a 
and primary human oral keratinocytes. The lack of significant induction of 
FOXM1 at high doses of nicotine (10-3 M) in NHOK is possibly a result of 
increased cytotoxicity (Figure 3.8 Ai), which was clearly evident under 
routine microscopic examination. Protein lysates from treated keratinocytes 
were also run in lower percentage SDS-PAGE, which revealed the presence of 
a slow migrating band immunoreactive to anti-FOXM1 antibody (Figure 3.8 
Aii). Again, this form of FOXM1 protein was sensitive to CIP treatment, 
indicating that FOXM1 protein is heavily phosphorylated in response to 
nicotine treatment, and therefore capable of downstream target transactivation, 
in both SVpgC2a and primary human oral keratinocytes (Figure 3.8 Aii).  
 
To further confirm that FOXM1 protein retains transcriptional activity in 
response to nicotine treatment, a construct containing five repeats of the 
consensus DNA binding sequence of FOXM1 (Ye et al., 1997) (5xBS), which 
upon binding of active FOXM1 protein can enhance transcription of luciferase 
gene (Ye et al., 1997), was used in SVpgC2a premalignant as well as two 
other malignant keratinocyte cell lines SqCC/Y1 and SCC25. Keratinocytes 
were transfected with 5BS and subsequently exposed to various concentrations 
of nicotine. FOXM1 protein activity was significantly increased in all types of 
keratinocytes (Figure 3.8 B). Maximum levels of protein activity were 
observed in premalignant SVpgC2a cell line, in a dose dependent manner, and 
FOXM1 protein reached its peak activity in the presence of 10-3 – 10-4 M 
nicotine (Gemenetzidis et al., 2009) (FOXM1 reporter assay in Figure 3.8 B 
was performed by Dr. Adeel Riaz).  
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Figure 3.8: FOXM1 is expressed and activated in response to nicotine treatment 
(A) Immunoblotting shows that nicotine dose-dependently activated endogenous 
FOXM1 protein in both the SVpgC2a (left panel) and primary normal human oral 
keratinocytes (right panel) as indicated. Bottom panels showed that protein lysates 
were either pretreated with or without calf-intestinal phosphatase (CIP) prior to 
immunoblotting. Nicotine at respective optimal doses for each cell type showed 
reduction of the phosphorylated FOXM1 (FOXM1-PP, top bands) in CIP-treated 
lysates. b-Tubulin and b-catenin were used as loading control. (B) Dose-response 
curves of nicotine on FOXM1 protein transcriptional activity SVpgC2a (closed black 
circles), SqCC/Y1 (grey shaded circles), and SCC25 (clear white circles) cells treated 
with the indicated doses of nicotine. Each data point indicates mean±SEM (n = 3). 
pEC50 = The potency of nicotine drug in relation to FOXM1 transactivation. 
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3.2.6 Identification of Novel FOXM1 Targets in Neoplastic Oral 
Keratinocytes 
Studies conducted in our group have shown that concomitant exposure to 
nicotine and overexpression of FOXM1B isoform, can induce the transition of  
SVpC2a keratinocytes from a pre-malignant, to a malignantly transformed cell 
line, as judged by its ability to form colonies in soft agar (Gemenetzidis et al., 
2009). By examining the genotype of eight transformed clones, using 10K 
SNP array analysis, several loci were identified as being among the most 
commonly amplified regions. Two of the putative loci contained centrosomal 
protein 55 (CEP55 ; also known in the literature as FLJ10540) and lymphoid- 
specific helicase (HELLS ; also known in the literature as LSH, PASG) genes 
(Gemenetzidis et al., 2009). 
 
Therefore, further investigation took place to understand whether the 
expression of CEP55 and HELLS, were physiologically relevant to OSCC 
biology. The mRNA expression levels of both genes were investigated in a 
large panel comprising NHOK control, pre-malignant, and OSCC derived 
keratinocytes (details on the cell lines used can be found in Chapter 2, section 
2.1.3). Both genes were significantly and consistently overexpressed in both 
pre-malignant and OSCC derived keratinocytes, compared to a series of 8 
individually derived keratinocytes from clinical normal oral mucosa (Figure 
3.9).  
 
Although CEP55 and HELLS were overexpressed in a variety of human pre-
malignant and OSCC derived keratinocytes, this did not constitute definite 
evidence that FOXM1 is the major regulator of either gene in neoplastic 
keratinocytes. To investigate whether FOXM1 may be regulating the 
expression of either gene, primary human oral keratinocytes were retrovirally 
transduced with pSIN-MCS (empty vector), pSIN-EGFP, or pSIN-EGFP-
FOXM1B retroviral vectors. For retroviral vector information and an 
experimental approach for the optimization of retroviral gene delivery 
methods in human keratinocytes, see Chapter 2, section 2.3.5. Ectopic 
overexpression of FOXM1B strongly induced the expression of both CEP55 
and HELLS in primary human oral keratinocytes (Figure 3.10). This evidence 
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shows that in addition to previously identified FOXM1 targets, two novel 
downstream targets, CEP55 and HELLS, are also significantly upregulated in 
oral neoplastic keratinocytes, further highlighting the importance of FOXM1 
in the generation and progression of OSCC. 
 
 
 
 
 
Figure 3.9: CEP55 and HELLS expression patterns in normal, premalignant and 
OSCC keratinocytes.  
Normal, pre-malignant, and OSCC keratinocytes were used to study the expression levels of 
CEP55 and HELLS. mRNA was extracted and qPCR was used to detect expression levels 
of (A) CEP55 and (B) HELLS. CEP55 expression (A) shows a gradual upregulation in pre-
malignant cancer cell lines by 3 fold (right hand panel) (***P≤0.001) and is significantly 
(***P≤0.001) increased by 4-fold in OSCC derived cell lines. (B) HELLS is significantly 
upregulated in oral pre-malignant (4-fold) (**P≤0.01) and OSCC derived cells (6-fold) 
(***P≤0.001). Bars represent the relative fold difference of mRNA copy number compared 
to the average mRNA copy number value of eight different normal control samples 
(arbitrary value of 1) ±SEM for triplicate samples. 
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Figure 3.10: FOXM1B induces the expression of CEP55 and HELLS 
(A) Exogenous overexpression of FOXM1B (determined using isoform-specific qPCR), but 
not MCS (empty vector) or EGFP, in primary human normal oral keratinocytes (NHOK1), 
showed significant (***P≤0.001) induction of endogenous mRNA of (B) CEP55 and (C) 
HELLS, respectively. Bars represent the relative fold difference of mRNA copy number 
compared to the average mRNA copy number value of pSINMCS (arbitrary value of 1) 
±SEM for triplicate samples.  
 
 
The fact that FOXM1B overexpression resulted in strong induction of CEP55 
(Figure 3.10 B), and the strong correlation between FOXM1B and CEP55 
expression in OSCC derived keratinocytes (FOXM1B:CEP55 R2=0.665; FOXM1B: 
HELLS R2=0.205, see Appendix 2), suggested that CEP55 may be a direct 
transcriptional target of FOXM1. This also fits with the well-known function of 
FOXM1 at mitosis, where it directly transactivates the expression of many 
important mitotic proteins (Laoukili et al., 2007). 
 
The possibility that FOXM1 transcription factor directly binds to, and activates the 
promoter of CEP55, was assessed by chromatin immuno-precipitation experiments. 
Putative FOXM1 DNA binding sites (TACGTTGTTATTTGTTTTTTTCG) (Ye et 
al., 1997) were identified within 1Kbp upstream (-570: -730 bp) of the CEP55 gene, 
using DsGene® Discovery Studio (Accelrys Inc.) ClustalW Alignment Tool, and 
specific qPCR primers were designed flanking the region of interest (See Table 2.3 
in Chapter 2, section 2.8). Primary human keratinocytes were either mock 
transduced (Mock; no virus), or retrovirally transduced with EGFP control, or 
EGFP-FOXM1B retroviral vector, and genomic DNA was extracted 48 hours later. 
Chromatin was immuno-precipitated (IP) with anti-FOXM1, anti-GAPDH (control), 
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or anti c-Myc (control) antibodies, to examine whether FOXM1 protein specifically 
binds to the putative promoter of CEP55 gene. The resultant IP fractions were 
amplified using primers specific for the CEP55 promoter region, which contained 
the DNA binding sites for FOXM1 protein (ChIP and qPCR amplification shown in 
Figure 3.11 was performed by Dr. Muy-Teck Teh). Results clearly show that the IP 
fractions retrieved by anti-FOXM1 antibody contain significantly more copies of the 
CEP55 promoter region, indicating preferential binding of FOXM1B protein, and 
providing evidence that CEP55 is direct transcriptional target of FOXM1B.   
 
 
 
 
 
 
Figure 3.11: CEP55 is a direct transcriptional target of FOXM1B 
ChIP-qPCR assays for CEP55 promoter in normal keratinocytes transduced with 
Mock (empty virus), EGFP or FOXM1B. Antibodies for GAPDH and cMYC were 
used as controls for immunoprecipitiation. **P≤0.01, ***P≤0.001 
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3.3 Discussion 
 
3.3.1 FOXM1 Expression in Normal Oral Epithelium 
The forkhead box transcription factor FOXM1 is abundantly expressed in actively 
proliferating cells and as a result its expression is often detected in tissues with high 
proliferative index such as the thymus and testis (Ye et al., 1997; Laoukili et al., 
2007). Although Foxm1 is expressed at high levels in mice embryonic developing 
tissues, its expression is significantly reduced in adult tissues, which are under 
homeostatic conditions. In mouse epithelial adult tissues, Foxm1 expression is 
restricted to the most proliferative layers, but is absent from differentiated layers 
(Ye et al., 1997). These observations, along with the fact that it can be strongly 
induced during tissue regeneration in response to injury (Ye et al., 1997), suggested 
that Foxm1 functions to replenish the short lived population of differentiated 
epithelial cells. 
 
The epithelial tissue undergoes continuous renewal, under a strictly organised 
system that is governed by a hierarchy of cells with differing capacities for 
proliferation. This process is believed to commence by the slow cycling stem cell 
(SC), which is thought to reside within the basal epithelial layer. The tissue 
undergoes expansion by rapid, but limited, rounds of cell division achieved by 
transit amplifying (TA) cells, to finally give rise to post-mitotic terminally 
differentiated cells (Slack, 2000). In human epidermis, which has a high degree of 
similarity with normal oral mucosa epithelium, FOXM1 is mainly localised in basal 
proliferative and immediate suprabasal keratinocytes (Teh et al., 2002). Similarly, 
FOXM1 is mainly expressed in basal and early suprabasal layers of human cervical 
epithelium (Chan et al., 2008), thereby confirming earlier predictions that this 
transcription factor may be involved in the overall proliferative output as well as in 
the continuous replenishment of the adult tissue.  
 
Consistently with these observations, FOXM1 was detected in both the cytoplasm 
and the nucleus of basal and parabasal keratinocytes of the oral mucosal epithelium 
(Figure 3.1). However, it was absent from the uppermost differentiated layers of the 
epithelium, which contain post-mitotic terminally differentiated squames (Figure 
3.1). The relative intensity and immunohistochemical positivity for FOXM1 in 
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human oral mucosa appeared to be higher compared to what was previously 
observed in normal human epidermis (Teh et al., 2002). This could be attributed to 
the fact that normal oral epithelium cell renewal occurs much faster than that of the 
epidermis (Garant, 2003). Consequently, FOXM1 protein levels could be elevated, 
either because it is required for, or as a result of increased proliferation of the oral 
epithelium compared to human epidermis. The localisation, regulation and relative 
expression of FOXM1 during human oral epithelial tissue renewal has been more 
extensively investigated and will be discussed later in Chapter 5. 
 
3.3.2 FOXM1 Overexpression in OSCC Tissues and Cell Lines 
In light of the fact that some FOX genes are active in the same developmental 
settings with sonic hedgehog signalling (Shh) in mice (Mahlapuu et al., 2001), 
FOXM1 was identified as downstream target of Shh effector, GLI1, during the 
generation of human basal cell carcinoma (Teh et al., 2002). This provided the first 
direct evidence for the involvement of FOXM1 in human carcinogenesis, and 
further studies have established that upregulation of FOXM1 is a common event in 
majority of human solid malignancies, strongly suggesting an important role for this 
transcription factor in the manifestation and/or the progression of human 
tumourigenesis. Several studies suggest that FOXM1 is directly associated to the 
transformation potential of human cells (van den Boom et al., 2003; Pilarsky et al., 
2004; Wonsey and Follettie, 2005; Madureira et al., 2006). In the epithelial context, 
FOXM1 protein elevation has been detected in the cases of human breast, lung, 
cervical, and gastric carcinomas (Wonsey and Follettie, 2005; Bektas et al., 2008; 
Chan et al., 2008; Francis et al., 2009; Yang et al., 2009; Zeng et al., 2009). 
Importantly, FOXM1 expression shows a gradual elevation toward the generation of 
lesions of cervical intraepithelial neoplasia III (severe dysplasia), and further 
increases are detected in fully formed cervical SCCs (Chan et al., 2008), while a 
similar correlation between tumour grade and FOXM1 expression was recently 
shown in the case of human lung cancer (Yang et al., 2009).  
 
In agreement with its anticipated role in carcinogenesis, FOXM1 protein levels were 
significantly upregulated even in very early lesions of mild oral dysplasias (Figure 
3.1). FOXM1 protein levels progressively increased through moderate and severe 
oral dysplasias, to maximum levels of expression observed in established carcinoma 
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in situ (CIS) and lymph node metastases (Figure 3.1 and Appendix 1). This 
expression pattern is consistent with evidence from numerous studies suggesting 
that FOXM1 has multiple roles in human tumour development and metastasis (see 
also Chapter 1, section 1.4.6) 
 
The same expression pattern, in terms of intensity and intracellular localisation, was 
also observed in cultured oral keratinocytes, obtained from oral epithelial dysplasias 
and OSCC tumours. Although oral keratinocytes derived from clinically normal oral 
mucosa display FOXM1 protein levels lower than those observed in neoplastic cells, 
FOXM1 was still abundantly detected in majority of normal oral keratinocytes. 
Since FOXM1 expression is tightly linked to the cycling status of cells, young 
normal oral keratinocytes were grown for a maximum of 3-4 PD before detection of 
endogenous levels of FOXM1, to avoid any growth inhibitory effects that may arise 
from in vitro senescence of primary cells. Early passage normal human 
keratinocytes can undergo rapid cell division when initially expanded in vitro, 
which can possibly explain the fact that a large majority of keratinocytes was 
stained positive for FOXM1 in culture, compared to normal oral mucosa tissue in 
vivo. Nevertheless, in comparison to normal oral keratinocytes, the intensity of 
FOXM1 immunoreactivity was significantly elevated in neoplastic keratinocytes, 
which was also evidenced by elevated FOXM1 protein levels in total cell protein 
extracts.  
 
Since FOXM1 is a proliferation associated transcription factor, it is possible to 
assume that the apparent increase of FOXM1 expression in neoplastic cells is an 
outcome of their increased proliferation rate. However, most of premalignant and 
OSCC cell lines examined here had similar, or even reduced, proliferation rates 
(personal observation) than young early passage normal oral keratinocytes grown 
under optimum conditions in serum free (feeder layer free) with low or high 
calcium, as well as in serum containing medium in the presence of NIH3T3 feeder 
layers. Similarly, upregulation of FOXM1 was also found in transformed human 
breast cancer cell lines when compared to their un-transformed, but proliferatively 
active counterparts (Wonsey and Follettie, 2005; Madureira et al., 2006). This 
strongly suggests that the effect of FOXM1 expression is also involved in processes 
other than cell proliferation, and could be directly associated with malignant 
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transformation of human cells. This is also consistent with the demonstration that 
FOXM1 and Ki67 proliferation marker, which show limited co-localisation in 
human basal cell carcinomas (Teh et al., 2002).  
 
3.3.3 FOXM1 Isoform Specific Expression in OSCC Keratinocytes 
The FOXM1 gene locus produces three separate isoforms; FOXM1A, FOXM1B, 
and FOXM1C, by alternative splicing of the A1 and A2 exons. Although FOXM1 
protein elevation could be readily detected in pre-malignant and OSCC tissues 
(Figure 3.1), this method did not allow discrimination between individual isoform 
expression. By using isoform specific primers, it was found that although all the 
expression of all FOXM1 isoforms was elevated in OSCC derived keratinocytes, 
only FOXM1B and C were significantly and consistently upregulated in pre-
malignant and OSCC keratinocytes (Figure 3.7). Since all isoforms are generated 
by a common FOXM1 gene locus, the relative differences in the abundance of 
mRNA of each isoform can be attributed to post transcriptional modifications, 
which may influence the stability of distinct FOXM1 isoform mRNAs. The inability 
of FOXM1A to transcativate downstream targets (Ye et al., 1997)may potentially 
render the expression of this isoform unnecessary for processes that are otherwise 
efficiently executed by the remaining functional FOXM1 isoforms. Consequently, 
there would be no selective advantage for neoplastic oral keratinocytes to enhance 
the stability of mRNA that encodes a transcriptionally inactive isoform. Gene 
expression and protein translation can be influenced by factors such as mRNA 
stability/decay (Ross, 1995; Guhaniyogi and Brewer, 2001) as well as by other 
regulatory mechanisms involving microRNA (miRNA) expression and 
miRNA/mRNA interactions which can lead to suppression of gene expression 
through mRNA degradation (Filipowicz et al., 2008). Although interesting and 
novel, further studies are required to delineate the post-transcriptional regulation of 
differential FOXM1 isoform mRNA abundance in human oral cancer cells.  
 
3.3.4 Overexpression of FOXM1 Downstream Targets in Oral Cancer 
FOXM1 protein localisation becomes increasingly nuclear in neoplastic cultured 
oral keratinocytes (Figure 3.2), which agrees with in vivo observations (Figure 
3.1). Upon nuclear translocation, and protein phosphorylation, FOXM1 can 
efficiently bind to genomic DNA, to activate transcription of a multitude of genes, 
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most of which are involved in mitotic progression (Wang et al., 2005; Laoukili et 
al., 2007). The expression signature of OSCC derived keratinocytes (Figure 3.4), 
further suggests that OSCC derived keratinocytes retain elevated, active levels of 
FOXM1 protein, which activates important mitotic regulatory proteins including 
cyclin B1 (CCNB1), centromere protein A (CENP-A), centromere protein (CENP-
F), and never in mitosis gene a-related kinase 2 (NEK2). CENP-A and CENP-F 
have vital roles in centromere formation and chromosome seggregation respectively 
(Howman et al., 2000; Wonsey and Follettie, 2005), while NEK2 kinase is an 
important regulator of centrosome disjunction (Faragher and Fry, 2003). 
Importantly, all of the above mitotic regulatory proteins have been found to be 
overexpressed and/or amplified (genomic locus amplification) in variety of human 
malignancies and tumour derived cell lines (Tomonaga et al., 2003; Perez de Castro 
et al., 2007).  
 
Consistent with the observation that FOXM1 and its downstream targets are 
upregulated in OSCC tissues and cultured keratinocytes respectively, CENP-F 
protein levels are also elevated in oral leukoplakias and high degree dysplasias (Liu 
et al., 1998), while a subset of head and neck tumours exhibits CENP-F gene 
amplification and increased gene expression (de la Guardia et al., 2001). The 
expression of NEK2 has not yet been reported as being elevated in human oral 
carcinomas, but evidence suggests that its expression is highly de-regulated by 
overexpression of HPV type16 E6 and E7 (risk factor associated with a subset of 
OSCC) oncoproteins in human epidermal keratinocytes (Patel et al., 2004). The fact 
that FOXM1 acts as a downstream effector of E7 (Luscher-Firzlaff et al., 1999) 
protein raises the possibility FOXM1 may be mediating the upregulation of NEK2 
in a proportion of OSCC that are associated with HPV infection. 
 
3.3.5 CEP55 and HELLS are Novel Downstream Targets of FOXM1 in 
OSCC 
The finding that FOXM1B-induced malignant transformation is accompanied by 
genomic amplification of CEP55 and HELLS (Gemenetzidis et al., 2009), raised 
two important possibilities. First, both genes are critical for malignant 
transformation of pre-malignant oral keratinocytes, and second FOXM1B may be 
the main regulator of both genes during that process.  
Chapter 3: Regulation of FOXM1 in OSCC  
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 122
The evidence presented here suggest that both CEP55 and HELLS are highly 
overexpressed in pre-malignant and OSCC derived keratinocytes (Figure 3.9), 
confirming the prediction that both genes might have an important role in the 
initiation and/or progression of head and neck cancer. CEP55 is strictly expressed at 
mitosis, during which it plays a crucial role in cytokenesis (Fabbro et al., 2005). 
Following the observation that CEP55 and FOXM1 tightly linked with OSCC 
initiation and progression (Gemenetzidis et al., 2009), a study further confirmed that 
CEP55 is correlated with aggressiveness of oral squamous cell carcinomas 
(OSCCs), and further suggested that CEP55 promotes cell migration and invasion 
through increased FOXM1 and matrix metalloproteinase-2 (MMP2) activity (Chen 
et al., 2009a). CEP55 overexpression has also been reported in hepatocellular (Chen 
et al., 2007), lung (Chen et al., 2009b), and breast (Martin et al., 2008) carcinomas. 
Most importantly, the latter study has also established that FOXM1 and CEP55 are 
amongst the signature prognostic markers which predicted breast cancer outcome 
(Martin et al., 2008). Lymphoid specific helicase (LSH or HELLS) belongs to the 
family of SNF2/helicases/chromatin remodelling proteins (Geiman et al., 1998), and 
has been shown to be a major regulator of DNA methylation (Dennis et al., 2001). A 
recent study demonstrated that overexpression of LSH is sufficient to delay in vitro 
senescence of human fibroblasts by silencing the expression of p16INK4a (Zhou et 
al., 2009). HELLS has been previously linked to human carcinogenesis, since its 
overexpression has been reported in leukaemia (Lee et al., 2000), non-small cell 
lung carcinomas (Yano et al., 2004), breast cancer (Einbond et al., 2007), and 
melanoma (Ryu et al., 2007). 
 
It is demonstrated here, that FOXM1 is potentially having an important role in the 
regulation of CEP55 and HELLS since ectopic expression of FOXM1B alone was 
sufficient to induce the expression of both genes in primary human oral 
keratinocytes (Figure 3.10). This, along with the high correlation exhibited by 
FOXM1B and CEP55 expressions in neoplastic keratinocytes, prompted 
investigation into whether FOXM1B can directly induce the expression of CEP55. 
Putative DNA binding sites for FOXM1 protein were identified within the CEP55 
promoter, and following ChIP-qPCR, it was confirmed that FOXM1B protein can 
directly bind to this specified region of the CEP55 promoter. This finding fits with 
the fact that FOXM1 is a critical regulator of mitotic proteins (Laoukili et al., 2007), 
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and is in line with the fact that depletion of FOXM1 mRNA (siRNA against 
FOXM1) from breast carcinoma cell lines, leads to dramatic down-regulation of 
CEP55 expression levels (Wonsey and Follettie, 2005) (Retrieved GEO Data Sets 
from Affymetrix Gene Expression Analysis; see Appendix 3). The finding that 
FOXM1B induced the expression of HELLS, is indeed an intriguing observation 
since, unlike most FOXM1 targets, HELLS is not directly linked to mitotic 
progression. This interaction seems to be indirect, since FOXM1 did not bind within 
the 1Kb putative promoter of HELLS (Gemenetzidis et al., 2009). However, the 
existence of a FOXM1 bindging site byond the 1Kbp promoter of HELLS remains 
to be investigated. Nevertheless, further investigation is needed to understand the 
mechanism by which FOXM1 enhances the transcription of HELLS, and whether 
through this interaction, FOXM1 may exert functions related to chromatin 
remodelling and regulation of gene transcription.  
 
In addition to the upregulation of previously identified FOXM1 targets, this study 
identified two novel targets of FOXM1, and further showed that both are also 
significantly overexpressed in cells derived from pre-malignant lesions and OSCC 
tumours.  
 
3.3.6 Potential Mechanisms Leading to FOXM1 Upregulation in OSCCs 
Head and neck squamous cell carcinoma (OSCC), like many epithelial 
malignancies, arises from a common premalignant progenitor, followed by the 
outgrowth of clonal populations, which are usually subjected to cumulative genetic 
alterations that lead to invasive malignancy (Hunter et al., 2005). This multistep 
process involves the inactivation of tumour suppressor genes and activation of 
proto-oncogenes as a result of deletions, point mutations, promoter methylation and 
gene amplification (Perez-Ordonez et al., 2006). Which of these mechanisms 
contributes the most to FOXM1 upregulation is currently unknown. FOXM1 gene 
locus (12p.13) was found to be amplified in keratinocytes derived from primary 
OSCCs. However, the very low frequency of gene amplification (only 1 out of 7 
OSCC related studies has reported 12p13 amplification, which was found in MD886 
OSCC keratinocytes) (Rao et al., 1994; Sreekantaiah et al., 1994; Mertens et al., 
1997; Bockmuhl et al., 1998; Jin et al., 2000; Singh et al., 2001), suggests that this 
is probably a late event occurring in only a small subset of tumour cells, and thus 
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unlikely to be the sole explanation for the high-level overexpression of FOXM1 in 
majority of OSCCs. 
 
Since FOXM1 is deregulated at both the transcription and protein levels in oral pre-
malignant and OSCC tissues and cultured keratinocytes, the pathway, or pathways, 
leading to its upregulation may influence both FOXM1 protein expression and 
stability. In terms of gene transcription, FOXM1 is regulated by proliferative 
stimuli, some of which have also been implicated in the pathogenesis of oral 
squamous cell carcinoma. c-MYC transcription factor, and HIF-1α (the active HIF-1 
subunit) transcription factor subunit, can both induce transcription of FOXM1 by 
direct binding to its promoter (Fernandez et al., 2003; Wierstra and Alves, 2007; 
Blanco-Bose et al., 2008; Xia et al., 2009), and more importantly, they have been 
reported to be either overexpressed or amplified in cases of OSCCs (Haughey et al., 
1992; Eversole and Sapp, 1993; Porter et al., 1994; Aebersold et al., 2001; Beasley 
et al., 2002). Moreover, the upstream regulator of FOXM1, GLI1, has been found 
overexpressed in oesophageal tumours and tumour derived cell lines, suggesting a 
mechanism of FOXM1 upregulation similar to that observed in BCCs (Teh et al., 
2002; Mori et al., 2006). The recent finding that GLI2, which can directly bind to, 
and activate the promoter of GLI1 in human epidermal keratinocytes (Regl et al., 
2002), is amplified in OSCCs (Snijders et al., 2009), suggests a mechanism whereby 
FOXM1 increased expression may be the outcome of a regulatory pathway between 
oncogenic transcription factors GLI1, and GLI2. Recent studies showed that 
FOXM1 expression is negatively regulated by the tumour suppressor p53, in human 
cell lines (Barsotti and Prives, 2009; Pandit et al., 2009). Since inactivating 
mutations of the latter are frequently seen in pre-malignant lesions of the oral 
mucosa and HNSCCs (Somers et al., 1992; Boyle et al., 1993; Shahnavaz et al., 
2000) as well as in HNSCC derived keratinocytes (see Table 2.1), it is possible to 
suggest that such a mechanism, alone or in combination with those suggested above, 
contributes to the apparent elevation of FOXM1 transcription levels. Although the 
information available in this study does not allow definitve correlations to be made, 
it is interesting that the expression levels of FOXM1 (isoforms B and C) are very 
similar between HNSCC derived keratinocytes with reported TP53 mutations or 
expression loss (DOK, POE9n, POE9n-hTERT, BICR31; see Materials and 
Chapter 3: Regulation of FOXM1 in OSCC  
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 125
Methods Table 2.1; see Figure 3.7), suggesting that such an event may be an 
important determinant of FOXM1 gene transcription control. 
 
Arguably, the abundance of information regarding FOXM1 protein stability and 
activation, provide much room for speculation, as to what may be a possible 
mechanism for the elevated levels of FOXM1 protein and its downstream 
transcriptional activity in OSCCs. The activity of FOXM1 can be increased by 
many important proliferative signals including MEK1, Ras, CyclinD1/Cdk4, 
CyclinE/Cdk2, CyclinA/Cdk1, CyclinB/Cdk1, and by inhibition of GSK3-α 
(Wierstra and Alves, 2007). One of the best documented molecular events in the 
generation of HNSCCs is that of CyclinD1 (CCND1) upregulation, which is 
frequently followed by whole gene amplification (Jares et al., 1994; Wang et al., 
1995; Izzo et al., 1998). CyclinD1 exerts its proliferative effect by forming 
complexes with cyclin dependent kinases (CDKs), which phosphorylate and 
inactivate retinoblastoma (Rb) tumour suppressor protein, thereby allowing 
progression through G1 phase (Sherr and Roberts, 1999). Rb protein normally 
retains FOXM1 in an inactive form by direct binding to its central N-terminal 
repressor domain (NRD-C) (Major et al., 2004; Wierstra and Alves, 2006d) (see 
also Chapter 1, section 1.4.5). CyclinD1 upregulation can therefore augment 
FOXM1 activity in two distinct ways. First, it does so by releasing the NRD-C of 
FOXM1 from Rb, and second by further releasing the transactivation domain of 
FOXM1 from auto-repression by its own N-terminus (see also Chapter 1, section 
1.4.5.2). Once released, FOXM1 is further subjected to post-translational 
modifications (mainly phosphorylation) by Cyclin/Cdk complexes that enhance its 
stability, as well as its transactivation and DNA binding activity (Major et al., 2004; 
Wierstra and Alves, 2006b) (discussed in more detail in Chapter 1, section 1.4.5.1). 
Prior to the onset of anaphase, the hyperphosporylated forms of FOXM1 rapidly 
decrease, and FOXM1 protein gets rapidly degraded by ubiquitin ligase complex 
APC/Cdh1 which can directly bind to the N-terminal domain of FOXM1 (Laoukili 
et al., 2008a; Park et al., 2008). Although no inactivating mutations have been 
reported for APC/C (or its co-activator Cdh1) in HNSCCs, many of its degradation 
targets/substrates are deregulated in human malignancies, including carcinomas of 
the head and neck (Lehman et al., 2007).  
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A more detailed comparison between different cell lines with defined genetic hits 
may help to further understand the mechanisms by which FOXM1 expression is 
upregulated. For example, the isolation and examination of the molecular 
background of cell lines which do not express high levels of FOXM1 (e.g. H357, 
BICR31, SCC4, PE/CA-PJ15) would be of great value. For example, it is possible 
to examine how the expression of FOXM1 is influenced by genetic modification 
that deregulates the mechanism of several candidate upstream regulators of 
FOXM1, such as the Rb/p16INK4a/CyclinD1 pathway of cell cycle control which 
reportedly is one of the most important detemrminants of FOXM1 expression and 
protein stability. Furthermore, pre-malignant lesion-derived and OSCC tumour-
derived cells can be extremely useful in examining all of the aforementioned 
pathways which directly and indirectly influence the expression and protein levels 
of FOXM1, and are implicated in the in vivo tumourigenesis of oral squamous cell 
carcinoma. This would further help to elucidate the exact mechanism of why 
FOXM1 is upregulated both in early as well as in later stages of epithelial malignant 
transformation in vitro. 
 
It was found it this study that FOXM1 expression and subsequent protein activity 
were significantly upregulated when oral keratinocytes were exposed to one of the 
major alkaloids found in tobacco, nicotine, at concentrations that are relevant to 
tobacco chewers (0.01 µM -100µM) (Figure 3.8). Importantly, this response 
remained intact in normal human oral keratinocytes, indicating that the expression 
FOXM1 can be directly induced by nicotine, even in a normal non-aberrant 
molecular background. This is surprising since nicotine is not perceived as being a 
carcinogen, and is therefore being used as a frontline measure for tobacco 
replacement. However, recent studies have also demonstrated the proliferative and 
angiogenic effects of nicotine in different cancer cell lines and established tumours 
in vivo (Heeschen et al., 2001; Heeschen et al., 2002; Dasgupta and Chellappan, 
2006; Dasgupta et al., 2009). Interestingly, nicotine has been shown to mediate cell 
proliferation by down-regulating the activity of Rb protein and subsequent 
activation Cyclin/Cdks, E2F’s 1, 2, and 3, and by activation of Cyclin D (Chu et al., 
2005; Dasgupta et al., 2006). Perturbation of the G1 control has an immediate 
impact on FOXM1 expression and stability, and therefore nicotine treatment could 
have indirectly led to the dramatic upregulation of FOXM1 observed in oral 
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keratinocytes (Figure 3.8). Given that tobacco (both smoke and smokeless form) is 
a major risk factor contributing to the genesis of HNSCC, it is plausible to suggest 
that repeated and continuous exposure of the oral epithelium to nicotine, can 
potentially contribute to the overexpression of FOXM1 in early pre-malignant 
lesions. This, in combination with previously discussed mechanisms, may account 
for the high level overexpression of FOXM1 observed at later stages of these 
tumours. Although in vitro evidence from previous work done in our group, support 
the fact that FOXM1 and nicotine work synergistically to promote malignant 
transformation (Gemenetzidis et al., 2009), future studies are needed to delineate 
whether FOXM1 can be physiologically induced by nicotine in vivo, and whether 
this response is functionally related to HNSCC development. 
 
The activity of FOXM1 depends on many different important cell cycle regulators. 
The fact that many of the latter are frequently deregulated in human malignancies, 
may explain why FOXM1 is one of the most commonly upregulated genes in 
human malignancies, including HNSCCs. The fact that FOXM1 can significantly 
contribute to, and promote, tumourigenesis (Kalinina et al., 2003; Kalinichenko et 
al., 2004; Kim et al., 2006; Liu et al., 2006; Dai et al., 2007; Wang et al., 2007; 
Wang et al., 2008a; Wang et al., 2008b; Gemenetzidis et al., 2009), suggests that its 
upregulation is an important step in the generation and progression of early pre-
malignancies, which is also supported by the fact that its expression is significantly 
elevated in numerous human pre-cancerous lesions (Chan et al., 2008; Gemenetzidis 
et al., 2009).  
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4 FOXM1B is Expressed at Mitosis and Induces 
Genomic Instability in Human Keratinocytes 
 
4.1 Introduction 
FOXM1 is a proliferation specific transcription factor, and as such, its 
expression is highly responsive to serum stimulation and cell cycle re-entry, 
possibly mediated by c-Myc/E2F dependent activation (Korver et al., 1997a; 
Laoukili et al., 2007; Blanco-Bose et al., 2008). Activation of FOXM1 occurs 
during late G1/S phase and reaches its peak at G2 phase and mitosis (Laoukili 
et al., 2008b). FOXM1 activation is also dependent on Ras/MEK/MAPK 
signalling (Major et al., 2004; Ma et al., 2005) and requires binding by cyclin 
E/A/Cdk2 complexes that facilitate its phosphorylation (Costa, 2005), and 
subsequent activation. In late G1, FOXM1 is also believed to regulate entry 
into the S-phase by promoting the degradation of key cell cycle inhibitors, 
p21CIP1 and p27KIP1 and by activation of CDC25A (Wang et al., 2002b; Costa, 
2005).  
 
FOXM1 is a major regulator of G2/M phase of the cell cycle, where a precise 
and controlled regulation of FOXM1 protein is required to ensure successful 
execution of the mitotic programme and the maintenance of chromosomal 
stability (Laoukili et al., 2005). Its downstream transcriptional targets 
comprise a variety of important G2/M regulatory proteins, including Plk1, 
Aurora B kinase, cyclin B, Cdc25B, Nek2 and CENP-F (Leung et al., 2001; 
Laoukili et al., 2005).  
 
More recent studies have shown that expression and protein stability of 
FOXM1 is indeed tightly regulated by its N-terminal inhibitory domain, which 
can inhibit its transcriptional activity at the G1/S phase of the cell cycle, and 
also harbours specific APC/C recognition sites, that facilitate FOXM1 protein 
degradation following mitosis(Park et al., 2007; Laoukili et al., 2008a).  
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Here, a normal neonatal foreskin keratinocyte cell line immortalized by 
hTERT, N/TERT (Dickson et al., 2000), and a cervical cancer derived cell 
line, HeLa, were used to investigate the expression pattern of each of the three 
distinct FOXM1 isoforms during normal cell cycle. Furthermore, by using 
high efficiency retroviral mediated gene transfer, FOXM1B was stably 
introduced in N/TERT keratinocytes to investigate and define the cell cycle 
dependent distribution of FOXM1B protein.  
It has been previously established that FOXM1 is critical for the regulation and 
maintenance of chromosomal stability (Laoukili et al., 2005). Given that genomic 
instability is a widespread feature of human tumours (Lengauer et al., 1998), and 
that FOXM1 is overexpressed in majority of human malignancies (Pilarsky et al., 
2004), including OSCC as shown here (Chapter 3), and by work from our group 
(Gemenetzidis et al., 2009), this study set out to investigate the effect of FOXM1 
overexpression in the maintenance of genomic stability. Due to the molecular and 
genetic aberrations present in many immortalised and/or tumour derived cell line 
systems, this study employed normal primary human epithelial keratinocytes 
derived from clinically normal epidermis and oral mucosa. To test this hypothesis, 
10K SNP array was employed to investigate global genomic instability events.  
4.2 Results 
 
4.2.1 FOXM1 Isoform Expression Pattern during Cell Cycle 
FOXM1 protein and mRNA levels vary during cell cycle progression. Its 
expression is activated at late G1/S and peaks at G2/M phase of the cell cycle, 
where it transactivates the vast majority of its downstream targets (Laoukili et 
al., 2008b). However, little is still known about the relative expression of 
FOXM1 specific isoforms throughout the cell cycle. 
 
First, the endogenous expression patterns of FOXM1A, FOXM1B, and 
FOXM1C were investigated in N/TERT keratinocytes, using FOXM1 isoform 
specific qPCR. N/TERT cells were synchronized at the G1/S boundary by 
double thymidine block, and then released from cell cycle block. Cell cycle 
synchronization was confirmed by flow cytometry analysis (Figure 4.1 A i, ii, 
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iii). mRNA was extracted at regular time intervals and FOXM1A, FOXM1B, 
and FOXM1C mRNA copy numbers were independently quantified using 
qPCR. Surprisingly, only FOXM1B showed a significant (~2 fold) increase at 
6 hours (corresponding to the time that cells pass through G2/M phase) after 
cell cycle was resumed (Figure 4.1 Bi). FOXM1A and FOXM1C were 
fluctuating between 0.5-1 fold throughout the whole time course.  
 
Due to the partial synchronization effect observed in N/TERT cells, HeLa 
cells that have been shown to be totally synchronized in culture following 
double thymidine block (Whitfield et al., 2002), were also used. FOXM1 
isoform specific quantitation revealed that FOXM1B is again the only isoform 
being significantly expressed in response to cell cycle events (Figure 4.1 Bii). 
FOXM1 (all isoforms) induction started being evident at 4 hours (S phase 
entry), but only FOXM1B reached a maximum of 3.3-fold increase 6-8 hours 
after release, which correlates with the time at which HeLa cells undergo the 
first synchronous mitosis (Whitfield et al., 2002)  (Figure 4.1 Bii). The higher 
fold increase in FOXM1B expression in HeLa cells, compared to N/TERT 
cells, could be attributed to the differences in the efficiency of synchronization 
between these two cell lines.  
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Figure 4.1: FOXM1B isoform expression is cell cycle dependent.  
(A) N/TERT cells were released from double thymidine cell cycle block (G1/S 
synchronization) and were stained with propidium iodide, followed by flow 
cytometry analysis at 0hours (i), 2hours (ii), and 6hours (iii). (B) (i) N/TERT cells 
were released from double thymidine cell cycle block (G1/S synchronization) and 
mRNA was harvested at regular time intervals. qPCR results indicated that FOXM1B 
was the only isoform that is significantly upregulated (*P≤0.05; **P≤0.01) during 
cell cycle re-entry. (ii) HeLa cells were released from double thymidine cell cycle 
block (G1/S) synchronization and mRNA was harvested at regular time intervals. 
FOXM1A and FOXM1C show an almost complete lack of induction throughout the 
cell cycle. FOXM1B shows a significant (**P≤0.01) increase (3.3 fold) at 6 hours 
and a 3 fold increase (***P≤0.001) at 8 hours after cell cycle re-entry. 
 
4.2.2 Ectopic FOXM1B Expression Peaks at G2/M 
A time-lapse video fluorescence microscopy was performed to visualize 
EGFP-FOXM1B protein expression during cell cycle. First, N/TERT 
keratinocytes were transduced with EGFP-FOXM1B retrovirus and allowed to 
express the transgene 72 hours prior to inducing growth arrest by growth 
factor deprivation for 18 hours. Next, cells were grown in normal growth 
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medium, and were subsequently observed at 20 minute intervals, using 
fluorescent time-lapse microscopy over a total time course of 72 hours. EGFP-
FOXM1B expressing cells showed strong nuclear protein accumulation as 
evidenced by increased fluorescence beginning at 7 hours and reached 
maximum expression level (~3-fold, Figure 4.2) at 15-25 hours, subsequently 
fluorescence level returned to basal level at 48 hours. This result is consistent 
with endogenous FOXM1B mRNA expression levels in Figure 4.1 Bi. The 
delay in FOXM1B induction observed in Figure 4.2, was due to the fact that 
cells were synchronized at G0/G1 phase whereas cells in Figure 4.1 were 
synchronized at G1/S boundary.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Exogenous FOXM1B protein expression is cell cycle dependent 
Time-lapse fluorescent video microscopy of G0/G1 synchronized N/TERT 
keratinocytes. FOXM1B protein expression level (fluorescence intensity) was 
quantitated by digital densitometry. Graphical representation of FOXM1B expression 
pattern during cell cycle re-entry. Each point represents mean ± S.E.M. (n=6) fold 
fluorescence activation over control time 0 hour. Inset images show the cellular 
distribution of EGFP-FOXM1B protein at the indicated time points. 
 
To further understand how FOXM1B protein is distributed throughout the cell 
cycle, N/TERT keratinocytes were stably transduced with EGFP-FOXM1B, 
and their cell cycle was examined by flow cytometry. Cells were stained with 
Hoechst-33342 and analyzed both for DNA content and green fluorescence 
(EGFP), which corresponds to exogenous EGFP-FOXM1B fusion protein. 
Populations of EGFP+ and EGFP- cells were obtained by using wild type 
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N/TERT (wt) as a control cell line to acquire background levels of 
fluorescence. EGFP- cells profile exhibited a normal cell cycle distribution 
with a major peak at G1 (73.5%) and a minor peak at G2/M phase (16%) 
(Figure 4.3 Ai). EGFP+ (EGFP-FOXM1B expressing) populations showed a 
significant ~3.3 fold increase in G2/M phase (52.7%) and a largely reduced 
G1 phase (33.8%) (Figure 4.3 Aii).  
 
EGFP-FOXM1B expressing populations were then subdivided into low and 
high fluorescence intensity groups. Cells with low EGFP-FOXM1B 
expression show a relatively normal cell cycle (Fig. 4.3 Bi), whereas, 89% of 
cells expressing high levels of EGFP-FOXM1B were found to be exclusively 
in the G2/M phase of the cell cycle (Fig. 4.3 Bii). This clearly suggests a role 
for FOXM1B protein in late G1/S, but mainly in G2/M phases of human 
keratinocytes, and confirms that ectopic FOXM1B expression is regulated in a 
similar fashion to the endogenous one, as observed in normal N/TERT human 
keratinocytes. 
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Figure 4.3: FOXM1B protein is present at G2/M phase of human keratinocytes.  
(A) N/TERT human keratinocytes were transduced with EGFP-FOXM1B and stained 
with Hoechst 33342 prior to DNA content analysis using flow cytometry. EGFP (+) 
and EGFP (-) populations were discriminated and their cell cycles were obtained. The 
cell cycle distribution of EGFP-FOXM1B expressing cells is altered showing a 
significantly lower G1 phase and 3.4-fold increase at the G2/M phase of the cell 
cycle. (B) EGFP (+) cells were further sub-divided into two groups: low (Bi) and high 
(Bii) expression of EGFP-FOXM1B. Low expressing cells display a relatively normal 
cell cycle (Bi), while high EGFP expressing cells (Bii) were exclusively at the G2/M 
phase (89%). 
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4.2.3 Overexpression of FOXM1B induces Genomic Copy Number 
Alterations 
It is well established that tumour progression requires sequential genomic 
alterations, and that FOXM1 has a role in the maintenance of genomic integrity. 
Since FOXM1 is strongly overexpressed in the majority of human malignancies, 
this study also investigated the effect of FOXM1 overexpression on the 
maintenance of genomic stability. Since only the B isoform of FOXM1 was 
preferentially expressed at mitosis (Figure 4.1, 4.2, 4.3), it was reasoned that this 
isoform may be predominantly involved in the execution of important mitotic 
processes, the deregulation of which could potentially affect the genomic stability 
epithelial keratinocytes.  
Early passage primary normal human epidermal keratinocytes (NHEK) (P1) were 
either mock transduced (no transgene expression) or transduced with either EGFP 
control or EGFP-FOXM1B (over 95% gene delivery was observed), and were let to 
grow until confluent (96 hours), and gDNA was harvested for SNP array profiling 
(see also Chapter 2, section 2.14). SNP genotype profile from transduced cells 
were compared with the mock-transduced wild-type NHEK in order to obtain 
genomic instability data in the form of loss of heterozygosity (LOH) and copy 
number alterations (CNA) (Figure 4.4).  
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Figure 4.4: Detection of genomic instability events using 10K SNP array  
(A) Early passage (P1) primary NHEK were either mock transduced, EGFP or 
FOXM1B transduced, left to grow for until confluent and (B) gDNA was harvested 
for SNP array analysis. (C) Loss of heterozygosity (LOH, blue lines) and copy 
number alterations (CNA, red dots) data were obtained by comparing test samples 
(EGFP or FOXM1B) with reference genome (mock transduced NHEK). 
EGFP overexpression did not induce any detectable LOH or CNV in the wildtype 
control NHEK. In contrast, FOXM1B overexpression induced a low level but 
detectable genomic instability where a small number of SNPs had undergone LOH 
(Figure 4.5 A, blue lines). Interestingly, using Affymetrix Copy Number Analysis 
Tool (CNAT) algorithm to determine the likelihood of LOH (Huang et al., 2004), 
FOXM1B-expressing cells showed marked increase (at least 2-fold) in LOH 
likelihood compared to EGFP-expressing cells (Fig 4.5 A, grey lines). The increase 
in LOH likelihood and CNA in FOXM1B-expressing cells is not due to the 
decrease in SNP call rate because all ‘No Call’ SNPs were excluded from analyses. 
Four days of FOXM1B expression in primary NHEK may not have sufficient time 
to accrue definitive LOH/CNA loci, which may explain the low number of SNPs 
acquiring LOH in the FOXM1B expressing cells. Nevertheless, this experiment 
shows that acute FOXM1B, but not EGFP, expression can induce genomic 
instability. Although FOXM1B did not significantly alter genome ploidy status, 
CNA (compare red-dot plots in Figure 4.5 A with B) appear to have more 
fluctuations (instability) in FOXM1B (genome ploidy ± sd: 1.999 ± 0.208; SNP 
Call: 97.27%) compared to EGFP (genome ploidy: 2.000 ± 0.122; SNP Call: 
98.24%) expressing cells. In agreement, when examining the copy number of 
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individual SNPs, FOXM1B expressing cells showed ~10-fold increased in CNA 
(534 losses and 160 gains) compared to EGFP expressing cells showed almost 
negligible CNA (65 loss and 0 gain). Similar results were obtained from two further 
independent SNP array experiments with primary NHEK from 2 different normal 
skin tissues of healthy volunteers (Figure 4.5 B). The differing degree of 
FOXM1B-induced genomic instability of the three normal patients is likely due to 
individual’s variations in intrinsic cellular susceptibility to oncogene expression. 
Overall on average, FOXM1B significantly (6.60-fold, *P<0.05, n=3; Figure 4.5 
C) induced genomic instability in primary normal human keratinocytes. EGFP 
overexpression did not induce significant genomic instability. Consistently, 
FOXM1B overexpression produced the same effect in primary human oral 
keratinocytes (Figure 4.5 E)  (Gemenetzidis et al., 2009). 
Next, it was investigated whether the acute genomic instability induced by 
FOXM1B overexpression, was transient or stable. In a separate experiment, SNP 
array mapping was performed in NHEK transduced with either EGFP or FOXM1B 
at three consecutive passages (P1, P2 and P3; Figure 4.5 D). The SNP data showed 
that the genomic instability induced by FOXM1B was maintained and accumulated 
with increasing passage number. EGFP-expressing cells did not show accumulation 
of genomic instability with increasing passage number. At passage 3, the total 
number of SNP copy number instability accumulated in FOXM1B-expressing cells 
(112 losses and 272 gains; total: 384 CNA) was substantially (42.7-fold) higher 
than in EGFP-expressing cells (0 losses and 9 gains). 
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Figure 4.5: Acute overexpression of FOXM1B induces genomic instability in 
primary NHEK 
(A) CNA (Log 2 ratio, red dots), LOH (blue lines) and LOH likelihood (grey lines) 
plots for EGFP or FOXM1B expressing cells. LOH likelihood was calculated based 
on Affymetrix GTYPE algorithm. (B) Three normal healthy primary keratinocytes 
(NHEK#1-3) SNP copy number analysis showing CAN as losses (N<2) or gains 
(N>2) in EGFP and FOXM1B overexpressing NHEK, respectively. (C) Average 
fold-increase in CNA of the tree normal primary NHEK cells in (C). *(P<0.05) 
indicates significant increase in FOXM1B-induced CNA. (D) FOXM1B-induced 
CNA (total SNP undergoing CNA as indicated above each bar) showed gradual 
accumulation during primary NHEK culture (3 passages, P1, P2 and P3). (E)Total 
number of SNPs that show copy number alterations (CNA), as observed in primary 
human oral keratinocytes overexpressing either EGFP or FOXM1B. Bars represent 
the mean ± S.E.M. of duplicate samples. *P≤0.0.5 
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4.2.4 Genotoxic Stress Cooperates with FOXM1B to Promote Genomic 
Instability 
The finding that FOXM1B expression induces genomic instability led to the 
hypothesis that upregulation of FOXM1B may predispose cells to oncogenesis by 
synergistically potentiating genomic instability induced by DNA damaging agents 
such as UVB. To test this hypothesis, the levels of genomic instability were 
quantified following UVB exposure on primary NHEK cells expressing either 
EGFP or FOXM1B. Unfortunately, following UVB, primary NHEK (both EGFP 
and FOXM1B expressing cells) undergo terminal differentiation and cell death 
which did not allow the clonal expansion of UVB resistant cells hence precluding 
further experiments. Instead, this experiment was performed using the immortalised 
N/TERT cells whereby UVB was used to induce >95% cell death and ~5% of 
surviving cells were allowed to proliferate (~50 days in culture) and gDNA was 
harvested for SNP array analyses. In agreement with the above hypothesis, 
following UVB exposure, cells overexpressing FOXM1B, but not EGFP, showed 
dramatic genomic instability especially in chromosome 6 and 7 as illustrated in 
Figure 4.6. EGFP-expressing cells showed low levels of random CNA throughout 
the genome and no LOH was detected. In contrast, FOXM1B-expressing cells 
showed specific genomic instability in two chromosomes (6 and 7) where a high 
number of CNA was observed in groups of no less than 16 adjacent SNPs each. 
LOH as a result of copy number loss was detected at 6q25.1-6q25.3 (SNP location: 
149761596 to 160783097), whereas, copy number gain was detected in most of 
chromosome 7 (7p21.3-7q36.3). The copy number gain in chromosome 7 did not 
amount to LOH status. This could be reflecting a mix population of cells bearing 
either without or with CNA in chromosome 7. It was hypothesised that given a 
longer proliferation time after UVB exposure, cells bearing copy number gain in 
chromosome 7 would be positively selected and resulted in an LOH status 
detectable by the SNP array. This also indicates that LOH/CNA at 6q represents an 
earlier genomic instability event preceding CNA of chromosome 7 in the 
FOXM1B-expressing cells following UVB exposure.  
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Figure 4.6: FOXM1B, but not EGFP, enhances LOH and CNA formation in 
N/TERT cells that survived UVB insult.  
N/TERT cells were transduced with either (A) EGFP or (B) EGFP-FOXM1B and 
were UVB irradiated with 10mJ/cm2. Cells were allowed to expand during a period of 
4 weeks and gDNA was extracted. LOH and CNA analysis revealed gross 
chromosomal abnormalities in EGFP-FOXM1B expressing cells but not in EGFP 
expressing cells. LOH, copy number gains and copy number losses are shown as 
indicated. EGFP expressing N/TERT cells show random CNA compared to EGFP-
FOXM1B where there is an almost complete chromosome gain on Chr.7 and a large 
region that had undergone LOH on Chr. 6q25.1-6q25.3. LOH Prob=LOH Probability 
as calculated by Affymetrix GTYPE Software. 
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4.3 Discussion 
 
4.3.1  Cell Cycle Dependent Expression of FOXM1 
Previous studies have investigated the expression pattern of FOXM1 during 
the cell cycle of mammalian cells (Korver et al., 1997a; Major et al., 2004; Ma 
et al., 2005; Laoukili et al., 2008b; Park et al., 2008). FOXM1 transcription 
factor is induced at both the mRNA and protein levels, when cells are 
stimulated to re-enter the cycle, and is further subjected to post-translational 
modifications, which result in the stabilization and further activation of the 
protein, when cells are entering G2/M phase. However, the role of each of the 
three FOXM1 isoforms in cell cycle remains unclear. Since there is evidence 
(Figure 3.6, 3.7) that FOXM1 isoforms can be differentially expressed in 
normal and tumour derived keratinocytes, this study aimed to investigate how 
each of the three isoforms is regulated during the cell cycle of human cells. 
By using synchronous cultures of N/TERT human keratinocytes and HeLa cells, it 
was confirmed that while all FOXM1 isoforms are slightly induced upon cell cycle 
re-entry, only the expression of FOXM1B was significantly induced during G2/M. 
The time of the strongest FOXM1B induction is consistent with the time during 
which N/TERT (Figure 4.1) and HeLa cells go through the first synchronous 
mitosis (Whitfield et al., 2002). The lack of induction in the other two FOXM1 
isoforms agrees with the fact that (a) FOXM1A is a transcriptionally inactive 
isoform (Ye et al., 1997) and (b) FOXM1C, although active, its mRNA remains 
similar between asynchronous, G1, S, or G2 synchronized 3T3 and BJ1 fibroblasts 
(Ma et al., 2005). FOXM1C is the most abundantly expressed isoform in human 
cell lines and various mouse tissues (Teh et al., 2002; Ma et al., 2005), while 
FOXM1B is expressed at low levels (Teh et al., 2002) and thus previous studies 
using semi-quantitative approaches have failed to detect FOXM1B mRNA 
expression, in either asynchronous, or synchronized in vitro cell systems (Ma et al., 
2005). The absolute qPCR used in this study revealed the relative levels of FOXM1 
isoform expression in human cells. This is the first experiment demonstrating a 
differential expression pattern of FOXM1 isoforms and that FOXM1B exhibits the 
most prominent cell-cycle dependent expression pattern during cell cycle. 
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Given that downstream target transactivation requires active proteins to be present, 
FOXM1B mRNA transcripts may be needed for the continuous supply of translated 
protein during late S and G2/M phases of the cell cycle. To examine the 
relationship between FOXM1B mRNA expression and protein translation, ectopic 
EGFP-FOXM1B was introduced in N/TERT keratinocytes. EGFP-FOXM1B 
protein was directly visualized by fluorescence microscopy in live human 
keratinocytes during a period of three days, which provided evidence for rapid 
protein turnover in cycling cells with no detectable cytoplasmic distribution. EGFP-
FOXM1B fluorescence was highly restricted to the nuclei of dividing cells. 
Consistently, flow cytometry analysis revealed that FOXM1B protein was 
upregulated partly at the G1/S phase boundary, but its peak expression was mainly 
found at G2 phase and mitosis, following exactly the same cell cycle dependent 
distribution as predicted from mRNA expression analysis. This indicates that 
mRNA and protein levels of FOXM1B are tightly linked during cell cycle. 
However, other studies have reported a different expression pattern of FOXM1, 
which is contradictory to the results presented here. In synchronized osteosarcoma 
U2OS cells, there was no evidence of a cell cycle dependent expression of neither 
FOXM1B isoform (Major et al., 2004) nor FOXM1 protein as a whole (all 
isoforms) (Laoukili et al., 2008b). This however is inconsistent with the fact that 
FOXM1 protein is rapidly degraded upon exit from mitosis (Laoukili et al., 2008a; 
Park et al., 2008), and therefore subsequent mitotic entry would require de novo 
synthesis of FOXM1 protein, unavoidably resulting in fluctuating protein levels 
throughout a normal cell cycle. This effect could be attributed to a specific property 
of the U2OS human osteosarcoma cell line, which may allow aberrant expression 
or abnormal stability of FOXM1, and therefore abolishing the intrinsic mechanism 
of FOXM1 regulation present in other cell line systems.  
In contrast, the evidence presented here and in previous studies, in synchronous 
cultures of N/TERT, HeLa cells, Rat-1 fibroblasts, and BJ-1 human fibroblasts, 
showed that FOXM1 protein follows a cell cycle dependent distribution, with 
highest levels being observed always at G2/M (Korver et al., 1997a; Ma et al., 
2005; Park et al., 2008), which is consistent with the fact that the downstream 
targets of FOXM1 are not induced until entry to G2/M (Leung et al., 2001; Laoukili 
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et al., 2005; Laoukili et al., 2008b).  
Taken together, these data suggest that FOXM1B mRNA expression, protein 
translation and subsequent nuclear accumulation must occur very rapidly. This 
isoform expression pattern is also consistent with the fact that FOXM1 protein 
becomes detectable in late S and remains stable throughout G2 phase and mitosis in 
HeLa cells (Leung et al., 2001; Park et al., 2008). At least for FOXM1B isoform, 
this may be the predominant mechanism for its cell cycle dependent expression and 
activation, as opposed to FOXM1C, which responds to cell cycle events by 
translocation from the cytoplasm to the nucleus, which is sufficient for DNA 
binding activity during G2/M (Ma et al., 2005).  
4.3.2 FOXM1 and Genomic Instability 
It is now well accepted that the manifestation of a human tumour requires 
sequential genomic alterations (Vogelstein and Kinzler, 1998). The 
accumulation of such events is thought to be driven by an underlying genomic 
instability during the process of tumourigenesis, and although it appears to be 
a widespread feature of human malignancies (Lengauer et al., 1998), the 
originating stage of such genomic instability is not clearly defined. Evidence 
suggests that genetic instability appears at the early stages of human 
malignancy, slowly driving the clonal expansion of tumourigenic progenies. In 
human colorectal tumourigenesis, allelic imbalances have been observed in 
early adenomas, by using chromosome specific SNP markers (Shih et al., 
2001). Similar genomic alterations have also been reported in metaplastic 
lesions of gastric carcinoma (Kobayashi et al., 2000), ulcerative colitis (UC) - 
associated neoplasia (Willenbucher et al., 1999), intraepithelial neoplasia of 
the vulva (Pinto et al., 2000), in dysplastic epithelium of Barrett’s oesophagus 
(Galipeau et al., 1999), and in pre-neoplastic lesions of the breast epithelium 
(O'Connell et al., 1998; Gong et al., 2001). 
 
This study has therefore focused in the genome-wide effects of FOXM1, 
aiming to provide a link between the established role of FOXM1 in the 
maintenance of genomic integrity (Laoukili et al., 2005), and the fact that it is 
overexpressed in early pre-malignant epithelial lesions (Chapter 3) 
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(Gemenetzidis et al., 2009). The evidence presented here are the first to show 
that constitutive and acute (4 days) expression of FOXM1B alone, is sufficient 
to induce LOH and CNA in primary human epidermal and oral keratinocytes. 
Furthermore, FOXM1B-induced genomic alterations were accumulated and 
amplified when these cells were passaged in culture (genomic instability). It is 
important to stress the fact that a SNP copy number loss, or gain at this stage, 
does not necessarily correspond to the loss or gain of gene loci that are 
important in cellular processes. These SNPs often comprise large segments of 
genomic DNA that may, or may not, contain genes with important regulatory 
functions. Therefore, the initial effects of FOXM1B on genome stability may 
not be readily assimilated to a genetic instability signature present in tumours. 
The latter is the culmination of many years of development, as a result of the 
positive selection and clonal expansion of populations with beneficial genomic 
alterations. The former, however, is suggesting that excessive accumulation of 
FOXM1B protein at mitosis (section 4.2.2; ectopic FOXM1B protein 
accumulates at G2/M phase of keratinocytes) is sufficient to disturb the 
genomic stability of human primary keratinocytes. Consistent with this notion, 
data obtained from genome-wide SNP analysis, across four individual primary 
keratinocyte cell lines overexpressing FOXM1B, did not show any trend of 
consensus genomic alterations. This leads to the anticipated conclusion that 
early genomic instability events introduced by overexpression of FOXM1B 
occur at random.  
 
4.3.3 Clonal Expansion of Genetically Unstable Cells  
The effect of FOXM1B occurred independently of any other stimuli, which 
suggests that its overexpression can generate a predisposition for the 
accumulation of genomic instability. Although FOXM1B overexpression 
alone is not sufficient to induce pathologically relevant genetic aberrations in 
this setting, it may trigger and facilitate the accumulation of subsequent 
oncogenic events required for malignant conversion. This is supported by 
recent studies showing that FOXM1 is linked to the progression of genomic 
instability in human cancer (Carter et al., 2006), and second that it can 
cooperate with environmental (i.e. UVB or carcinogens) stress to promote 
genomic instability (Gemenetzidis et al., 2009; Teh et al., 2010). The clonal 
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expansion of cells with beneficial genomic alterations can be expedited by 
selective killing of normal surrounding cells. It was therefore plausible to 
think, that if FOXM1B overexpression can promote genomic instability, a 
genotoxic insult would serve as a selection pressure for the clonal expansion 
of progenies that have acquired beneficial genomic alterations. Indeed, results 
presented here show that the genetic profile of UVB irradiated N/TERT 
keratinocytes expressing FOXM1B, showed gross chromosomal CNA and 
LOH following UVB exposure. Interestingly, numerous genes (including 
MAP3K7IP2, SUMO4, p34/ZC3H12D, LATS1, RAET1 cluster, ULBP 
cluster, AKAP12, ESR1, MYCT1, VIP, TIAM2, SOD2, WTAP, MAS1, 
SLC22A cluster, IGF2R, etc.) found within the FOXM1B-induced LOH at 
6q25.1-6q25.3, have been previously linked to oncogenesis of various human 
cancers (Rabin et al., 1987; Chiu et al., 1999; Qiu et al., 2003; Jiang et al., 
2006; Rong et al., 2006; Cao et al., 2007; Valdehita et al., 2007; Yildirim et 
al., 2007; Yoon et al., 2007; Jin et al., 2008; Kotsinas et al., 2008; Martinez-
Galan et al., 2008; Wheatley-Price et al., 2008). Furthermore, genes including 
EGFR and IGFB1-3 found within the FOXM1-induced CNA gain in 
chromosome 7p12-22 were previously reported to be amplified in early stages 
of HNSCC (Patmore et al., 2005).  
 
These observations suggest that overexpression of FOXM1B can render cells 
susceptible to the acquisition of additional genetic alterations, an effect that 
was largely accelerated by additional genotoxic stress. This is further 
supported by the established role of environmental DNA damaging insults in 
the genesis of tumours. Importantly, BCC tumours are strongly associated 
with skin exposure to UVB irradiation, and further to that, they exhibit both 
FOXM1B overexpression and genomic instability (Teh et al., 2002; Teh et al., 
2005).  However, with the exception of distinct LOH events, BCC tumours are 
generally characterized by genetic homogeneity (Teh et al., 2005) and it is 
therefore thought that the extent of genomic instability present in those skin 
tumours is appreciably lower when compared to that of other human 
malignancies. This is consistent with the lack of aggression seen in BCCs 
(Wong et al., 2003), and further suggests that additional oncogenic hits may be 
necessary for the manifestation of widespread genomic instability events, 
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contrarily to OSCC tumours which display extensive genomic alterations 
comparable to a genetic instability signature present in other human tumours 
(Chapter 1; reviewed in Hunter et al, 2005). The effects of FOXM1B on 
genomic stability were present in epithelial keratinocytes from both the 
epidermis and the oral mucosa, indicating that the effect of FOXM1 is not 
tissue specific. Further experiments are required to understand the mechanisms 
underlying this observation, and to establish whether the FOXM1B-induced 
genomic instability is responsible for generating oncogenic LOH and CNA 
relevant to human malignant transformation. Nevertheless, evidence from 
work in our group suggest that FOXM1B indeed cooperates with 
environmental stress, to direct a program of genomic instability that drives 
malignant transformation (Gemenetzidis et al., 2009; Teh et al., 2010).  
 
4.3.4 Mechanisms of Genomic Instability  
A possible reason for the immediate impact of FOXM1 in genomic integrity is 
that the list comprising its downstream targets contains many genes associated 
with centrosome function and chromosome segregation (reviewed in Wierstra 
& Alves, 2007). The relative abundance of each of these genes’ products 
during mitosis is tightly regulated, since any deviations from their 
physiological critical concentrations may cause defects (Carter et al., 2006). 
Numerous studies have demonstrated that proteins which are important in the 
maintenance of genomic stability are often found amplified in human cancers, 
with centrosome amplification being a well characterized mechanism 
contributing to genomic instability (D'Assoro et al., 2002a; D'Assoro et al., 
2002b; Gisselsson et al., 2002; Lingle et al., 2002; Pihan et al., 2003; 
Fukasawa, 2005; Jefford and Irminger-Finger, 2006). CENP-F overexpression 
has been linked to the generation of chromosomal instability in breast cancer 
patients, while NEK2 is consistently overexpressed in a variety of human 
tumours contributing to genomic instability (Hayward and Fry, 2006; O'Brien 
et al., 2007). Overexpression of Aurora centrosome kinase is also invariably 
associated to genomic instability in primary non-small cell lung carcinomas, 
breast carcinomas, and ovarian cancer derived cell lines (Li et al., 2004b; Hu 
et al., 2005; Smith et al., 2005), two of which (breast and lung) are reported to 
express high levels of FOXM1 (Wonsey and Follettie, 2005; Kim et al., 2006; 
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Madureira et al., 2006; Bektas et al., 2008; Francis et al., 2009). Specifically, 
Aurora kinase B (AURKB), a direct downstream target of FOXM1, is a 
marker of tumours with extensive allelic imbalances (Smith et al., 2005). 
Given the important role of FOXM1 in the regulation of downstream targets 
involved in normal chromosome segregation and cell division, it would be 
interesting to investigate the effect of FOXM1B overexpression on the mitotic 
processes of primary human keratinocytes.  
 
4.3.5 Contrasting Effects of FOXM1 
The evidence shown here supports the view that FOXM1B overexpression can 
disturb the mitotic process, thereby leading to genomic instability. That said, it 
is also known that lack of FOXM1 protein during mitosis, can impair cell 
division and lead to mitotic failure and endoreduplication, thereby leading to 
genomic instability (Laoukili et al., 2005; Wonsey and Follettie, 2005). An 
important observation however, is that the effects of FOXM1B overexpression 
observed here, are largely permissive for cell cycle and cell division, as 
opposed to the mitotic break-down and cell cycle arrest caused by FOXM1 
depletion. This was particularly demonstrated when keratinocytes 
overexpressing FOXM1B, could be serially passaged in culture while 
accumulating further genomic aberrations (see Figure 4.5 D). It therefore 
follows, that although both lack and overexpression of FOXM1 may produce 
overlapping effects, only the latter can allow cell cycle progression and 
concomitant genomic aberrations. This can also explain why tumours exhibit 
both elevated levels of FOXM1, and genomic instability, and is in keeping 
with a recent study supporting a strong requirement for both in human 
malignancy (Carter et al., 2006). Recently, Carter et al. (Carter et al., 2006) 
have attempted to characterize the levels of aneuploidy, as a result of genomic 
instability in human tumours, based on a specific gene expression pattern. 
Each sample was given a total functional aneuploidy (tFA) ‘score’, based on 
its functional aneuploid features. A chromosomal instability score for a wide 
array of genes was therefore derived, by combining the level of correlation of 
each gene to tFA, from diverse types of human malignancies. The results of 
this study are highly relevant to the evidence presented here, since FOXM1 
was found to be the third highest ranked, and thus overexpressed, gene with an 
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expression pattern that was consistently associated with genomic instability 
(Carter et al., 2006). The same study showed that FOXM1 downstream target 
genes, including CCNB1, AURKB, NEK2, and the novel target of FOXM1 
reported here, CEP55, were amongst the top 70 highest ranked genes (Carter 
et al., 2006). Another study has also shown that the expression of FOXM1B is 
also invariably associated with genomic instability in hepatocellular 
carcinomas (Calvisi et al., 2009).  
 
4.3.5.1 Implication of FOXM1 in DNA Repair  
A recent study by Tan et al. (2007) provided evidence that depletion of 
FOXM1 leads to the generation DNA strand breaks and cell cycle arrest 
mediated by the induction of TP53 and p21WAF-1/CIP1 genes (Tan et al., 2007). 
More importantly, the same study showed that FOXM1 is stabilized by Chk2 
mediated phosphorylation during DNA damage, and suggested a role for 
FOXM1 in DNA repair, by regulating the expression of DNA repair 
associated genes, BRCA2 and XRCC1. Based on these findings, the authors 
concluded that FOXM1 depletion renders cells susceptible to mutations and 
chromosomal aberrations, which they associated with the high tumour 
incidence in aged populations where FOXM1 expression is diminished (Tan et 
al., 2007). Since FOXM1 can lead to the induction of DNA repair pathways, it 
would then be expected that its loss will inevitably lead to increased 
susceptibility to oncogenesis given the increased rate of spontaneous 
mutations and DNA breaks, which was indeed evidenced in FOXM1 depleted 
MEFs (Tan et al., 2007). In fact, DNA repair genes are among the most 
susceptible genes to be targeted by inactivating mutations in human 
malignancies (Negrini et al., 2010).  
 
However, in light of the observations from models of carcinogenesis in mice it 
is difficult to comprehend how loss of FOXM1 may contribute to oncogenesis 
as suggested by Tan et al. (Tan et al., 2007). Studies, many of which were 
conduced by the same group, have clearly shown that the loss of FOXM1 is 
efficiently protecting mice from chemically induced carcinogenesis (Kim et 
al., 2006; Gusarova et al., 2007; Wang et al., 2009), while its overexpression is 
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tumour promoting (Kalinina et al., 2003; Kalinichenko et al., 2004; Kalin et 
al., 2006; Kim et al., 2006; Yoshida et al., 2007; Wang et al., 2008b). It is 
known that the chemicals used to induce carcinogenesis can cause extensive 
DNA damage, and according to the DNA repair hypothesis, loss of FOXM1 
would be expected to lead to the accumulation DNA adducts, and therefore to 
an increased susceptibility to oncogenesis. However, this is not seen in vivo, as 
mice develop very few tumours in the absence of FOXM1, supposedly due to 
the proliferative block caused by lack of FOXM1 protein. Therefore, even if 
FOXM1 has a role in repairing DNA damage, this effect is likely to be 
abolished due to the lack of proliferation in the absence of FOXM1.  
 
In the alternative scenario of overexpression, it is shown that FOXM1 confers 
a proliferative advantage to pre-malignant and tumour cells, leading to 
development of more proliferative and aggressive tumours in vivo, while it 
enhances the tumourigenic potential of already transformed cell lines in vitro 
(see Chapter 1, section 1.4.6). This of course fits with the established fact that 
most human tumours are characterized by overexpression, rather than 
suppression of FOXM1. But how could the expression of a DNA repair 
associated gene be tumourigenic? One explanation is that DNA repair genes 
also have functions other than DNA repair. For example, it was shown that 
BRCA2 overexpression in a small subset of breast tumours correlated with 
increased tumour proliferation rates (Bieche et al., 1999). There is also 
evidence suggesting that the re-acquisition of wild type function of DNA 
repair genes is responsible for the resistance to chemotherapy, by repairing 
DNA adducts and allowing cell survival of already malignant cells (Sakai et 
al., 2008). This certainly fits well with a role for FOXM1 as a DNA repair 
associated gene, since Kwok et al. (2010) provided conclusive data that 
expression of ΔN-FOXM1 in MCF-7 breast carcinoma cells can confer 
resistance to cisplatin (Kwok et al., 2010). Even though depletion of FOXM1 
did not result in the reduction of BRCA2 and XRCC1, the resistant breast 
cancer cell line MCF-7CISR was still sensitised to cisplatin. This suggests that 
either FOXM1 is either regulating DNA repair through other genes or that it is 
regulating the DNA damage response and recognition differently.  
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Nevertheless, this provides insight into the mechanism by which FOXM1 may 
be involved in DNA repair in already established tumour cells where DNA 
repair may be needed to maintain a more stable genotype as suggested 
previously (Cahill et al., 1999), or to confer resistance to genotoxic insults (i.e. 
chemotherapy). However FOXM1 is also upregulated early in cancer, prior to 
malignant conversion. At least in the cases of early lesions of cervical 
intraepithelial hyperplasia (Chan et al., 2008), ductal breast hyperplasia, 
Barrett’s metaplasia, uterine fibroid, transitional cell carcinoma without CIS, 
and OSCC mild dysplasias, FOXM1 appears to be significantly overexpressed 
(Gemenetzidis et al., 2009) (also Chapter 3), and almost certainly not as a 
result of gene mutation, since only one missense mutation with a yet 
unidentified phenotypic effect has been reported for FOXM1, and was found 
in malignant melanoma cells targeting the protein’s C-terminus (source: 
Sanger; COSMIC- catalogue of somatic mutations in cancer). Since numerous 
pre-neoplastic epithelial lesions exhibit signs of DNAds breaks (Bartkova et 
al., 2005; Gorgoulis et al., 2005) , it appears that there is also the need for 
DNA repair in early stages of human malignancy. Some pre-malignant 
epithelial lesions show constitutive activation of ATM-CHK2-p53 pathway 
which is suggested to function as an anti-cancer barrier, triggered by the 
presence DNA breaks, which occur as a result of sustained oncogenic 
stimulation (Bartkova et al., 2005; Gorgoulis et al., 2005). Since CHK2 is 
shown to phosphorylate FOXM1, leading to protein stabilisation and 
activation, it is possible that FOXM1 is part of this tumour anti-cancer 
response that is triggered by DNA damage. The other alternative, which is also 
supported by the findings in this study, suggests that aberrant activation of 
FOXM1 can induce copy number alterations at multiple genomic loci and 
thereby could also explain both its overexpression (Chan et al., 2008; 
Gemenetzidis et al., 2009) and the presence of such alterations in early pre-
malignant lesions (Lengauer et al., 1998; O'Connell et al., 1998; Vogelstein 
and Kinzler, 1998; Willenbucher et al., 1999; Kobayashi et al., 2000; Pinto et 
al., 2000; Gong et al., 2001; Shih et al., 2001; Bartkova et al., 2005; Gorgoulis 
et al., 2005; Negrini et al., 2010). Whether FOXM1 upregulation is observed 
because it is necessary to repair damaged DNA in pre-neoplastic lesions, or 
whether it is the cause of such genome de-stabilising events, remains unclear. 
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Its primary role in important mitotic processes favours the latter, while its 
suggested role in the regulation of DNA repair favours the former. The 
findings herein that FOXM1 could be activated by genotoxic agents (e.g., 
UVB and nicotine) and that ectopic FOXM1B expression causes genomic 
instability favour the view that the upregulation of this transcription factor is 
contributing the genomic instability seen in human malignancies. However, 
the possibility that FOXM1-induced overexpression of DNA repair genes can 
trigger genomic instability and DNA repair, to an extent that will allow tumour 
cell survival, could also grant further consideration.  
 
Human carcinogenesis is a multistep process driven by the selection of cells 
with an acquired survival advantage. During this process cells need to 
overcome numerous anti-cancer barriers (Stevenson and Volsky, 1986; Hahn 
and Weinberg, 2002).  The data presented here indicate that aberrant 
upregulation of FOXM1B may serve as a ‘first hit’ where cells acquire a 
susceptibility to genomic instability. This can predispose cells to a ‘second 
hit’, presumably mediated by extrinsic factors (i.e. UVB irradiation), whereby 
a DNA-damage/proliferative stress checkpoint response is abolished, to allow 
uncontrolled proliferation and the accumulation of genetic 
aberrations/mutations required for human cancer initiation.  
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5 FOXM1 Modulates Human Keratinocyte 
Progenitor Differentiation 
 
5.1 Introduction 
Many epithelial malignancies, including HNSCC, are heterogeneous in nature 
and arise from a common premalignant progenitor, followed by the outgrowth 
of clonal populations, which are usually subjected to cumulative genetic 
alterations that lead to invasive malignancy (Hunter et al., 2005). Endogenous 
FOXM1 protein is normally expressed at low levels within the basal and 
suprabasal layers of human oral mucosa (Chapter 3) and skin epithelium (Teh 
et al., 2002). The finding that FOXM1 expression precedes oral (Chapter 3), 
esophagus, lung, breast, kidney, bladder and uterus malignancies, predicts a 
vital role for this transcription factor in the early stages of human neoplasia 
(Gemenetzidis et al., 2009).  
 
The superior proliferative potential and capacity for self-renewal are two 
attributes that render stem cells potential targets of epithelial tumour initiation. 
Being the long term residents of epithelial tissues, stem cells have the ability 
to accumulate the number of genetic hits necessary for tumour formation 
(Owens and Watt, 2003). Given that FOXM1 is upregulated in the majority of 
human cancers, it was hypothesized that aberrant FOXM1 expression may 
play a pivotal role in cancer initiation by modulating the balance between 
epithelial stem cell proliferation and differentiation. It is therefore essential to 
investigate how FOXM1 is regulated in epithelial stem cell populations, with 
an aim to understand how its upregulation may contribute to the initiation of 
epithelial malignancies. 
 
To date, studies of FOXM1 as a cancer causing gene have been performed in 
the context of transformed and/or immortalized cell lines, undoubtedly 
providing invaluable insight into the molecular mechanisms mediated by 
FOXM1. However, due to the aberrant molecular background already present 
in most cell line systems, the role of FOXM1 in the earliest stage of neoplasia 
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could not be delineated and it is not fully understood. Therefore the regulation 
and the effect of FOXM1 (isoform B) proto-oncogene overexpression, was 
examined in normal primary human epithelial cells as they represent the main 
target population of human malignancies.  
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5.2 Results 
 
5.2.1 Expression Pattern of FOXM1 in Normal Human Oral Epithelium 
During epithelial regeneration, the slow cycling immature basal populations 
give rise to rapidly proliferating keratinocytes, which migrate upwards to 
finally give rise to terminally differentiating squames. In order to investigate 
the functional significance of FOXM1 in the initiation of epithelial tumours, it 
is important to first understand how its expression is regulated under normal 
homeostatic conditions in the epithelial tissue. Therefore, normal human oral 
mucosa epithelium was examined by means of immunohistochemistry using 
high power confocal imaging, to visualize the relative expression patterns of 
both FOXM1, and a previously characterized oral keratinocyte stem cell 
marker, p75NTR (Nakamura et al., 2007).  
 
The immunoreactivity of p75NTR was strictly localised to the basal layer, 
with regions of intense p75NTR positivity at the tips of tissue papillae, 
whereas p75NTR staining was notably less intense in deep rete ridges (Fig. 
5.1 C, i). Unlike the epidermis, proliferative activity in the oral epithelium is 
present in both the basal and parabasal epithelial layers (2-3 layers above the 
basal layer). Reportedly, Cyclin D1 and CENP-F, an established FOXM1 
target (Laoukili et al., 2005), are predominantly expressed in mitotic cells of 
the parabasal layers of oral mucosa epithelium (Liu et al., 2007). In line with 
these observations, FOXM1 was found to be mainly expressed in the 
proliferative parabasal layers of oral epithelium, while it was also detected in 
isolated cells within the basal layer (Figure 5.1). Nuclear FOXM1 
immunostaining was also infrequently found in the suprabasal layers, possibly 
marking early differentiating cells, undergoing the last stages of cell division 
prior to terminal differentiation. Importantly, the expressions of p75NTR and 
FOXM1 were mutually exclusive in within the oral epithelium. Specifically, in 
areas of intense p75NTR (see Fig. 5.1 A, magnified in B), FOXM1 is mainly 
expressed in cells above the basal layer with no significant co-localisation with 
p75NTR. In deep rete ridges, both proteins show a higher degree of co-
expression (Fig. 5.1 A magnified in C, and D). The presence of isolated basal 
keratinocytes co-expressing p75NTR and FOXM1 could represent either early 
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progenitor TA keratinocytes, or the rarely dividing oral keratinocyte ‘stem 
cell’ population. 
 
 
 
 
 
 
Figure 5.1: Mutually exclusive expression pattern of FOXM1 and p75NTR in 
normal human oral epithelium 
(A) Immunohistochemistry of p75NTR (green) (i), and FOXM1 (red) (ii) in normal 
human oral mucosa epithelium. (B) (C) and (D) High magnification of sections in C 
showing co-expression (yellow) of p75NTR and FOXM1 protein within discrete cells 
within the basal cell layer above the connective tissue papillae. 
 
5.2.2 Oral Keratinocyte Stem Cell Isolation and Validation 
To further understand how FOXM1 expression is regulated during 
keratinocyte stem cell expansion, this study aimed to directly isolate putative 
oral keratinocyte stem cells. This would allow keratinocyte stem cell 
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population expansion in vitro in a controlled environment, where FOXM1 
expression could be directly assessed.   
 
Enrichment of keratinocyte stem cells has been previously demonstrated in 
vitro, based on the differential expression of cell surface markers. Immature 
populations of basal epidermal keratinocytes have been identified by 
differential expression of β1 integrins. Integrin β1-positive fluorescence 
activated cell sorting (FACS) sorted fractions of epidermal keratinocytes that 
adhere rapidly to extracellular matrices (Collagen IV and Fibronectin), possess 
greater regenerative and proliferative capacity in vitro (Watt, 1998). Whereas, 
human oesophageal and oral mucosal keratinocyte stem cells have been 
previously shown to express high levels of the low affinity nerve growth factor 
receptor, p75NTR (Okumura et al., 2003; Nakamura et al., 2007).  
 
In order to investigate the regulation of FOXM1 in oral keratinocyte stem cells 
(OKSCs), fluorescence activated cell sorting (FACS) was used to isolate 
specific population subsets that express either integrin β1 or p75NTR or both 
(Fig. 5.2A). Secondary cultures of normal human oral keratinocytes 
(population doublings, PD 6-9) were used for fluorescence activated cell 
sorting (FACS) and equal numbers from each sorted population were seeded 
diretly onto mitomycin C-treated 3T3 feeder layers, and in vitro clonogenic 
assays were performed, to examine their proliferative potential. To verify the 
FACS procedure integrin β1+ bright/p75NTR- (represented on Fig. 5.2A as 
fraction P3) and integrin β1+ bright /p75NTR+ (represented on Fig. 5.2A as 
fraction P4) populations were examined under fluorescence microscopy 
immediately after plating (Fig. 5.2B).  
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Figure 5.2: Oral keratinocyte stem cell isolation. 
(A) FACS staining profile of primary human oral keratinocytes stained with anti-
integrin β1 (CD29) and anti-p75NTR (CD271) antibodies. Populations marked as P1, 
P2, P3 and P4 were used for combined cell sorting analysis. The relative abundance 
of each population is derived from experiments performed on oral keratinocytes 
derived from three different donors and were carried out in triplicates. (B) 
Fluorescence microscopy on oral keratinocyte populations immediately after flow 
sorting to demonstrate successful discrimination between the indicated populations. 
 
In line with previous observations, p75NTR+ cells possessed a superior 
clonogenic capacity compared to p75NTR- (Figure 5.3A i, ii, and Figure 5.3 
B) cells when examined 12 days after flow sorting. Although p75NTR- cells 
gave rise to some large colonies, many of them were highly irregular and 
displayed characteristics of terminal differentiation (Figure 5.3 Aii). The 
p75NTR+ cells gave rise mostly to large colonies with a smooth perimeter 
(Figure 5.3 Aii). The latter colony morphology signifies that such populations 
originate from the cells of a holoclone, which contains cells of high self-
renewal and proliferative capacity (Barrandon and Green, 1987).  
 
Chapter 5: FOXM1 Modulates Human Keratinocyte Differentiation  
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 160
 
Figure 5.3: Oral Keratinocytes sorted for p75NTR display high clonogenic 
capacity 
(A) Oral keratinocytes sorted for p75NTR- or p75NTR+ were allowed to grow for 12 
days. Keratinocyte colonies were examined under bright field microscopy (i) and 
were later stained with Rhodamine B (ii) for quantification of the clonogenic potential 
of each separate keratinocyte population. (B) Colony growth values for each different 
keratinocyte population were obtained by means of area coverage (pixels) as 
described in materials and methods. Clonogenic assays were carried out in 6 replicate 
wells for each sample. RS stands for random sorted control cells. Integrin β1 positive 
keratinocytes were further discriminated according to p75NTR positivity. p75NTR 
expression determined the clonogenic potential of integrin β1 (+) keratinocytes. 
Values represent the fold difference from p75NTR- control samples ±SEM for each 
average values. *P≤0.05, **P≤0.01, ***P≤0.001 
 
Keratinocytes with the highest integrin β1 expression levels, were observed 
mainly in the p75NTR+ subset (represented as fraction P4 in Figure 5.1 A), 
which is consistent with the fact that β1 integrins are highly expressed in the 
stem cell containing basal layers of human epidermis (Watt, 1998). However, 
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integrin β1 positivity conferred an advantage only when combined with 
p75NTR positivity, since only integrin β1+ bright / p75NTR+ (Figure 5.2 A 
fraction P4) cells showed high levels (comparable to integrin β1+ dim / 
p75NTR+ (P3) or p75NTR+ alone) of clonogenic potential (Figure 5.3 B, and 
Appendix 4), colony forming efficiency % (CFE), population doublings (PD) 
(Figure 5.4 B) and total cell output (Figure 5.4 A). As expected, all random 
sorted (RS; double stained keratinocytes randomly sorted from the same pool 
of cells) population showed intermediate levels between the (-) and (+) 
populations, indicating a mixed population.  
 
 
 
Figure 5.4: Proliferative potential of distinct keratinocyte subsets 
(A) Total cell output values were calculated as mentioned in materials and methods 
section after 12 days of culture. RS stands for random sorted control cells. Values are 
representative of two independent experiments carried out in duplicates. Bars 
represent the average fold difference from p75NTR- control samples ±SEM.*P≤0.05, 
**P≤0.005, ***P≤0.001. (B) Clonogenicity % and population doublings (PD) 
measurements of all sorted oral keratinocytes after 12 days in culture. RS stands for 
random sorted populations. Values are representative of three independent 
experiments carried out in duplicate wells, ±SEM for each average value. 
 
Next, the molecular profile of putative human OKSC (p75NTR+ cells) was 
investigated by qPCR. The mRNA expression levels of p75NTR were 
significantly elevated (~3.5 fold), in the p75NTR+ subsets proving successful 
FACS sorting (Figure 5.5 Ai, ii). Confluent cultures of lethally treated 3T3 
feeders were also included in expression analysis to control for possible 
contamination during cDNA preparations. Although 3T3 feeders were 
routinely removed prior to experiments, there is a possibility that a small 
amount of 3T3 cells may interfere with expression analysis. However, qPCR 
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results confirmed that lethally treated 3T3 feeders did not express detectable 
mRNA levels of either gene (see Figures 5.5 A, 5.6 A and 5.7) 
 
By examining the levels of a well established keratinocyte stem cell marker, 
ΔNp63α (Pellegrini et al., 2001), shortly after cell sorting, it was found that 
ΔNp63α protein was slightly more abundant in both the p75NTR+ and integrin 
β1+ bright / p75NTR+ ) compared to the p75NTR- population (Figure 5.5 Bi).  
As expected, random sorted (RS) control cells retained intermediate levels of 
ΔNp63α protein (Figure 5.5 Bi). The differences in ΔNp63α protein levels 
became much more pronounced after 12 days in culture, indicating the long 
term ability of OKSC derived populations to maintain the expression of stem 
cell associated markers (Figure 5.5 Bii). This comes in agreement with the 
first report identifying ΔNp63α  as a keratinocyte stem cell marker, which 
showed that it was still present in holoclone (but not in meroclone or 
paraclone) derived populations of limbal and epidermal keratinocytes, after 
11-12 days in culture (Pellegrini et al., 2001).  
 
Further qPCR expression analysis of freshly isolated p75NTR+ oral 
keratinocytes, revealed significantly higher expression levels of two other 
putative stem cell genes NESTIN and NUMB, when compared to non-stem 
cell fractions (Figure 5.5 C). NESTIN has been shown to be neuronal stem 
cell marker (Lendahl et al., 1990) while NUMB was reported as a maker of 
asymmetric division in mouse epidermal keratinocytes in vivo (Clayton et al., 
2007) and mouse satellite muscle progenitor cells in vitro (Shinin et al., 2006). 
The expression of cytokeratin 4 which is a marker specific for differentiating 
oral epithelia (Moharamzadeh et al., 2007) was also reduced in the stem cell 
enriched fractions of oral keratinocytes (see Appendix 5A). Collectively, 
these experiments validate the use of p75NTR as a stem cell marker for 
isolating human oral keratinocyte stem cells which are undifferentiated, highly 
clonogenic and proliferative.  
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Figure 5.5: Molecular profile of putative oral keratinocyte stem cells 
(A) Absolute qPCR analysis of p75NTR expression levels in sorted oral keratinocytes 
three days after flow sorting. All values are representative of three independent 
experiments. Graphs show single (p75NTR) (i) or double-sorted (p75NTR/initegrin 
β1) cells (ii). Bars represent the average fold difference from p75NTR- (arbitrary 
value of 1) control samples ±SEM.*P≤0.05, **P≤0.005, ***P≤0.001. (B) OKSCs 
retain high levels of ΔΝp63α protein after short and long term culture. Oral 
keratinocyte sorted populations were harvested for total protein at 72 hours (i) and 12 
days  (ii) and immunoblotted with anti-p63 antibody recognizing human ΔΝp63 
isoforms, and β-tubulin as protein loading control. (C) Absolute qPCR analysis of 
p75NTR, NESTIN, and NUMB in p75NTR+ oral keratinocytes. All values are fold 
expression relative to p75NTR- cells (arbitrary value of 1). Each bar represents the 
mean ± SEM of two independent experiments performed in duplicates. .*P≤0.05, 
**P≤0.005, ***P≤0.001.  
 
 
5.2.3 FOXM1B Is tightly Regulated in OKSC 
The slow cycling nature of putative epithelial stem cells is well supported, 
from in vivo labelling experiments, in vitro cultured cells and observations 
made from organotypic reconstructs of human epidermis (Barrandon and 
Green, 1987; Morris and Potten, 1994; Morris, 2000; Muffler et al., 2008). In 
order to investigate the endogenous expression level of proliferation specific 
transcription factor, FOXM1, in freshly isolated OKSCs, sorted cells were 
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allowed to settle and grow for 72 hours (to generate sufficient cell number) 
prior to experiments. In these early p75NTR+ fractions of OKSCs, FOXM1B 
was significantly reduced at both mRNA (Figure 5.6 Ai, ii) and protein 
(Figure 5.6 Bi) when compared to p75NTR- fractions. However, when the 
expression patterns of these cells were examined after 12 days in culture, 
FOXM1 protein was exclusively upregulated in the stem cell enriched 
fractions (Figure 5.6 Bii) compared to the p75NTR- fraction. Furthermore, the 
upward shift of FOXM1 protein band in the p75NTR+ and RS cells compared 
to p75NTR- cells indicates that FOXM1 protein remained in its active 
phosphorylated form in the OKSCs (Figure 5.6 Bii). 
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Figure 5.6: FOXM1 expression in OKSC.  
(A) Absolute qPCR analysis of FOXM1B expression levels in single p75NTR (i) and 
double integrin β1/p75NTR (ii) sorted oral keratinocytes three days after flow sorting. 
RS stands for random sorted populations. All values are representative of three 
independent experiments and graphs show the relative FOXM1B mRNA copy 
number against p75NTR- (i) or integrin β1 (+) p75NTR- (ii) samples. Bars represent 
the mean ± SEM of three replicate samples.*P≤0.05, **P≤0.005, ***P≤0.001. (B) 
FOXM1 protein expression pattern in OKSC. Oral keratinocyte sorted populations 
were harvested for total protein at 72 hours (i) and 12 days (ii) and immunoblotted 
with anti-FOXM1 (C20) antibody and β-tubulin as protein loading control. 
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The downregulation of FOXM1 protein in the remaining cell populations after 
long term culture suggests that FOXM1 is switched off during terminal 
differentiation of oral keratinocytes. In support, FOXM1 protein levels are 
diminished after a 12-day period in the p75NTR- fraction (Figure 5.6 Bii). 
Additionally, FOXM1 and involucrin protein levels were inversely correlated 
during prolonged culture of p75NTR- oral keratinocytes (see Appendix 5 B). 
 
As decribed earlier in Chapter 4, the mRNA expression pattern of FOXM1B 
isoform, but not isoforms A or C, oscillates during cell cycle whereby its peak 
expression coincides with the G2/M phases of the cell cycle (Figure 4.1). 
Consistent with the observation that FOXM1C was not induced during cell 
cycle progression, there was no differential expression for this isoform 
between p75NTR- and p75NTR+ enriched populations (Figure 5.7). It is worth 
mentioning that the antibody used to detect FOXM1 does not discriminate 
between all different isoforms, and hence, the reduction of FOXM1B protein 
levels in OKSC derived keratinocytes, could be potentially underestimated. 
 
 
Figure 5.7: FOXM1C isoform is not differentially expressed in OKSCs.  
Oral keratinocytes were either single (i) or double (ii) sorted as indicated. FOXM1C 
mRNA copy number was quantified using absolute qPCR. RS stands for random 
sorted populations. All values are fold expression relative to p75NTR- (i) or integrin 
β1+ p75NTR+ cells (ii). Each bar represents the mean ± SEM of two independent 
experiments performed in triplicates.  
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5.2.4 FOXM1B Modulates Primary OKSC Expansion 
The elevation of FOXM1 in the majority of human solid cancers raises the 
possibility its overexpression may be an initiating event required for 
oncigenesis possibly by targeting the long lived residents of epithelial tissues 
resulting in persistent expression of FOXM1 in cancers. Given that FOXM1 
was found to be an early event in the progression of OSCC (Chapter 3) 
(Gemenetzidis et al., 2009), I sought to investigate the effect of FOXM1B 
overexpression on OKSCs, since sustained overexpression of this oncogenic 
transcription factor could constitute an initiating event whereby cells acquire a 
proliferative advantage. Consistent with its proliferation specific role, FOXM1 
was only found to be transiently expressed during OKSC expansion (Figure 
5.6), while its expression was strongly suppressed in terminally differentiated 
keratinocytes. In order to gain a better understanding of how the deregulation 
of this expression pattern contributes to the initiation of oncogenesis, 
FOXM1B was ectopically expressed in distinct subsets of normal primary 
human keratinocytes, distinguished by their degree of ‘stemness’, by using the 
expression levels of p75NTR as an indicator. Due to the heterogeneity of 
human primary keratinocytes (see also Chapter 1, section 1.2), it was 
hypothesized that diverse populations may respond differently to FOXM1B 
overexpression.   
 
Primary oral keratinocytes FACS sorted into p75NTR+ and p75NTR- 
populations representing OKSCs and lineage committed 
differentiating/differentitated keratinocytes respectively. Sorted keratinocytes 
were then transduced with either empty (MCS) or EGFP control retroviruses, 
or with EGFP-FOXM1B retrovirus (diagrammatic representation of the 
experimental procedure is shown in Appendix 6). Three days following 
transduction, keratinocytes were plated at low densities (500 cells /8cm2) in 
the presence of 3T3 feeder layers. Total protein lysates were also prepared, in 
order to assess the relative expression levels of FOXM1B in the p75NTR+ 
fraction (Figure 5.8B). In a separate experiment conducted to acquire 
sufficient numbers of transduced p75NTR- keratinocytes, it was confirmed 
that even ectopically expressed FOXM1B protein levels are still down-
regulated in OKSC (Figure 5.8 C), suggesting that FOXM1 proteins are also 
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regulated at the protein level in putative OKSC populations. It is important to 
mention that the downregulation of FOXM1 in p75NTR+ populations is much 
more evident at the level of ectopic FOXM1B protein when compared to 
FOXM1 protein as a whole which represents all three FOXM1 isoforms. 
Given that FOXM1B, but not FOXM1C, transcription is also significantly 
downregulated (Figure 5.6A, 5.7), it is possible that this mechanism is 
specific for the B isoform of FOXM1 both at mRNA and protein levels. 
 
Although p75NTR- keratinocytes failed to grow extensively after transduction 
with either construct, it was noteworthy that individual keratinocyte p75NTR+ 
stem cell colonies expressing EGFP-FOXM1B (p75NTR+FOXM1B) showed an 
altered phenotype in that they contained cells with a higher nuclear to 
cytoplasmic ratio, and were highly cohesive. A representative image on 
Figure 5.8A v, and vi shows the relative size of a keratinocyte colony 
expressing EGFP-FOXM1B compared to an un-transduced keratinocyte 
colony. Overall, approximately 87% of clonogenic keratinocytes were 
efficiently transduced, as judged by quantification of EGFP-positive 
keratinocyte colonies.  
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Figure 5.8: FOXM1B expressing keratinocyte stem cell colonies  
(A) Primary human oral keratinocyte stem cells (p5NTR+) were transduced with 
either (i) pSINEGFP or (ii) pSINEGFP-FOXM1B and individual keratinocyte 
colonies were examined under bright and fluorescence (FfIT-C) microscopy 
following 3T3 feeder removal. Figures (v), (vi) depict two keratinocyte stem cell 
colonies the size of which correlates with the level of FOXM1B expression as 
evidenced by green fluorescence intensity. (B) Keratinocytes were harvested and total 
protein was immunoblotted against anti-FOXM1 antibody. Anti-GAPDH antibody 
was used to confirm equal protein loading. (C) Oral keratinocytes were sorted in 
p75NTR+ and p75NTR- fractions and were transduced with pSINEGFP or 
pSINEGFP-FOXM1B. Cells were allowed to grow for 5 days prior to harvesting to 
assess the relative expression levels of FOXM1. Proteins were immunoblotted against 
anti-FOXM1 antibody and anti-GAPDH antibody as a protein loading control. Cells 
overexpressing FOXM1B also show massive increase in the levels of FOXM1 
endogenous protein suggesting a positive feedback loop, whereby exogenous 
FOXM1B could in turn promote the expression of FOXM1 gene. The excessive 
levels of FOXM1 proteins are significantly reduced in the stem cell fraction of oral 
keratinocytes (p75NTR+). 
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Twelve days after clonal plating, keratinocyte colonies were stained with 
Rhodamine B and the total number and surface areas (mm2) of colonies from 
each population were measured as described in Chapter 2, section 2.4. The 
more committed progeny of oral keratinocytes (p75NTR-) failed to show any 
significant differences in colony growth, following transduction with MCS, 
EGFP, or FOXM1B. However, within the p75NTR+ transductants, the average 
area of colonies founded by p75NTR+FOXM1B was significantly increased 
compared to both MCS and EGFP-expressing control cells (Figure 5.9). 
 
 
Figure 5.9: FOXM1B expression induces progenitor keratinocyte colony growth 
p75NTR+ oral human keratinocytes were infected with pSINMCS, EGFP, or 
FOXM1B and were plated at clonal densities. Cells were allowed to grow for 12 days 
prior to counting colony number and size. >100 colonies were measured for each 
construct. The bars represent the mean relative fold difference in colony area value, 
against MCS control (arbitrary value of 1) ±S.E.M for replicate samples (n=6) 
***P≤0.001. 
 
When plating human keratinocytes at low densities, morphologically distinct 
types of colonies become apparent after 12-14 days of culture (Barrandon and 
Green, 1987; Jones and Watt, 1993). The larger keratinocyte colonies (10-
30mm2), which are thought to be founded by putative stem cells, and consist 
of a mixture of transit amplifying and differentiated keratinocytes, as well the 
smaller keratinocyte colonies (<5mm2) which are thought to consist primarily 
of transit amplifying and terminally differentiated keratinocytes (Barrandon 
and Green, 1987). Based on these features, we found that the progeny of 
p75NTR+FOXM1B showed a ~2.6 fold increase (compared to p75NTR+MCS or 
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p75NTR+EGFP) in the percentage of large keratinocyte colonies (>10mm2), and 
a concomitant reduction in the percentage of smaller/abortive colonies 
(<5mm2) after 12 days in culture (Figure 5.10). This evidence suggests that 
elevation of FOXM1B expression confers a proliferative advantage in OKSC 
(p75NTR+), but not in committed keratinocytes (p75NTR-), thereby increasing 
their intrinsic capacity to clonally expand in vitro. This indicates that 
FOXM1B overexpression can either directly promote the maintenance of the 
stem cell population, or oppose/delay the terminal differentiation of their 
immediate progeny (TA keratinocytes). 
 
 
 
 
Figure 5.10: FOXM1B induces expansion of p75NTR+ OKSC colonies 
p75NTR+ oral human keratinocytes were infected with pSINMCS, EGFP, or 
FOXM1B and were plated at clonal densities. Cells were allowed to grow for 12 days 
prior to counting colony number and size. >100 colonies were measured for each 
construct. The bars represent the mean percentage of colonies >10mm2 (red) or 
<5mm2 (black) ±S.E.M for replicate samples (n=6) *P≤0.05 
 
In order to gain a better understanding of how aberrant expression FOXM1B 
contributes to stem cell colony expansion, the function of keratinocyte stem 
cell differentiation was studied using a well-established 3D organotypical 
epithelium regeneration model system using primary human oral keratinocytes 
(Moharamzadeh et al., 2007; Teh et al., 2007). Oral keratinocytes were 
transduced with either pSINEGFP (the empty vector pSINMCS produces 
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identical results in keratinocyte colony growth assays; Figures 5.9, 5.10) or 
pSINEGFP-FOXM1B and were cultured on de-epidermalised dermis (DED) 
for 15 days with the support of normal human oral fibroblasts as described 
previously in Chapter 2. EGFP-FOXM1B overexpressing organotypic 
cultures showed a hyper-proliferative phenotype producing thicker spinous 
cell layers than the control EGFP expressing organotypic culture (compare 
Figures 5.11 A and B). Consistent with its expression pattern in normal oral 
mucosa, FOXM1 (Figure 5.1) was expressed at low levels in the basal 
epithelial layers of the control (pSINEGFP) organotypic DED culture (Figure 
5.11 C). Importantly, FOXM1 protein localization is mainly nuclear in 
dividing keratinocytes within the basal layer. Similar to normal oral mucosa 
tissue, low levels of FOXM1 protein were detected in the basal layers of the 
control organotypic DED culture  
 
In contrast to control DED, high levels of FOXM1 protein were detected in 
both the basal and suprabasal layers of the DED culture derived from 
FOXM1B overexpressing oral keratinocytes (compare Figures 5.11 C and D). 
The keratinocytes in the spinous and granular layers of FOXM1B derived 
reconstructs retain ectopic FOXM1B, which also correlated with increased Ki-
67 immunoreactivity throughout these layers (Figure 5.11 F, H). On the other 
hand, Ki-67 immunoreactivity was strictly confined to basal proliferative layer 
of the control DED (Figure 5.11 E). This was not an artefact due to increased 
tissue thickness, since the same pattern and extent of Ki-67 immunoreactivity 
was observed even in thickness-matched areas of EGFP and EGFP-FOXM1B 
derived DEDs (Figure 5.11 G and H). In agreement with previous FOXM1 
and Ki-67 immunohistochemical staining patterns in basal cell carcinoma (Teh 
et al., 2002), only a subset of FOXM1 expressing cells are also Ki-67 positive. 
The expansion of keratinocyte populations seen in organotypic reconstructs, is 
highly consistent with the expansion of p75NTR+FOXM1B keratinocytes after the 
same period of time in monolayer cultures (Figures 5.9, 5.10). The patterns of 
keratinocyte proliferation seen in the organotypics suggest that FOXM1B 
overexpression did not increase the proliferative rate of basal keratinocytes, 
but instead, it resulted in sustained proliferation of the more mature spinous 
keratinocytes. This suggests that FOXM1B alone does not have an immediate 
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proliferative effect on OKSC, but it leads to the defective terminal 
differentiation of their immediate progeny (TA keratinocytes). In addition, 
staining with integrin β1, a marker for basal keratinocytes, revealed the 
presence of intact basement membranes with no breaks, or any other 
abnormalities between EGFP and EGFP-FOXM1B (Figure 5.11 I, K). 
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Figure 5.11: FOXM1B induces hyper-proliferation phenotype in oral mucosa 
organotypical culture model.  
Representative images taken from haematoxylin and eosin stained 3D organotypic 
cultures of human oral mucosa, derived from DEDs from (A) pSINEGFP or (B) 
pSINEGFP-FOXM1B transduced oral keratinocytes. DED tissues were stained with 
anti-FOXM1 (green) (C, D), Ki-67 (red) (E, F, G, H), and anti-integrin β1 (I, K). 
DED sections were counterstained with DAPI for nuclear DNA visualization (blue). 
 
To further investigate the effect of aberrant FOXM1B overexpression during 
epithelial regeneration, I looked for the expression of cytokeratin 16, which is 
a marker of the regenerating epithelium and is induced prior to, or during, 
hyper-proliferative conditions such as wound healing (Tyner and Fuchs, 
1986), and trans-glutaminase 1 (TGA-1), which is specifically expressed in the 
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granular and cornified layers of the oral epithelium (Ta et al., 1990), but  is 
also a maker of the upper spinous layers of the organotypic epithelium 
(Tsunenaga et al., 1994).  Both cytokeratin 16 and TGA were significantly 
upregulated in FOXM1B derived DED cultures (Figure 5.12 A, B, C, D), 
compared to control DED cultures. Overexpression of Cytokeratin 16 has been 
reported in hyperproliferative disorders of human epidermis (Stoler et al., 
1988), and its increased abundance in FOXM1B derived DED tissues, 
indirectly indicates sustained keratinocyte expansion. This along with the 
inappropriate mitotic activity in the suprabasal layers suggested that the 
expanding FOXM1B expressing keratinocyte population is not immature, and 
it has probably acquired a defective terminal differentiation programme.  
 
Following up on this hypothesis, I performed immunostaining using 
keratinocyte terminal differentiation markers, cytokeratin 13 and filaggrin. 
Control EGFP DED cultures showed specific cytokeratin 13 (Figure 5.12 E) 
and Filaggrin (Figure 5.12 G) expression within the granular and cornified 
layers. In contrast, FOXM1B-derived DED cultures showed complete absence 
of immunoreactivity of these late differentiation markers (Figure 5.12 F, H). 
This effect was not only restricted to areas of increased thickness in FOXM1B 
derived DEDs, but was also notable across the whole sections of FOXM1B 
reconstructed tissues.  
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Figure 5.12: Abnormal differentiation characteristics of FOXM1B organotypic 
reconstructs.  
DED tissues were stained with anti-cytokeratin 16 (CK16) (A, B), transglutaminase-1 
(TGA-1) (C, D) anti-cytokeratin 13 (E, F) or anti-Filaggrin (G, H). Note the 
complete absence of cytokeratin 13 and filaggrin from FOXM1B organotypic tissues 
(F, H). DED sections were counterstained with DAPI for nuclear DNA visualization 
(blue).  
 
5.3 Discussion 
The aberrant upregulation of FOXM1 in the majority of human epithelial 
cancers indicates a key role of FOXM1 in oncogenesis. The finding that 
FOXM1 expression precedes human epithelial malignancy (Chapter 3) 
(Gemenetzidis et al., 2009) led to the hypothesis that excessive FOXM1 serves 
as an oncogenic 1st hit rendering cells susceptible to subsequent hits required 
for cancer initiation. The epithelial tissue undergoes continuous renewal, under 
a strictly organised system that is governed by a hierarchy of cells with 
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differing capacities for proliferation. The gene expression profile across the 
hierarchy of cells within the epithelial tissue provides valuable insight into 
normal tissue homeostatic control mechanisms, which are frequently perturbed 
in human neoplasia. It is generally thought that a stem cell, owing to its longer 
lifespan within the tissue, serves as a host which allows long-term 
accumulation of oncogenic mutations giving rise to premalignant and 
malignant cells (Morris, 2000).  
 
5.3.1 Oral Keratinocyte Stem Cell Properties 
The localisation of p75NTR positive keratinocytes presented herein is in 
agreement with that of previous studies and is consistent with putative location 
of oral epithelial stem cells (Watt, 1998; Seery and Watt, 2000; Watt, 2001; 
Nakamura et al., 2007). Consistent with previous reports (Okumura et al., 
2003; Nakamura et al., 2007), it was observed that human primary oral 
keratinocytes that express high levels of p75NTR, represent a population of 
OKSC which fulfils many in vitro stem cell characteristics (Barrandon and 
Green, 1987; Jones and Watt, 1993; Morris and Potten, 1994; Morris, 2000), 
whereby they showed enhanced holoclone-type colony formation, proliferative 
potential and life span in culture compared to p75NTR- cells. Furthermore, 
p75NTR+ cells exhibited basal-like undifferentiated morphology, and low or 
suppressed expression of keratinocyte differentiation-specific marker 
cytokeratin 4. Contrarily to previous observations, suggesting that integrin β1 
can also be used for the enrichment for human OKSC (Jensen et al., 2008), 
there were no significant differences between integrin β1+ and integrin β1- 
populations examined here. The reason for this apparent disparity could be 
that the enrichment protocols used here, did not include rapid adhesion to 
extracellular matrix proteins, or further enrichment based on cell size, as 
previously suggested (Jones and Watt, 1993). Nevertheless, the results 
presented here show that inclusion of integrin β1 as an additional marker for 
OKSC enrichment did not provide significant advantage. Although integrin β1 
is a well demonstrated marker of epidermal stem cells, it is yet unclear 
whether its expression pattern in other epithelia correlates with a stem cell 
status. For example in human oesophangeal epithelia integrin β1 correlates 
with a decreased clonogenic capaicy of keratinocytes in vitro (Seery and Watt, 
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2000).  It is also demonstrated that highly proliferative populations of 
p75NTR+ keratinocytes display, among other stem cell related markers 
(NESTIN and NUMB (Lendahl et al., 1990; Clayton et al., 2007)), elevated 
levels of ΔNp63α protein, which is also preferentially expressed in holoclone-
derived populations of epidermal and limbal keratinocytes (Pellegrini et al., 
2001). This suggests that ΔNp63α may also serve as a potential in vitro stem 
cell marker for keratinocytes of the oral epithelium. In support, there is 
significant overlap between the localization of p75NTR and p63 in normal oral 
and oesophageal epithelium (Hatakeyama et al., 2007; Huang et al., 2009).  
 
5.3.2 The Regulation of FOXM1 in OKSC 
The expression pattern of FOXM1 in normal oral epithelium in vivo is 
consistent with that of a proliferation associated protein as it is predominantly 
expressed in the parabasal, most proliferative, layers of the oral epithelium. Its 
expression was not seen in areas of intense p75NTR expression suggesting 
that FOXM1 is possibly down-regulated in the more immature populations of 
oral keratinocytes. This hypothesis was confirmed after analysis of the 
molecular gene expression profile of putative OKSC in vitro.  
 
When keratinocyte populations are expanded in vitro under optimized 
conditions, they are expected to contain the slow cycling immature population, 
the more rapidly proliferating transit amplifying keratinocytes as well as 
terminally differentiated keratinocytes. This heterogeneity was previously 
shown to exist in ex vivo human epidermal keratinocyte cultures (Eisinger et 
al., 1979). By isolating each separate population, it is therefore expected that 
putative keratinocyte stem cells will display features of quiescence.  
 
The evidence presented here, as well as in previous studies, demonstrate that 
the expression and activity of FOXM1 is mainly restricted to the G2/M phases 
of the cell cycle (Leung et al., 2001; Laoukili et al., 2008b). Therefore, it is 
possible that the suppression of FOXM1 in OKSC is a requirement for the 
maintenance of their slow cycling status. Others have found that the majority 
of isolated p75NTR+ human oesophageal keratinocytes, are mainly in a G0/G1 
state, and are characterized by a slow cell cycle profile in vitro (Okumura et 
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al., 2003). Expression analysis of human epidermal keratinocyte stem cells in 
vitro revealed that the maintenance of their quiescent state is partly attributed 
to a negative regulator of c-MYC, namely LRIG1 (Jensen and Watt, 2006). As 
there is evidence that c-MYC transactivates FOXM1 (Blanco-Bose et al., 
2008), it is possible, that LRIG1-induced suppression of c-MYC, indirectly 
contributed to the observed repression of FOXM1, in OKSC populations. It 
should be noted however, that while this may be a possible mechanism in 
normal physiological conditions, it is not necessarily applicable in cases of 
pathological activation of FOXM1. For example, FOXM1B is highly 
overexpressed in basal cell carcinomas (BCCs), despite the fact that these 
tumours exhibit reduced levels of c-MYC protein (Bonifas et al., 2001). 
 
Although keratinocyte stem cells are slow cycling, they are capable of 
sustained proliferation and are solely responsible for the expansion and 
replenishment of the keratinocyte population. This can explain the finding that 
after prolonged culture, FOXM1 protein was present only in the originally 
isolated p75NTR+ cells. Given that FOXM1 promotes cellular proliferation by 
regulating the expression of G1/S and G2/M transition specific genes 
(Wierstra and Alves, 2007), its expression pattern represents the expansion of 
OKSCs, which give rise to the more rapidly dividing transit amplifying 
keratinocytes.  
 
During the course of the experiments, it was observed that the initial 
expression levels of FOXM1 in freshly isolated primary keratinocytes, 
positively correlated with their clonogenic and proliferative potential in culture 
(personal observation). FOXM1 is broadly expressed in all embryonic tissues, 
while in adult organs its expression is restricted to tissues of a high 
proliferative index (e.g. testis, thymus and bone marrow), where it is important 
for replenishing the post-mitotic differentiated cells and for tissue expansion in 
response to injury (Ye et al., 1997). Hepatic deletion of Foxm1b in mice can 
result in diminution of mitotic entry during liver regeneration, while ectopic 
Foxm1b is alone sufficient to re-establish proliferation of aged mouse 
hepatocytes, following partial hepatectomy (Wang et al., 2002b). More 
recently, Foxm1 was shown to be critical for the maintenance and expansion 
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of pancreatic β-cell mass and pancreatic-wide deletion of Foxm1 resulted in 
impaired glucose tolerance and diabetes in mice (Zhang et al., 2006).  In the 
context of epithelial carcinogenesis, a recent report provided in vivo evidence, 
suggesting that the presence of Foxm1 is essential for the successful expansion 
of tumourigenic progenies in chemically induced carcinogenesis in mice 
(Wang et al., 2009). Overall, these observations led to the hypothesis that the 
initial expression levels of FOXM1 in the keratinocyte stem cell pool may be 
an important determinant of their total proliferative output, and the successful 
expansion of their progeny. This is further supported by data presented here, 
where specific overexpression of FOXM1B in putative OKSC (p75NTR+), 
increased the ability of keratinocytes for clonal expansion. 
 
The suppression of FOXM1 following prolonged culture of p75NTR- cells, 
suggests that FOXM1 is down-regulated in the progeny of keratinocytes 
undergoing terminal differentiation. This is consistent with the finding that 
FOXM1 protein and mRNA expression levels decline during confluence-
induced differentiation of a human epithelial colon carcinoma cell line (Caco-
2) toward the enterocyte cell lineage (Ye et al., 1997). Although the onset of 
replicative senescence could also contribute to a the downregulation of 
FOXM1 in primary normal oral keratinocytes, FOXM1 expression levels were 
diminished in differentiating keratinocytes, well before they entered a state of 
replicative senescence, which became evident at approximately PD~23-28. 
Furthermore, FOXM1 protein is absent from the differentiated layers of 
normal oral epithelium (Figures 3.1, 5.1). The down-modulation of the 
proliferative effects of FOXM1 may allow exit from the cell cycle and signify 
the onset of keratinocyte terminal differentiation.   The p75NTR- population 
consists of a good model of in vitro keratinocyte differentiation, in that it is a 
committed keratinocyte progeny with an early passage history, which allows a 
clear demonstration of the differentiation programme, devoid of the 
‘contaminating’ effects of replicative senescence.  
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5.3.3 The Impact of FOXM1B Overexpression in OKSC 
Given the fact that FOXM1B is upregulated in early epithelial pre-
malignancies (Gemenetzidis et al., 2009), it was reasoned that its 
overexpression may constitute an initiating proliferative stimulus, possibly 
targeting the immature basal populations of the human epithelium.  
 
Since FOXM1 expression is mainly detected during the expansion of OKSCs 
in vitro, and is localised in proliferative expanding  parabasal layers of oral 
epithelium in vivo, it was possible that overexpression of this transcription 
factor could in turn promote keratinocyte population expansion and 
consequently, prematurely forcing the exit of keratinocytes from the stem cell 
compartment. However, this was not the case as ectopic expression of 
FOXM1B was maintained in OKSCs with no loss or premature differentiation 
of keratinocyte stem cells. Genomic DNA copy number of EGFP-FOXM1B 
viral transgene remained similar between day 3 and day 10 in culture 
indicating that there was no loss of viral transgene in prolonged culture (see 
Appendix 7). FOXM1B expressing OKSCs showed evidence of increased 
clonal expansion and were also able to efficiently support epithelial 
reconstruction in vitro, indicating that overexpression of FOXM1B did not 
deplete the stem cell population. This observation could be contradictory if 
one considers that forced overexpression of the downstream target of FOXM1, 
c-Myc, has been shown to deplete the stem cell population of human 
epidermal keratinocytes by forcing them to commit to premature 
differentiation (Gandarillas and Watt, 1997). However, ectopic expression of a 
constitutively active, non-degradable form of β-catenin (ΔNβ-catenin), an 
upstream regulator of c-Myc, not only did not lead to premature 
differentiation, but instead it was shown to increase the proliferative capacity 
of human epidermal keratinocytes (Zhu and Watt, 1999). These studies 
indicate that the mechanism of stem cell exit and differentiation is complex 
and dependent upon the nature of the stimuli.  
 
The overexpression of FOXM1B resulted in increased population expansion, 
only when it was specifically targeted to the p75NTR+ populations, but had no 
effect when directed to the committed progeny of p75NTR- keratinocytes. 
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p75NTR+ cells strictly represent the basal oral keratinocyte population, which 
apart from putative OKSCs also includes the early TA keratinocytes (see also 
Chapter 1, section 1.2.1). The evidence provided herein as well as in previous 
reports suggest that this p75NTR expression signature is largely maintained in 
vitro (Okumura et al., 2003; Nakamura et al., 2007). Therefore, FOXM1B 
overexpression in both the OKSC and/or early TA (p75NTR+) compartment 
could have produced the observed effect. In the case of the latter, the 
oncogenic event should occur immediately after a cell exits the stem cell 
compartment (still at p75NTR+ state), since it will only be proliferative for a 
brief period of time prior to initiation of terminal differentiation (enters a 
p75NTR- state).  
 
It is known that FOXM1B protein is subject to extensive post-translational 
modifications. As such, its nuclear translocation and subsequent activation 
requires mitogenic signalling (Ye et al., 1999; Ma et al., 2005), while it is also 
shown that it can mainly transactivate its downstream targets upon entry in 
G2/M phase, at which time it is heavily phosphorylated (Leung et al., 2001; 
Laoukili et al., 2005; Laoukili et al., 2008b). Hence, this oncogenic insult can 
only be effective during normal OKSC expansion, when cells engage in 
limited but rapid cycles of cell division, and in support of our findings, it could 
not theoretically have any effect on late differentiating/differentiated 
keratinocytes where mitogenic signalling is normally completely lost 
(Barrandon and Green, 1987; Fuchs, 1993). Therefore, consistent with the 
notion that stem cells are hosts of oncogenic events (Morris, 2000; Morris et 
al., 2000) (see also Chapter 1, section 1.2.4), the most conceivable 
explanation is that a ‘successful’ FOXM1B ‘hit’ would have to be present in 
OKSC prior to their expansion. The inability of TA cells to subsequently 
suppress levels of excessive FOXM1B proteins can induce sustained 
proliferation, at the expense of terminal differentiation, as seen in the 
organotypic epithelial reconstructs. As discussed above, we have found that 
OKSCs (early passage immature p75NTR+ cells) are able to retain the 
FOXM1B transgene without causing stem cell exit, presumably through a yet 
unknown intrinsic mechanism that prevents FOXM1B-induced cell cycle entry 
and mains a slow cycling status of OKSCs, whereas, OKSCs committed to 
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differentiation (p75NTR- cells) were not able to suppress FOXM1B transgene 
expression. In a similar fashion, human FOXM1B was shown to exert a strong 
proliferative advantage in the livers of transgenic mice, only following partial 
liver hepatectomy, which is known to induce liver regeneration, at which time 
mitogenic signalling is abundant (Ye et al., 1999). The availability of 
additional markers, to discriminate between early TA keratinocytes and 
OKSCs, would allow more extensive characterisation of the target population 
of FOXM1B oncogenic insults.  
 
5.3.4 FOXM1B Overexpression Perturbs Normal Epithelial 
Differentiation 
In a functional differentiation 3D model of human epithelium, FOXM1B 
induced a hyperproliferative phenotype leading enhanced development of 
multiple proliferative spinous cell layers. As keratinocyte proliferation is a 
main characteristic of transit amplifying cells before undergoing permanent 
cell cycle arrest and commitment to terminal differentiation (Watt, 1998), 
excessive proliferation detected in the suprabasal layer is perceived to be 
pathological. It is therefore possible that FOXM1B-induced keratinocyte 
expansion may interfere with the normal keratinocyte differentiation program 
by rendering keratinocytes refractory to growth arrest and terminal 
differentiation.  
 
In this respect, the expansion of Cytokeratin 16 positive layers, as observed in 
FOXM1B organotypics, has been suggested to be a marker of suprabasal 
epithelial keratinocytes in a transient state, during which they maintain their 
proliferative capacity while being resilient to terminal differentiation (Bernot 
et al., 2002). The upregulation of cytokeratin 16, along with the inappropriate 
mitotic activity detected in the spinous layers of FOXM1B organotypics, 
suggest the presence of a defective or perturbed differentiation program within 
the progenitor TA cells that have acquired/inherited ectopic FOXM1B. This 
hypothesis is further supported by the complete inhibition of two terminal 
differentiation markers, cytokeratin 13 and filaggrin, in FOXM1B-derived 
organotypics. The mechanism behind this is yet unclear, since FOXM1B could 
be directly suppressing keratinocyte differentiation, or the latter could be a 
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result of sustained proliferation of progenitor (TA) keratinocytes. Both are 
equally possible, and require further investigation to fully understand the 
underlying mechanisms involved, since they can provide additional insight to 
the early oncogenic effects mediated by FOXM1B. 
 
In summary, it is demonstrated for the first time that FOXM1B is involved in 
epithelial stem cell expansion and that ectopic expression of FOXM1B in this 
population of cells resulted in hyper-proliferation and concomitant suppression 
of keratinocyte terminal differentiation. It is therefore proposed that aberrant 
upregulation of FOXM1B in oral keratinocyte stem cell cells may constitute 
an early event in OSCC development, which may explain why upregulation of 
FOXM1 precedes epithelial malignancy.  
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6 General Discussion  
The present study investigated the role of FOXM1, a cell-cycle dependent 
transcription factor, in human oral squamous cell carcinoma (OSCC). Despite 
the fact that FOXM1 is overexpressed in the majority of human malignancies 
(Pilarsky et al., 2004), its expression had not yet been investigated in the case 
of human oral SCCs. This study showed that FOXM1 is significantly 
upregulated at both protein and mRNA levels in early pre-malignant lesions of 
human oral mucosa, as well as in more advanced stages of oral cancer such as 
CIS, invasive malignancy and lymph node metastases. This expression pattern 
was also maintained in vitro, as observed from expression analysis of cultured 
neoplastic and pre-neoplastic human oral keratinocytes. In addition, it was 
demonstrated that neoplastic oral keratinocytes retain high levels of active, 
phosphorylated FOXM1 protein and consistently, they exhibit enhanced 
expression of established FOXM1 downstream target genes including 
CENPA, CENPF, CCNB1, and NEK2, which agrees with a FOXM1-
dependent expression signature. The fact that FOXM1 upregulation is evident 
in mildly dysplastic oral epithelia suggests a role for this gene in the early 
stages of epithelial carcinogenesis. This is also consistent with the fact that 
FOXM1 has been found to promote cellular proliferation in pre-neoplastic 
lesions of mouse liver epithelium (Kalinina et al., 2003). Hence, it is proposed 
that its expression might be a marker of heightened proliferation in such 
lesions. As many pre-malignant lesions of the oral mucosa do not progress to 
form SCCs later on, it is currently unknown whether the levels of FOXM1 
expression in such lesions show any correlation with an advanced risk for 
malignant transformation. Certainly, other studies have shown that FOXM1 
expression is an indicator of tumour stage and poor prognosis in other human 
tumours (Kalin et al., 2006; Liu et al., 2006; Chandran et al., 2007; Bektas et 
al., 2008; Chan et al., 2008; Martin et al., 2008; Yang et al., 2009), and as 
such, it would be very important to study the relationship between its 
expression in pre-neoplastic lesions and the incidence of tumour development 
in the oral epithelium since the failure in early diagnosis is one of the most 
important caveats in the management of OSCCs. 
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FOXM1 mRNA expression and protein transcriptional activation were found 
to be enhanced by exposing human oral epithelial keratinocytes to nicotine, 
which represents one of the main constituents of tobacco. Surprisingly, this 
response was present in both pre-malignant and normal human primary oral 
keratinocytes. It is known that the fate of oral epithelial pre-malignancies such 
as leukoplakias is largely dependent upon exposure to tobacco smoke. Taken 
together, these observations suggest that exposure of human oral epithelium to 
nicotine can activate the expression and transactivation ability of FOXM1, 
explaining its presence in oral pre-malignancies and SCCs. Given the fact that 
many leukoplakias regress after smoking cessation, it would be interesting to 
investigate the levels of FOXM1 expression in leukoplakias. By screening the 
expression patterns of candidate genes downstream of FOXM1, it was found 
that centrosome associated protein, CEP55, is a direct transcriptional target of 
FOXM1 and further that it is significantly overexpressed in pre-malignant and 
malignant oral keratinocytes in vitro. In addition, lymphoid-specific helicase 
(HELLS) was also found to be significantly upregulated in pre-malignant and 
OSCC derived keratinocytes, and together with CEP55 they represent novel 
targets whose expressions are regulated by FOXM1, and could therefore be 
useful markers in the pathogenesis of OSCC. 
 
The fact that early pre-malignant oral lesions display features of genetic 
aberrations, further implies that progression to OSCC is largely dependent 
upon oncogenic stimulation which is thought to initiate, and promote genomic 
instability (Negrini et al., 2010). Consistent with this hypothesis, thie present 
study shows that FOXM1B overexpression compromises the genomic 
integrity of primary human epidermal and oral keratinocytes. By allowing 
primary human epidermal keratinocytes to grow in the presence of ectopic 
FOXM1B protein levels, these cells were able to undergo sequential 
population expansions while accumulating genomic CNV consistent with a 
pattern of genomic instability. Following genotoxic stress (UVB), human 
N/TERT keratinocytes overexpressing FOXM1B showed gross genomic 
abnormalities mainly characterised by long stretches of contiguous copy 
number losses and/or gains leading to whole chromosome 7 amplification and 
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extensive LOH at chromosome 6. Since it was shown here that both the 
endogenous, as well as exogenous FOXM1B, are exclusively expressed at 
G2/M phase of human keratinocytes, it is proposed that the observed effects 
may result from the excessive accumulation of FOXM1B proteins at mitosis. 
FOXM1 is known to have multiple roles in mitotic progression, which is also 
evidenced by the fact that the list comprising it downstream targets includes 
many genes that regulate chromosome segregation, the assembly of the spindle 
checkpoint, chromosome alignment and attachment to kinetochores, all of 
which are important processes, and their deregulation can affect genomic 
stability (D'Assoro et al., 2002a; D'Assoro et al., 2002b; Gisselsson et al., 
2002; Lingle et al., 2002; Li et al., 2004b; Hu et al., 2005; Smith et al., 2005; 
Hayward and Fry, 2006). The fact that depletion of FOXM1 can lead to 
mitotic catastrophe, genomic instability and apoptosis, further highlights its 
critical importance in mitotic division. The finding that FOXM1B 
overexpression can cause genomic instability while being permissive for 
normal cell cycle is consistent with the fact that both FOXM1 and genomic 
instability occur in parallel in many human malignancies (Carter et al., 2006). 
 
The appearance of a human epithelial malignancy, such as OSCC, is the 
culmination of many years of development. Epithelial tumours are thought to 
arise from common pre-malignant progenitors, which are slowly subjected to 
cumulative genetic aberrations that ultimately lead to invasive malignancy. 
Owing to their self-renewal capacity, epithelial stem cells have been long 
proposed as being the hosts for initiating mutations (Morris, 2000). In this 
respect, this study examined the effect of FOXM1B overexpression in the 
immature basal epithelial stem cell population of the oral mucosa (OKSC), in 
the attempt to create an oncogenic ‘first hit’ in OKSC. It is shown that 
FOXM1 expression is normally kept at low levels in human OKSC both in 
vivo and in vitro. Consistent with the enhanced proliferation of TA 
keratinocytes, FOXM1 levels were increased upon keratinocyte population 
expansion, but were subsequently diminished upon terminal keratinocyte 
differentiation. Aiming to understand its potential role in tumour initiation, 
FOXM1B was ectopically expressed in human OKSCs. OKSCs 
overexpressing FOXM1B show enhanced population expansion in vitro, while 
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TA keratinocytes failed to show any responses to FOXM1B overexpression. In 
addition, FOXM1B overexpressing keratinocytes show abnormal patterns of 
proliferation and epithelial differentiation in organotypic 3D models of human 
oral musocal epithelium. The phenotype and the pattern of differentiation 
marker expression of FOXM1B organotypics was reminiscent of that observed 
in early hyperplastic lesions of oral mucosa, which are the earliest detectable 
alteration in the progression of OSCC. These results led to my subsequent 
proposal of a mechanistic model of how FOXM1 induce cancer formation. 
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6.1 A Model of Oncogenic Activity for FOXM1 
 
This study has provided several lines of evidence that support the notion that 
FOXM1 is a gene that can affect various biological processes relevant to 
human malignancy. By combining and translating the results that were 
obtained from in vivo observations and the manipulation of primary human 
epithelial keratinocytes in vitro, the deduction of a model for the oncogenic 
activity of FOXM1 is proposed. 
 
This study proposes that oral epithelial keratinocyte stem cells are a good 
candidate cell population to host a genetic hit resulting in the activation of 
FOXM1 expression. This event could be randomly introduced either through a 
stochastic somatic mutation that directly affects the transcriptional regulation 
or FOXM1 or, as proposed from in vitro observations, through the sustained 
exposure of oral mucosal keratinocytes to one of the main constituents of 
tobacco, nicotine. This fits well with the notion that epithelial stem cells are 
the main target population of carcinogens in exposed epithelium (Morris, 
2000). Exploiting the normal process of epithelial renewal, FOXM1 
overexpression is later established in the expanding population of epithelial 
keratinocytes, resulting in increased proliferation and subsequent suppression 
of epithelial differentiation. Since FOXM1 overexpression in primary human 
keratinocytes leads to the generation of genetically unstable progenies as 
shown herein, it is further suggested that epithelial population expansion 
occurs parallel to the acquisition of genetic aberrations.  
 
This proposed model is in keeping with the general consensus regarding oral 
epithelial carcinogenesis, suggesting that a common pre-malignant progenitor, 
in this case an oral epithelial stem cell overexpressing FOXM1B, undergoes 
rounds of clonal expansion due to an acquired deficiency in epithelial 
differentiation, leading to the propagation of genetically unstable progenies. 
Although this is a proposed model by which FOXM1 could possibly 
contribute or mediate the early transition from a normal to a potentially pre-
malignant clone, the conversion to invasive malignancy would further require 
sequential molecular and genetic alterations. The proposed model can further 
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provide a reasonable explanation for the observed upregulation of FOXM1 in 
pre-malignant as well as in invasive neoplastic keratinocytes both in vivo and 
in vitro. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: A model of oncogenic activity for FOXM1 
(A) An initiating mutation in oral epithelial stem cells can result in the clonal 
expansion of pre-malignant epithelial progenies due to acquired defect in epithelial 
differentiation. Aberrant activation of FOXM1 leads to the acquisistion of genomic 
instability which can potentially give rise to a pre-malignant ‘field’.Contrarily, a 
mutation targeted in more commited transit amplifying (TA) progenitor cells would 
be lost through the process of epithelial renewal. (B) Following further genetic hits 
which may result in the activation of oncogenes and/or suppression of tumour 
suppressor genes, can later enable the malignant conversion of epithelial 
keratinocytes, leading to invasive malignancy. 
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Appendix 1 
 
 
Digital pixel densitometry for FOXM1 protein immunoreactivity in a panel of 
25 oral tissues (n = 5 in each group) as shown in Chapter 3 Figure 3.1. 
**(P≤0.01) and ***(P≤0.001) indicate statistically significant elevation of 
FOXM1 protein levels when compared to NOM tissues. 
Appendix 
The Role of FOXM1 in Oral Squamous Cell Carcinoma                           
 223
Appendix 2 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) Linear regression analysis between FOXM1B and CEP55 expression in 
the panel of cell lines used in Figures 3.6 and 3.7. (B) Linear regression 
analysis between FOXM1B and HELLS expression in the panel of cell lines 
used in Figures 3.6 and 3.7. 
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Appendix 3 
  
 
Bioinformatics analysis of CEP55 gene expression level from a published microarray 
dataset (GEO accession: GDS1477) comparing BT-20 breast cancer cells expressing 
either mock, siGFP or siFOXM1 at 48 h post-transfection (Wonsey and Follettie, 
2005). 
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Appendix 4 
 
 
Oral keratinocytes sorted for p75NTR and Integrin β1 levels. After sorting 
each separate population as shown, cells were allowed to grow for 12 days in 
the presence of 3T3 feeders. Keratinocyte colonies were examined under 
bright field microscopy and were later stained with Rhodamine B for 
quantification of the clonogenic potential of each separate keratinocyte 
population 
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Appendix 5 
  
 
 
 
(A) Oral keratinocytes were sorted as described and were allowed to grow 5 
days prior to harvesting for total RNA. The levels of differentiation specific 
Cytokeratin 4 were measured by qRT-PCR. Bars represent the average fold 
difference from p75NTR- control samples (arbitrary value 1) ±S.E.M. of three 
replicate samples for each type. *P≤0.05. (B) NHOK were FACS sorted 
(PD~10) and were allowed to grow for 12 days (PD~17). Protein extracts were 
prepared from the p75NTR- fraction and were immunoblotted against anti-
FOXM1 and anti-Involucrin antibodies. 
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Appendix 6 
 
 
Early passage primary NOK were allowed to grow to 70% confluence prior to 
staining with anti-p75NTR-PE antibody. Stained keratinocytes were flow 
sorted into p75NTR+ or p75NTR- populations. Each population was 
retrovirally transduced with pSINMCS, pSINEGFP, or pSINEGFP-FOXM1B. 
Transduced clones were allowed to grow for another 48hours prior to being 
plated at very low densities. After another 12 days, keratinocytes were fixed, 
stained and approximately 100 colonies from each construct, and their relative 
areas (mm2) were measured 
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Appendix 7 
 
 
Transduced human keratinocytes were harvested either 72 hours, or 10 days 
after retroviral transduction. 10ng of genomic DNA (gDNA) were used for 
qRT-PCR analysis for the detection of EGFP transgene copy number (see also 
Chapter 2, section 3.5). 
 
